Index Sample Index Original Filename Sample Name Sample ID Sample Comment Sample Type Acquisition Date & Time Rack Number Plate Number Vial Number Dilution Factor Injection Volume Operator Name Acq. Method Name IS Component Name Component Index Component Comment IS Comment Mass Info IS Mass Info IS Name Component Group Name Conc. Units Failed Query IS Failed Query Peak Comment IS Peak Comment Actual Concentration IS Actual Concentration Concentration Ratio Expected RT IS Expected RT Integration Type IS Integration Type Area IS Area Corrected Area IS Corrected Area Area Ratio Height IS Height Corrected Height IS Corrected Height Height Ratio Area / Height IS Area / Height Corrected Area/Height IS Corrected Area/Height Region Height IS Region Height Quality IS Quality Retention Time IS Retention Time Start Time IS Start Time End Time IS End Time Total Width IS Total Width Width at 50% IS Width at 50% Signal / Noise IS Signal / Noise Baseline Delta / Height IS Baseline Delta / Height Modified Relative RT Used Calculated Concentration Accuracy SF Peak Width Confidence SF Model Source SF Candidate Model Quality SF Asymmetry SF Saturated SF Integration Quality SF Group Confidence SF Num Peaks Score_IMPAQT MSSimScore_IMPAQT HeightScore_IMPAQT RTminScore_IMPAQT RankScore_IMPAQT MSSim_IMPAQT MSSimSita_IMPAQT RTminDiff_IMPAQT RankSum_IMPAQT CosSimilarity_IMPAQT CosSimilaritySita_IMPAQT Height_IMPAQT InterfereTrans_IMPAQT InterfereTransAll_IMPAQT LScore_IMPAQT LRTminScore_IMPAQT LSNScore_IMPAQT LSNAllScore_IMPAQT HLSimScore_IMPAQT HLSim_IMPAQT HLSimSita_IMPAQT BaseLine_IMPAQT BaseLineUnitNum_IMPAQT BaseLineMaxCount_IMPAQT Symbol Description 1 1 C20140403_SF097_05 C20140403_SF097_05 TB480596.[MT7]-TSDAYLLFYELASPPSR.3b6_1.heavy 692.025 / 795.401 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 3 1 C20140403_SF097_05 C20140403_SF097_05 TB480596.[MT7]-TSDAYLLFYELASPPSR.3b4_1.heavy 692.025 / 519.253 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 5 1 C20140403_SF097_05 C20140403_SF097_05 TB480596.[MT7]-TSDAYLLFYELASPPSR.3b5_1.heavy 692.025 / 682.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 7 1 C20140403_SF097_05 C20140403_SF097_05 TB480596.[MT7]-TSDAYLLFYELASPPSR.3b7_1.heavy 692.025 / 908.485 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 9 2 C20140403_SF097_05 C20140403_SF097_05 TB480459.[MT7]-FLLDGLHNEVNR.3y6_1.heavy 524.287 / 768.375 1288.0 35.16769981384277 40 15 10 5 10 3.675153884027231 27.209744994519813 0.047801971435546875 3 0.9508467537602109 5.543589972219719 1288.0 16.011097643097642 0.0 - - - - - - - 212.14285714285714 2 7 USP2 ubiquitin specific peptidase 2 11 2 C20140403_SF097_05 C20140403_SF097_05 TB480459.[MT7]-FLLDGLHNEVNR.3y5_1.heavy 524.287 / 631.316 6537.0 35.16769981384277 40 15 10 5 10 3.675153884027231 27.209744994519813 0.047801971435546875 3 0.9508467537602109 5.543589972219719 6537.0 87.31407070707071 0.0 - - - - - - - 212.14285714285714 13 7 USP2 ubiquitin specific peptidase 2 13 2 C20140403_SF097_05 C20140403_SF097_05 TB480459.[MT7]-FLLDGLHNEVNR.3b4_1.heavy 524.287 / 633.373 891.0 35.16769981384277 40 15 10 5 10 3.675153884027231 27.209744994519813 0.047801971435546875 3 0.9508467537602109 5.543589972219719 891.0 5.199999999999999 1.0 - - - - - - - 0.0 1 0 USP2 ubiquitin specific peptidase 2 15 2 C20140403_SF097_05 C20140403_SF097_05 TB480459.[MT7]-FLLDGLHNEVNR.3b5_1.heavy 524.287 / 690.394 1882.0 35.16769981384277 40 15 10 5 10 3.675153884027231 27.209744994519813 0.047801971435546875 3 0.9508467537602109 5.543589972219719 1882.0 27.564646464646465 0.0 - - - - - - - 160.875 3 8 USP2 ubiquitin specific peptidase 2 17 3 C20140403_SF097_05 C20140403_SF097_05 TB148212.[MT7]-DVPDGPLLR.2y8_1.heavy 563.323 / 866.509 752.0 30.67990016937256 44 17 10 7 10 2.797115639058834 35.75111397026393 0.027799606323242188 3 0.9776115253753573 8.232590334047512 752.0 -0.3912845528455283 2.0 - - - - - - - 174.55555555555554 2 9 BCAR1 breast cancer anti-estrogen resistance 1 19 3 C20140403_SF097_05 C20140403_SF097_05 TB148212.[MT7]-DVPDGPLLR.2y5_1.heavy 563.323 / 555.361 5810.0 30.67990016937256 44 17 10 7 10 2.797115639058834 35.75111397026393 0.027799606323242188 3 0.9776115253753573 8.232590334047512 5810.0 99.57022955523672 0.0 - - - - - - - 165.92857142857142 11 14 BCAR1 breast cancer anti-estrogen resistance 1 21 3 C20140403_SF097_05 C20140403_SF097_05 TB148212.[MT7]-DVPDGPLLR.2b4_1.heavy 563.323 / 571.284 2187.0 30.67990016937256 44 17 10 7 10 2.797115639058834 35.75111397026393 0.027799606323242188 3 0.9776115253753573 8.232590334047512 2187.0 20.23860779775681 0.0 - - - - - - - 179.25 4 16 BCAR1 breast cancer anti-estrogen resistance 1 23 3 C20140403_SF097_05 C20140403_SF097_05 TB148212.[MT7]-DVPDGPLLR.2y7_1.heavy 563.323 / 767.441 3144.0 30.67990016937256 44 17 10 7 10 2.797115639058834 35.75111397026393 0.027799606323242188 3 0.9776115253753573 8.232590334047512 3144.0 46.20142210730447 0.0 - - - - - - - 110.15384615384616 6 13 BCAR1 breast cancer anti-estrogen resistance 1 25 4 C20140403_SF097_05 C20140403_SF097_05 TB148768.[MT7]-VEAELAASRPGSVAASVR.3y17_2.heavy 638.689 / 835.945 3801.0 28.675800323486328 43 13 10 10 10 1.6079476567543054 49.474477413093894 0.0 3 0.9221934148983724 4.3953880848160285 3801.0 58.47692307692307 0.0 - - - - - - - 115.66666666666667 7 9 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 27 4 C20140403_SF097_05 C20140403_SF097_05 TB148768.[MT7]-VEAELAASRPGSVAASVR.3b4_1.heavy 638.689 / 573.3 1823.0 28.675800323486328 43 13 10 10 10 1.6079476567543054 49.474477413093894 0.0 3 0.9221934148983724 4.3953880848160285 1823.0 8.933406198118428 0.0 - - - - - - - 149.58333333333334 3 24 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 29 4 C20140403_SF097_05 C20140403_SF097_05 TB148768.[MT7]-VEAELAASRPGSVAASVR.3y16_2.heavy 638.689 / 771.423 1406.0 28.675800323486328 43 13 10 10 10 1.6079476567543054 49.474477413093894 0.0 3 0.9221934148983724 4.3953880848160285 1406.0 8.663461538461538 1.0 - - - - - - - 135.2 2 15 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 31 4 C20140403_SF097_05 C20140403_SF097_05 TB148768.[MT7]-VEAELAASRPGSVAASVR.3y9_1.heavy 638.689 / 843.468 2343.0 28.675800323486328 43 13 10 10 10 1.6079476567543054 49.474477413093894 0.0 3 0.9221934148983724 4.3953880848160285 2343.0 25.532692307692308 0.0 - - - - - - - 116.07692307692308 4 13 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 33 5 C20140403_SF097_05 C20140403_SF097_05 TB346480.[MT7]-C[CAM]LLLGTDMAENQK[MT7].3y3_1.heavy 594.311 / 533.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 35 5 C20140403_SF097_05 C20140403_SF097_05 TB346480.[MT7]-C[CAM]LLLGTDMAENQK[MT7].3b4_1.heavy 594.311 / 644.392 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 37 5 C20140403_SF097_05 C20140403_SF097_05 TB346480.[MT7]-C[CAM]LLLGTDMAENQK[MT7].3b3_1.heavy 594.311 / 531.308 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 39 5 C20140403_SF097_05 C20140403_SF097_05 TB346480.[MT7]-C[CAM]LLLGTDMAENQK[MT7].3b7_1.heavy 594.311 / 917.488 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 41 6 C20140403_SF097_05 C20140403_SF097_05 TB480450.[MT7]-IQIPGIMNDEK[MT7].2y4_1.heavy 773.431 / 649.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 43 6 C20140403_SF097_05 C20140403_SF097_05 TB480450.[MT7]-IQIPGIMNDEK[MT7].2y8_1.heavy 773.431 / 1047.53 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 45 6 C20140403_SF097_05 C20140403_SF097_05 TB480450.[MT7]-IQIPGIMNDEK[MT7].2y5_1.heavy 773.431 / 780.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 47 6 C20140403_SF097_05 C20140403_SF097_05 TB480450.[MT7]-IQIPGIMNDEK[MT7].2y7_1.heavy 773.431 / 950.473 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 49 7 C20140403_SF097_05 C20140403_SF097_05 CH10_ECO24.SAGGIVLTGSAAAK.2y7.peptide 601.84 / 605.33 52247.0 25.800800323486328 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 52247.0 402.1473108613797 0.0 - - - - - - - 352.0 104 8 51 7 C20140403_SF097_05 C20140403_SF097_05 CH10_ECO24.SAGGIVLTGSAAAK.2y8.peptide 601.84 / 718.41 65180.0 25.800800323486328 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 65180.0 1031.3158064516128 0.0 - - - - - - - 749.7142857142857 130 7 53 7 C20140403_SF097_05 C20140403_SF097_05 CH10_ECO24.SAGGIVLTGSAAAK.2y9.peptide 601.84 / 817.48 58906.0 25.800800323486328 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 58906.0 70.076898402285 0.0 - - - - - - - 680.0 117 8 55 8 C20140403_SF097_05 C20140403_SF097_05 TB346301.[MT7]-VNIISVTNK[MT7].2y6_1.heavy 638.397 / 805.49 2159.0 30.502399444580078 46 16 10 10 10 2.756116663430168 29.054469263782988 0.0 3 0.9677686990907365 6.855671633198491 2159.0 30.978430141287284 0.0 - - - - - - - 153.76470588235293 4 17 EIF2A eukaryotic translation initiation factor 2A, 65kDa 57 8 C20140403_SF097_05 C20140403_SF097_05 TB346301.[MT7]-VNIISVTNK[MT7].2y8_1.heavy 638.397 / 1032.62 2159.0 30.502399444580078 46 16 10 10 10 2.756116663430168 29.054469263782988 0.0 3 0.9677686990907365 6.855671633198491 2159.0 45.88033470346448 0.0 - - - - - - - 99.82352941176471 4 17 EIF2A eukaryotic translation initiation factor 2A, 65kDa 59 8 C20140403_SF097_05 C20140403_SF097_05 TB346301.[MT7]-VNIISVTNK[MT7].2y5_1.heavy 638.397 / 692.406 2748.0 30.502399444580078 46 16 10 10 10 2.756116663430168 29.054469263782988 0.0 3 0.9677686990907365 6.855671633198491 2748.0 55.94509544740973 0.0 - - - - - - - 179.75 5 8 EIF2A eukaryotic translation initiation factor 2A, 65kDa 61 8 C20140403_SF097_05 C20140403_SF097_05 TB346301.[MT7]-VNIISVTNK[MT7].2y3_1.heavy 638.397 / 506.306 2225.0 30.502399444580078 46 16 10 10 10 2.756116663430168 29.054469263782988 0.0 3 0.9677686990907365 6.855671633198491 2225.0 11.803345191287525 0.0 - - - - - - - 142.9375 4 16 EIF2A eukaryotic translation initiation factor 2A, 65kDa 63 9 C20140403_SF097_05 C20140403_SF097_05 TB148357.[MT7]-VNIISVTNK[MT7].3y3_1.heavy 425.934 / 506.306 89872.0 30.523625373840332 47 20 10 7 10 8.169193905655053 12.241109851827103 0.028301239013671875 3 0.9933568719610143 15.133359255672627 89872.0 88.32286131545372 0.0 - - - - - - - 774.0 179 7 EIF2A eukaryotic translation initiation factor 2A, 65kDa 65 9 C20140403_SF097_05 C20140403_SF097_05 TB148357.[MT7]-VNIISVTNK[MT7].3b4_1.heavy 425.934 / 584.389 17528.0 30.523625373840332 47 20 10 7 10 8.169193905655053 12.241109851827103 0.028301239013671875 3 0.9933568719610143 15.133359255672627 17528.0 29.168391000717932 0.0 - - - - - - - 669.2 35 10 EIF2A eukaryotic translation initiation factor 2A, 65kDa 67 9 C20140403_SF097_05 C20140403_SF097_05 TB148357.[MT7]-VNIISVTNK[MT7].3b3_1.heavy 425.934 / 471.305 106635.0 30.523625373840332 47 20 10 7 10 8.169193905655053 12.241109851827103 0.028301239013671875 3 0.9933568719610143 15.133359255672627 106635.0 103.86199905673901 0.0 - - - - - - - 669.5 213 8 EIF2A eukaryotic translation initiation factor 2A, 65kDa 69 9 C20140403_SF097_05 C20140403_SF097_05 TB148357.[MT7]-VNIISVTNK[MT7].3y5_1.heavy 425.934 / 692.406 30722.0 30.523625373840332 47 20 10 7 10 8.169193905655053 12.241109851827103 0.028301239013671875 3 0.9933568719610143 15.133359255672627 30722.0 270.5701774738973 0.0 - - - - - - - 168.95 61 20 EIF2A eukaryotic translation initiation factor 2A, 65kDa 71 10 C20140403_SF097_05 C20140403_SF097_05 TB480147.[MT7]-RDNTEAR.2y5_1.heavy 503.263 / 590.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 73 10 C20140403_SF097_05 C20140403_SF097_05 TB480147.[MT7]-RDNTEAR.2b6_1.heavy 503.263 / 831.408 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 75 10 C20140403_SF097_05 C20140403_SF097_05 TB480147.[MT7]-RDNTEAR.2y6_1.heavy 503.263 / 705.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 77 10 C20140403_SF097_05 C20140403_SF097_05 TB480147.[MT7]-RDNTEAR.2b5_1.heavy 503.263 / 760.371 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 79 11 C20140403_SF097_05 C20140403_SF097_05 TB148861.[MT7]-YGSSLEFTELLTLVNRK[MT7].3y7_1.heavy 753.426 / 987.643 7775.0 46.61009979248047 44 14 10 10 10 1.2507502725254578 53.30134090801066 0.0 3 0.9353405689335951 4.827008707682416 7775.0 50.95185350936079 0.0 - - - - - - - 184.25 15 20 CASP6 caspase 6, apoptosis-related cysteine peptidase 81 11 C20140403_SF097_05 C20140403_SF097_05 TB148861.[MT7]-YGSSLEFTELLTLVNRK[MT7].3y6_1.heavy 753.426 / 874.559 7407.0 46.61009979248047 44 14 10 10 10 1.2507502725254578 53.30134090801066 0.0 3 0.9353405689335951 4.827008707682416 7407.0 90.63036585365853 0.0 - - - - - - - 171.66666666666666 14 21 CASP6 caspase 6, apoptosis-related cysteine peptidase 83 11 C20140403_SF097_05 C20140403_SF097_05 TB148861.[MT7]-YGSSLEFTELLTLVNRK[MT7].3b6_1.heavy 753.426 / 781.385 5402.0 46.61009979248047 44 14 10 10 10 1.2507502725254578 53.30134090801066 0.0 3 0.9353405689335951 4.827008707682416 5402.0 24.309625707383262 0.0 - - - - - - - 131.15 10 20 CASP6 caspase 6, apoptosis-related cysteine peptidase 85 11 C20140403_SF097_05 C20140403_SF097_05 TB148861.[MT7]-YGSSLEFTELLTLVNRK[MT7].3b4_1.heavy 753.426 / 539.258 2701.0 46.61009979248047 44 14 10 10 10 1.2507502725254578 53.30134090801066 0.0 3 0.9353405689335951 4.827008707682416 2701.0 10.198708602674223 0.0 - - - - - - - 272.2608695652174 5 23 CASP6 caspase 6, apoptosis-related cysteine peptidase 87 12 C20140403_SF097_05 C20140403_SF097_05 TB480506.[MT7]-ATAVLVIASTDVDK[MT7].3b6_1.heavy 564.332 / 699.452 1817.0 36.67084884643555 41 15 10 6 10 3.2519400962685103 30.750873952059134 0.0363006591796875 3 0.9533832887601569 5.693637749045769 1817.0 17.178685191460524 0.0 - - - - - - - 285.42857142857144 3 7 EIF2A eukaryotic translation initiation factor 2A, 65kDa 89 12 C20140403_SF097_05 C20140403_SF097_05 TB480506.[MT7]-ATAVLVIASTDVDK[MT7].3y3_1.heavy 564.332 / 505.31 1181.0 36.67084884643555 41 15 10 6 10 3.2519400962685103 30.750873952059134 0.0363006591796875 3 0.9533832887601569 5.693637749045769 1181.0 12.199340659340658 0.0 - - - - - - - 163.6 2 10 EIF2A eukaryotic translation initiation factor 2A, 65kDa 91 12 C20140403_SF097_05 C20140403_SF097_05 TB480506.[MT7]-ATAVLVIASTDVDK[MT7].3b5_1.heavy 564.332 / 600.384 2634.0 36.67084884643555 41 15 10 6 10 3.2519400962685103 30.750873952059134 0.0363006591796875 3 0.9533832887601569 5.693637749045769 2634.0 31.56207065661611 0.0 - - - - - - - 258.3076923076923 5 13 EIF2A eukaryotic translation initiation factor 2A, 65kDa 93 12 C20140403_SF097_05 C20140403_SF097_05 TB480506.[MT7]-ATAVLVIASTDVDK[MT7].3y4_1.heavy 564.332 / 620.337 817.0 36.67084884643555 41 15 10 6 10 3.2519400962685103 30.750873952059134 0.0363006591796875 3 0.9533832887601569 5.693637749045769 817.0 0.9002754820936639 0.0 - - - - - - - 0.0 1 0 EIF2A eukaryotic translation initiation factor 2A, 65kDa 95 13 C20140403_SF097_05 C20140403_SF097_05 TB148867.[MT7]-VRFPNLFPPLK[MT7]PETVAR.4y9_2.heavy 568.091 / 577.854 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 97 13 C20140403_SF097_05 C20140403_SF097_05 TB148867.[MT7]-VRFPNLFPPLK[MT7]PETVAR.4y10_2.heavy 568.091 / 626.381 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 99 13 C20140403_SF097_05 C20140403_SF097_05 TB148867.[MT7]-VRFPNLFPPLK[MT7]PETVAR.4y6_1.heavy 568.091 / 672.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 101 13 C20140403_SF097_05 C20140403_SF097_05 TB148867.[MT7]-VRFPNLFPPLK[MT7]PETVAR.4b6_1.heavy 568.091 / 871.527 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 103 14 C20140403_SF097_05 C20140403_SF097_05 TB148662.[MT7]-VYTVNNVNVITK[MT7].3y3_1.heavy 551.326 / 505.347 4034.0 31.0100998878479 40 14 10 6 10 3.3565000175706206 29.79293891747939 0.03560066223144531 3 0.9354694256974295 4.831878816126537 4034.0 22.245458945168565 0.0 - - - - - - - 197.33333333333334 8 18 ANKRD13A ankyrin repeat domain 13A 105 14 C20140403_SF097_05 C20140403_SF097_05 TB148662.[MT7]-VYTVNNVNVITK[MT7].3b6_1.heavy 551.326 / 835.443 1461.0 31.0100998878479 40 14 10 6 10 3.3565000175706206 29.79293891747939 0.03560066223144531 3 0.9354694256974295 4.831878816126537 1461.0 30.647215313463512 0.0 - - - - - - - 147.0 2 9 ANKRD13A ankyrin repeat domain 13A 107 14 C20140403_SF097_05 C20140403_SF097_05 TB148662.[MT7]-VYTVNNVNVITK[MT7].3b5_1.heavy 551.326 / 721.4 1878.0 31.0100998878479 40 14 10 6 10 3.3565000175706206 29.79293891747939 0.03560066223144531 3 0.9354694256974295 4.831878816126537 1878.0 34.43321685508736 0.0 - - - - - - - 121.91666666666667 3 12 ANKRD13A ankyrin repeat domain 13A 109 14 C20140403_SF097_05 C20140403_SF097_05 TB148662.[MT7]-VYTVNNVNVITK[MT7].3b3_1.heavy 551.326 / 508.289 974.0 31.0100998878479 40 14 10 6 10 3.3565000175706206 29.79293891747939 0.03560066223144531 3 0.9354694256974295 4.831878816126537 974.0 12.0768010936432 0.0 - - - - - - - 0.0 1 0 ANKRD13A ankyrin repeat domain 13A 111 15 C20140403_SF097_05 C20140403_SF097_05 TB148415.[MT7]-FSDLGFEVK[MT7].2y6_1.heavy 665.368 / 836.5 1605.0 36.909125328063965 37 13 10 6 8 1.0622972786908327 58.04538233966237 0.035701751708984375 4 0.9064619745910045 4.003348706691775 1605.0 32.50125 1.0 - - - - - - - 160.22222222222223 5 9 CASP6 caspase 6, apoptosis-related cysteine peptidase 113 15 C20140403_SF097_05 C20140403_SF097_05 TB148415.[MT7]-FSDLGFEVK[MT7].2y8_1.heavy 665.368 / 1038.56 2327.0 36.909125328063965 37 13 10 6 8 1.0622972786908327 58.04538233966237 0.035701751708984375 4 0.9064619745910045 4.003348706691775 2327.0 19.739670643153524 0.0 - - - - - - - 167.45454545454547 4 11 CASP6 caspase 6, apoptosis-related cysteine peptidase 115 15 C20140403_SF097_05 C20140403_SF097_05 TB148415.[MT7]-FSDLGFEVK[MT7].2y5_1.heavy 665.368 / 723.416 963.0 36.909125328063965 37 13 10 6 8 1.0622972786908327 58.04538233966237 0.035701751708984375 4 0.9064619745910045 4.003348706691775 963.0 -0.5 1.0 - - - - - - - 0.0 1 0 CASP6 caspase 6, apoptosis-related cysteine peptidase 117 15 C20140403_SF097_05 C20140403_SF097_05 TB148415.[MT7]-FSDLGFEVK[MT7].2y3_1.heavy 665.368 / 519.326 642.0 36.909125328063965 37 13 10 6 8 1.0622972786908327 58.04538233966237 0.035701751708984375 4 0.9064619745910045 4.003348706691775 642.0 3.461236514522821 3.0 - - - - - - - 207.25 4 12 CASP6 caspase 6, apoptosis-related cysteine peptidase 119 16 C20140403_SF097_05 C20140403_SF097_05 TB148660.[MT7]-WEFTSWVPLVSR.3b4_1.heavy 550.964 / 708.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 121 16 C20140403_SF097_05 C20140403_SF097_05 TB148660.[MT7]-WEFTSWVPLVSR.3b5_1.heavy 550.964 / 795.379 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 123 16 C20140403_SF097_05 C20140403_SF097_05 TB148660.[MT7]-WEFTSWVPLVSR.3b3_1.heavy 550.964 / 607.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 125 16 C20140403_SF097_05 C20140403_SF097_05 TB148660.[MT7]-WEFTSWVPLVSR.3y5_1.heavy 550.964 / 571.356 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 127 17 C20140403_SF097_05 C20140403_SF097_05 TB480502.[MT7]-LTSPVINTSLDTK[MT7].3y3_1.heavy 559.661 / 507.289 2448.0 32.71889877319336 48 18 10 10 10 4.39280552431081 22.76449513791965 0.0 3 0.9802079969340427 8.757871831017622 2448.0 9.951144895070811 0.0 - - - - - - - 251.13333333333333 4 15 ANKRD13A ankyrin repeat domain 13A 129 17 C20140403_SF097_05 C20140403_SF097_05 TB480502.[MT7]-LTSPVINTSLDTK[MT7].3b6_1.heavy 559.661 / 755.478 753.0 32.71889877319336 48 18 10 10 10 4.39280552431081 22.76449513791965 0.0 3 0.9802079969340427 8.757871831017622 753.0 6.408510638297873 0.0 - - - - - - - 0.0 1 0 ANKRD13A ankyrin repeat domain 13A 131 17 C20140403_SF097_05 C20140403_SF097_05 TB480502.[MT7]-LTSPVINTSLDTK[MT7].3b5_1.heavy 559.661 / 642.394 3014.0 32.71889877319336 48 18 10 10 10 4.39280552431081 22.76449513791965 0.0 3 0.9802079969340427 8.757871831017622 3014.0 25.645388815665598 0.0 - - - - - - - 188.2 6 5 ANKRD13A ankyrin repeat domain 13A 133 17 C20140403_SF097_05 C20140403_SF097_05 TB480502.[MT7]-LTSPVINTSLDTK[MT7].3y4_1.heavy 559.661 / 620.374 848.0 32.71889877319336 48 18 10 10 10 4.39280552431081 22.76449513791965 0.0 3 0.9802079969340427 8.757871831017622 848.0 9.559488638930297 1.0 - - - - - - - 0.0 1 0 ANKRD13A ankyrin repeat domain 13A 135 18 C20140403_SF097_05 C20140403_SF097_05 TB148418.[MT7]-NK[MT7]PITNSK[MT7].3y3_1.heavy 445.277 / 492.29 4770.0 14.816499710083008 31 13 0 10 8 1.6041784988095271 43.879018120746586 0.0 4 0.9195857279589014 4.322565977656068 4770.0 10.895351335864195 0.0 - - - - - - - 180.45454545454547 9 22 EIF2A eukaryotic translation initiation factor 2A, 65kDa 137 18 C20140403_SF097_05 C20140403_SF097_05 TB148418.[MT7]-NK[MT7]PITNSK[MT7].3y6_1.heavy 445.277 / 803.474 2261.0 14.816499710083008 31 13 0 10 8 1.6041784988095271 43.879018120746586 0.0 4 0.9195857279589014 4.322565977656068 2261.0 27.29049288061336 0.0 - - - - - - - 81.125 4 16 EIF2A eukaryotic translation initiation factor 2A, 65kDa 139 18 C20140403_SF097_05 C20140403_SF097_05 TB148418.[MT7]-NK[MT7]PITNSK[MT7].3y4_1.heavy 445.277 / 593.338 5404.0 14.816499710083008 31 13 0 10 8 1.6041784988095271 43.879018120746586 0.0 4 0.9195857279589014 4.322565977656068 5404.0 10.148777220818317 0.0 - - - - - - - 122.0952380952381 10 21 EIF2A eukaryotic translation initiation factor 2A, 65kDa 141 18 C20140403_SF097_05 C20140403_SF097_05 TB148418.[MT7]-NK[MT7]PITNSK[MT7].3b4_2.heavy 445.277 / 371.247 6038.0 14.816499710083008 31 13 0 10 8 1.6041784988095271 43.879018120746586 0.0 4 0.9195857279589014 4.322565977656068 6038.0 6.546671420992168 1.0 - - - - - - - 709.2727272727273 99 11 EIF2A eukaryotic translation initiation factor 2A, 65kDa 143 19 C20140403_SF097_05 C20140403_SF097_05 TB148419.[MT7]-GGSGATLEDLDR.2y4_1.heavy 667.837 / 518.257 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 145 19 C20140403_SF097_05 C20140403_SF097_05 TB148419.[MT7]-GGSGATLEDLDR.2b6_1.heavy 667.837 / 575.291 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 147 19 C20140403_SF097_05 C20140403_SF097_05 TB148419.[MT7]-GGSGATLEDLDR.2y11_1.heavy 667.837 / 1133.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 149 19 C20140403_SF097_05 C20140403_SF097_05 TB148419.[MT7]-GGSGATLEDLDR.2y7_1.heavy 667.837 / 861.431 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 151 20 C20140403_SF097_05 C20140403_SF097_05 TB148216.[MT7]-YFAQALK[MT7].3y3_1.heavy 376.893 / 475.336 27439.0 31.63385009765625 33 7 10 6 10 0.6050645495715606 92.18908319425003 0.037899017333984375 3 0.7274442535232953 2.3080063313424435 27439.0 55.30775653141515 0.0 - - - - - - - 178.33333333333334 54 12 TTC35 tetratricopeptide repeat domain 35 153 20 C20140403_SF097_05 C20140403_SF097_05 TB148216.[MT7]-YFAQALK[MT7].3b4_1.heavy 376.893 / 654.337 7004.0 31.63385009765625 33 7 10 6 10 0.6050645495715606 92.18908319425003 0.037899017333984375 3 0.7274442535232953 2.3080063313424435 7004.0 124.45171027346638 0.0 - - - - - - - 140.0 14 10 TTC35 tetratricopeptide repeat domain 35 155 20 C20140403_SF097_05 C20140403_SF097_05 TB148216.[MT7]-YFAQALK[MT7].3b5_1.heavy 376.893 / 725.374 2225.0 31.63385009765625 33 7 10 6 10 0.6050645495715606 92.18908319425003 0.037899017333984375 3 0.7274442535232953 2.3080063313424435 2225.0 38.61172579453067 0.0 - - - - - - - 164.8 4 5 TTC35 tetratricopeptide repeat domain 35 157 20 C20140403_SF097_05 C20140403_SF097_05 TB148216.[MT7]-YFAQALK[MT7].3b3_1.heavy 376.893 / 526.278 5603.0 31.63385009765625 33 7 10 6 10 0.6050645495715606 92.18908319425003 0.037899017333984375 3 0.7274442535232953 2.3080063313424435 5603.0 75.07937176644495 0.0 - - - - - - - 117.57142857142857 11 7 TTC35 tetratricopeptide repeat domain 35 159 21 C20140403_SF097_05 C20140403_SF097_05 TB148161.[MT7]-ETWLFSR.2b3_1.heavy 541.791 / 561.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100509010;HS6ST3;HS6ST2;HS6ST1 heparan-sulfate 6-O-sulfotransferase 3-like;heparan sulfate 6-O-sulfotransferase 3;heparan sulfate 6-O-sulfotransferase 2;heparan sulfate 6-O-sulfotransferase 1 161 21 C20140403_SF097_05 C20140403_SF097_05 TB148161.[MT7]-ETWLFSR.2y5_1.heavy 541.791 / 708.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100509010;HS6ST3;HS6ST2;HS6ST1 heparan-sulfate 6-O-sulfotransferase 3-like;heparan sulfate 6-O-sulfotransferase 3;heparan sulfate 6-O-sulfotransferase 2;heparan sulfate 6-O-sulfotransferase 1 163 21 C20140403_SF097_05 C20140403_SF097_05 TB148161.[MT7]-ETWLFSR.2b4_1.heavy 541.791 / 674.363 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100509010;HS6ST3;HS6ST2;HS6ST1 heparan-sulfate 6-O-sulfotransferase 3-like;heparan sulfate 6-O-sulfotransferase 3;heparan sulfate 6-O-sulfotransferase 2;heparan sulfate 6-O-sulfotransferase 1 165 21 C20140403_SF097_05 C20140403_SF097_05 TB148161.[MT7]-ETWLFSR.2y6_1.heavy 541.791 / 809.43 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100509010;HS6ST3;HS6ST2;HS6ST1 heparan-sulfate 6-O-sulfotransferase 3-like;heparan sulfate 6-O-sulfotransferase 3;heparan sulfate 6-O-sulfotransferase 2;heparan sulfate 6-O-sulfotransferase 1 167 22 C20140403_SF097_05 C20140403_SF097_05 TB148760.[MT7]-DGTAGIPNLQLYDVK[MT7].3b6_1.heavy 631.35 / 659.348 2157.0 37.58679962158203 39 9 10 10 10 0.6793447241960626 90.60291897923031 0.0 3 0.8147256678925622 2.8216899815884835 2157.0 31.46667633410673 0.0 - - - - - - - 122.3 4 10 EIF2A eukaryotic translation initiation factor 2A, 65kDa 169 22 C20140403_SF097_05 C20140403_SF097_05 TB148760.[MT7]-DGTAGIPNLQLYDVK[MT7].3y3_1.heavy 631.35 / 505.31 719.0 37.58679962158203 39 9 10 10 10 0.6793447241960626 90.60291897923031 0.0 3 0.8147256678925622 2.8216899815884835 719.0 2.2189623995159478 2.0 - - - - - - - 0.0 1 0 EIF2A eukaryotic translation initiation factor 2A, 65kDa 171 22 C20140403_SF097_05 C20140403_SF097_05 TB148760.[MT7]-DGTAGIPNLQLYDVK[MT7].3b5_1.heavy 631.35 / 546.264 1294.0 37.58679962158203 39 9 10 10 10 0.6793447241960626 90.60291897923031 0.0 3 0.8147256678925622 2.8216899815884835 1294.0 20.937638888888884 0.0 - - - - - - - 160.46153846153845 2 13 EIF2A eukaryotic translation initiation factor 2A, 65kDa 173 22 C20140403_SF097_05 C20140403_SF097_05 TB148760.[MT7]-DGTAGIPNLQLYDVK[MT7].3y4_1.heavy 631.35 / 668.374 1869.0 37.58679962158203 39 9 10 10 10 0.6793447241960626 90.60291897923031 0.0 3 0.8147256678925622 2.8216899815884835 1869.0 30.760624999999997 0.0 - - - - - - - 192.0 3 6 EIF2A eukaryotic translation initiation factor 2A, 65kDa 175 23 C20140403_SF097_05 C20140403_SF097_05 TB148543.[MT7]-DLAHQFTQVQR.3y6_1.heavy 496.268 / 778.421 15149.0 26.54199981689453 44 18 10 6 10 3.2511134617195254 30.75869273018532 0.039798736572265625 3 0.98020911472322 8.758119971600955 15149.0 171.33118518047792 0.0 - - - - - - - 185.75 30 16 CD38 CD38 molecule 177 23 C20140403_SF097_05 C20140403_SF097_05 TB148543.[MT7]-DLAHQFTQVQR.3b4_1.heavy 496.268 / 581.316 12568.0 26.54199981689453 44 18 10 6 10 3.2511134617195254 30.75869273018532 0.039798736572265625 3 0.98020911472322 8.758119971600955 12568.0 23.975220592698427 0.0 - - - - - - - 257.4117647058824 25 17 CD38 CD38 molecule 179 23 C20140403_SF097_05 C20140403_SF097_05 TB148543.[MT7]-DLAHQFTQVQR.3y4_1.heavy 496.268 / 530.305 11110.0 26.54199981689453 44 18 10 6 10 3.2511134617195254 30.75869273018532 0.039798736572265625 3 0.98020911472322 8.758119971600955 11110.0 41.69083969465649 0.0 - - - - - - - 257.52941176470586 22 17 CD38 CD38 molecule 181 23 C20140403_SF097_05 C20140403_SF097_05 TB148543.[MT7]-DLAHQFTQVQR.3y5_1.heavy 496.268 / 631.352 25866.0 26.54199981689453 44 18 10 6 10 3.2511134617195254 30.75869273018532 0.039798736572265625 3 0.98020911472322 8.758119971600955 25866.0 229.48088617265088 0.0 - - - - - - - 196.21428571428572 51 14 CD38 CD38 molecule 183 24 C20140403_SF097_05 C20140403_SF097_05 TB346625.[MT7]-YDVPSNAELWQVSWQPFLDGIFPAK[MT7].4b8_1.heavy 799.665 / 1020.48 8268.0 53.77470016479492 38 8 10 10 10 2.621191596749452 30.532046130084584 0.0 3 0.7777110588479252 2.567491470558493 8268.0 64.11389915440026 0.0 - - - - - - - 94.67857142857143 16 28 EIF2A eukaryotic translation initiation factor 2A, 65kDa 185 24 C20140403_SF097_05 C20140403_SF097_05 TB346625.[MT7]-YDVPSNAELWQVSWQPFLDGIFPAK[MT7].4y4_1.heavy 799.665 / 606.373 6640.0 53.77470016479492 38 8 10 10 10 2.621191596749452 30.532046130084584 0.0 3 0.7777110588479252 2.567491470558493 6640.0 62.37238072404699 0.0 - - - - - - - 132.3793103448276 13 29 EIF2A eukaryotic translation initiation factor 2A, 65kDa 187 24 C20140403_SF097_05 C20140403_SF097_05 TB346625.[MT7]-YDVPSNAELWQVSWQPFLDGIFPAK[MT7].4b9_1.heavy 799.665 / 1133.56 7570.0 53.77470016479492 38 8 10 10 10 2.621191596749452 30.532046130084584 0.0 3 0.7777110588479252 2.567491470558493 7570.0 78.22614015572859 0.0 - - - - - - - 155.9655172413793 15 29 EIF2A eukaryotic translation initiation factor 2A, 65kDa 189 24 C20140403_SF097_05 C20140403_SF097_05 TB346625.[MT7]-YDVPSNAELWQVSWQPFLDGIFPAK[MT7].4b3_1.heavy 799.665 / 522.268 5684.0 53.77470016479492 38 8 10 10 10 2.621191596749452 30.532046130084584 0.0 3 0.7777110588479252 2.567491470558493 5684.0 156.05125232255668 0.0 - - - - - - - 145.85714285714286 11 28 EIF2A eukaryotic translation initiation factor 2A, 65kDa 191 25 C20140403_SF097_05 C20140403_SF097_05 TB148542.[MT7]-DLAHQFTQVQR.2y8_1.heavy 743.898 / 1043.54 7821.0 26.551949501037598 34 16 2 6 10 3.4602299838838815 28.899813152811465 0.039798736572265625 3 0.9662172551151113 6.695524768630742 7821.0 66.5969228264409 0.0 - - - - - - - 227.88888888888889 15 18 CD38 CD38 molecule 193 25 C20140403_SF097_05 C20140403_SF097_05 TB148542.[MT7]-DLAHQFTQVQR.2y9_1.heavy 743.898 / 1114.58 1886.0 26.551949501037598 34 16 2 6 10 3.4602299838838815 28.899813152811465 0.039798736572265625 3 0.9662172551151113 6.695524768630742 1886.0 10.212996389891696 2.0 - - - - - - - 147.73333333333332 37 15 CD38 CD38 molecule 195 25 C20140403_SF097_05 C20140403_SF097_05 TB148542.[MT7]-DLAHQFTQVQR.2y6_1.heavy 743.898 / 778.421 3106.0 26.551949501037598 34 16 2 6 10 3.4602299838838815 28.899813152811465 0.039798736572265625 3 0.9662172551151113 6.695524768630742 3106.0 34.34704005210029 0.0 - - - - - - - 153.46153846153845 6 13 CD38 CD38 molecule 197 25 C20140403_SF097_05 C20140403_SF097_05 TB148542.[MT7]-DLAHQFTQVQR.2y7_1.heavy 743.898 / 906.479 4604.0 26.551949501037598 34 16 2 6 10 3.4602299838838815 28.899813152811465 0.039798736572265625 3 0.9662172551151113 6.695524768630742 4604.0 105.5894370208105 0.0 - - - - - - - 117.5625 9 16 CD38 CD38 molecule 199 26 C20140403_SF097_05 C20140403_SF097_05 TB148203.[MT7]-WREENSR.2b3_1.heavy 560.784 / 616.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 201 26 C20140403_SF097_05 C20140403_SF097_05 TB148203.[MT7]-WREENSR.2y5_1.heavy 560.784 / 634.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 203 26 C20140403_SF097_05 C20140403_SF097_05 TB148203.[MT7]-WREENSR.2b4_1.heavy 560.784 / 745.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 205 26 C20140403_SF097_05 C20140403_SF097_05 TB148203.[MT7]-WREENSR.2b5_1.heavy 560.784 / 859.418 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 207 27 C20140403_SF097_05 C20140403_SF097_05 TB147949.[MT7]-NIAFER.2y4_1.heavy 447.252 / 522.267 35766.0 25.073699951171875 50 20 10 10 10 21.333593659975538 4.687442800019782 0.0 3 0.9905004148905141 12.652188362087779 35766.0 75.4023757536533 0.0 - - - - - - - 772.7142857142857 71 7 ANKRD13A ankyrin repeat domain 13A 209 27 C20140403_SF097_05 C20140403_SF097_05 TB147949.[MT7]-NIAFER.2y5_1.heavy 447.252 / 635.351 42663.0 25.073699951171875 50 20 10 10 10 21.333593659975538 4.687442800019782 0.0 3 0.9905004148905141 12.652188362087779 42663.0 51.949680544466204 0.0 - - - - - - - 304.125 85 8 ANKRD13A ankyrin repeat domain 13A 211 27 C20140403_SF097_05 C20140403_SF097_05 TB147949.[MT7]-NIAFER.2b4_1.heavy 447.252 / 590.342 12778.0 25.073699951171875 50 20 10 10 10 21.333593659975538 4.687442800019782 0.0 3 0.9905004148905141 12.652188362087779 12778.0 37.10335643101837 0.0 - - - - - - - 685.7142857142857 25 7 ANKRD13A ankyrin repeat domain 13A 213 27 C20140403_SF097_05 C20140403_SF097_05 TB147949.[MT7]-NIAFER.2b5_1.heavy 447.252 / 719.385 12778.0 25.073699951171875 50 20 10 10 10 21.333593659975538 4.687442800019782 0.0 3 0.9905004148905141 12.652188362087779 12778.0 84.34738916256157 0.0 - - - - - - - 213.52631578947367 25 19 ANKRD13A ankyrin repeat domain 13A 215 28 C20140403_SF097_05 C20140403_SF097_05 TB480137.[MT7]-YLSEWR.2y4_1.heavy 499.265 / 577.273 2612.0 32.67625141143799 27 13 2 6 6 1.198146625403606 55.374411987913774 0.034999847412109375 5 0.900499065622793 3.879539510027051 2612.0 8.634680773649944 1.0 - - - - - - - 244.75 11 16 HS6ST2;HS6ST1 heparan sulfate 6-O-sulfotransferase 2;heparan sulfate 6-O-sulfotransferase 1 217 28 C20140403_SF097_05 C20140403_SF097_05 TB480137.[MT7]-YLSEWR.2b3_1.heavy 499.265 / 508.289 746.0 32.67625141143799 27 13 2 6 6 1.198146625403606 55.374411987913774 0.034999847412109375 5 0.900499065622793 3.879539510027051 746.0 0.30000000000000004 4.0 - - - - - - - 0.0 1 0 HS6ST2;HS6ST1 heparan sulfate 6-O-sulfotransferase 2;heparan sulfate 6-O-sulfotransferase 1 219 28 C20140403_SF097_05 C20140403_SF097_05 TB480137.[MT7]-YLSEWR.2y5_1.heavy 499.265 / 690.357 1866.0 32.67625141143799 27 13 2 6 6 1.198146625403606 55.374411987913774 0.034999847412109375 5 0.900499065622793 3.879539510027051 1866.0 3.001876675603217 1.0 - - - - - - - 233.25 3 12 HS6ST2;HS6ST1 heparan sulfate 6-O-sulfotransferase 2;heparan sulfate 6-O-sulfotransferase 1 221 28 C20140403_SF097_05 C20140403_SF097_05 TB480137.[MT7]-YLSEWR.2b4_1.heavy 499.265 / 637.331 1773.0 32.67625141143799 27 13 2 6 6 1.198146625403606 55.374411987913774 0.034999847412109375 5 0.900499065622793 3.879539510027051 1773.0 10.117883880825058 2.0 - - - - - - - 210.0 5 12 HS6ST2;HS6ST1 heparan sulfate 6-O-sulfotransferase 2;heparan sulfate 6-O-sulfotransferase 1 223 29 C20140403_SF097_05 C20140403_SF097_05 TB480136.[MT7]-FFWHLTLPER.3y6_1.heavy 497.274 / 728.43 5699.0 42.21845054626465 44 18 10 6 10 2.035603765758225 37.82508681489475 0.03459930419921875 3 0.981197649796562 8.986145855473163 5699.0 89.20173913043479 0.0 - - - - - - - 100.625 11 16 CASP6 caspase 6, apoptosis-related cysteine peptidase 225 29 C20140403_SF097_05 C20140403_SF097_05 TB480136.[MT7]-FFWHLTLPER.3b3_1.heavy 497.274 / 625.326 2941.0 42.21845054626465 44 18 10 6 10 2.035603765758225 37.82508681489475 0.03459930419921875 3 0.981197649796562 8.986145855473163 2941.0 118.91869565217391 0.0 - - - - - - - 117.55555555555556 5 9 CASP6 caspase 6, apoptosis-related cysteine peptidase 227 29 C20140403_SF097_05 C20140403_SF097_05 TB480136.[MT7]-FFWHLTLPER.3y4_1.heavy 497.274 / 514.298 7262.0 42.21845054626465 44 18 10 6 10 2.035603765758225 37.82508681489475 0.03459930419921875 3 0.981197649796562 8.986145855473163 7262.0 100.24717391304348 0.0 - - - - - - - 133.1578947368421 14 19 CASP6 caspase 6, apoptosis-related cysteine peptidase 229 29 C20140403_SF097_05 C20140403_SF097_05 TB480136.[MT7]-FFWHLTLPER.3y5_1.heavy 497.274 / 615.346 17327.0 42.21845054626465 44 18 10 6 10 2.035603765758225 37.82508681489475 0.03459930419921875 3 0.981197649796562 8.986145855473163 17327.0 138.02408385093167 0.0 - - - - - - - 187.53846153846155 34 13 CASP6 caspase 6, apoptosis-related cysteine peptidase 231 30 C20140403_SF097_05 C20140403_SF097_05 TPX_ECO57.DLSDVTLGQFAGK.2y7.peptide 675.85 / 720.4 80495.0 36.31880187988281 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 80495.0 165.14682106356756 0.0 - - - - - - - 177.25 160 8 233 30 C20140403_SF097_05 C20140403_SF097_05 TPX_ECO57.DLSDVTLGQFAGK.2y8.peptide 675.85 / 821.45 146025.0 36.31880187988281 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 146025.0 92.79405401042293 0.0 - - - - - - - 221.5 292 6 235 30 C20140403_SF097_05 C20140403_SF097_05 TPX_ECO57.DLSDVTLGQFAGK.2y6.peptide 675.85 / 607.32 174008.0 36.31880187988281 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 174008.0 142.45025342918794 0.0 - - - - - - - 206.66666666666666 348 6 237 31 C20140403_SF097_05 C20140403_SF097_05 TB346060.[MT7]-VVVPTR.2y4_1.heavy 407.767 / 472.288 14973.0 22.50860023498535 50 20 10 10 10 3.9060562415004663 20.047102479012366 0.0 3 0.9926358101600273 14.372522675307208 14973.0 20.16198142267134 0.0 - - - - - - - 792.0 29 8 BCAR1 breast cancer anti-estrogen resistance 1 239 31 C20140403_SF097_05 C20140403_SF097_05 TB346060.[MT7]-VVVPTR.2b3_1.heavy 407.767 / 442.315 27902.0 22.50860023498535 50 20 10 10 10 3.9060562415004663 20.047102479012366 0.0 3 0.9926358101600273 14.372522675307208 27902.0 24.44562095771396 0.0 - - - - - - - 301.7142857142857 55 14 BCAR1 breast cancer anti-estrogen resistance 1 241 31 C20140403_SF097_05 C20140403_SF097_05 TB346060.[MT7]-VVVPTR.2y5_1.heavy 407.767 / 571.356 51451.0 22.50860023498535 50 20 10 10 10 3.9060562415004663 20.047102479012366 0.0 3 0.9926358101600273 14.372522675307208 51451.0 80.72756905783692 0.0 - - - - - - - 255.75 102 8 BCAR1 breast cancer anti-estrogen resistance 1 243 31 C20140403_SF097_05 C20140403_SF097_05 TB346060.[MT7]-VVVPTR.2y3_1.heavy 407.767 / 373.219 22097.0 22.50860023498535 50 20 10 10 10 3.9060562415004663 20.047102479012366 0.0 3 0.9926358101600273 14.372522675307208 22097.0 23.170251287288885 0.0 - - - - - - - 418.0 44 3 BCAR1 breast cancer anti-estrogen resistance 1 245 32 C20140403_SF097_05 C20140403_SF097_05 TB480466.[MT7]-YYEVLTAPITK[MT7].2y4_1.heavy 793.458 / 602.399 27364.0 37.01487445831299 43 17 10 6 10 3.9095302645640757 25.57852049551797 0.034702301025390625 3 0.971050186942417 7.235793325407226 27364.0 97.98523232323231 0.0 - - - - - - - 675.0 54 10 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 247 32 C20140403_SF097_05 C20140403_SF097_05 TB480466.[MT7]-YYEVLTAPITK[MT7].2b3_1.heavy 793.458 / 600.279 22953.0 37.01487445831299 43 17 10 6 10 3.9095302645640757 25.57852049551797 0.034702301025390625 3 0.971050186942417 7.235793325407226 22953.0 109.23927777777777 0.0 - - - - - - - 288.0 45 15 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 249 32 C20140403_SF097_05 C20140403_SF097_05 TB480466.[MT7]-YYEVLTAPITK[MT7].2b4_1.heavy 793.458 / 699.347 19533.0 37.01487445831299 43 17 10 6 10 3.9095302645640757 25.57852049551797 0.034702301025390625 3 0.971050186942417 7.235793325407226 19533.0 49.20737575757576 0.0 - - - - - - - 337.5 39 16 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 251 32 C20140403_SF097_05 C20140403_SF097_05 TB480466.[MT7]-YYEVLTAPITK[MT7].2y7_1.heavy 793.458 / 887.568 12692.0 37.01487445831299 43 17 10 6 10 3.9095302645640757 25.57852049551797 0.034702301025390625 3 0.971050186942417 7.235793325407226 12692.0 29.216911680911682 0.0 - - - - - - - 253.63636363636363 25 11 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 253 33 C20140403_SF097_05 C20140403_SF097_05 TB480132.[MT7]-RAESQTR.2b3_1.heavy 496.274 / 501.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 255 33 C20140403_SF097_05 C20140403_SF097_05 TB480132.[MT7]-RAESQTR.2b6_1.heavy 496.274 / 817.428 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 257 33 C20140403_SF097_05 C20140403_SF097_05 TB480132.[MT7]-RAESQTR.2y6_1.heavy 496.274 / 691.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 259 33 C20140403_SF097_05 C20140403_SF097_05 TB480132.[MT7]-RAESQTR.2b5_1.heavy 496.274 / 716.381 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 261 34 C20140403_SF097_05 C20140403_SF097_05 TB148402.[MT7]-AVAASPFPAWR.3b4_1.heavy 439.579 / 457.289 54384.0 36.85570049285889 44 18 10 6 10 7.417573165264729 13.481498297621584 0.035602569580078125 3 0.9887573467600641 11.62840730835335 54384.0 165.14033913018648 0.0 - - - - - - - 306.64285714285717 108 14 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 263 34 C20140403_SF097_05 C20140403_SF097_05 TB148402.[MT7]-AVAASPFPAWR.3b5_1.heavy 439.579 / 544.321 54465.0 36.85570049285889 44 18 10 6 10 7.417573165264729 13.481498297621584 0.035602569580078125 3 0.9887573467600641 11.62840730835335 54465.0 99.17334788765638 0.0 - - - - - - - 218.7 108 10 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 265 34 C20140403_SF097_05 C20140403_SF097_05 TB148402.[MT7]-AVAASPFPAWR.3y4_1.heavy 439.579 / 529.288 193301.0 36.85570049285889 44 18 10 6 10 7.417573165264729 13.481498297621584 0.035602569580078125 3 0.9887573467600641 11.62840730835335 193301.0 390.4486662096757 0.0 - - - - - - - 310.5 386 6 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 267 34 C20140403_SF097_05 C20140403_SF097_05 TB148402.[MT7]-AVAASPFPAWR.3y5_1.heavy 439.579 / 676.357 10617.0 36.85570049285889 44 18 10 6 10 7.417573165264729 13.481498297621584 0.035602569580078125 3 0.9887573467600641 11.62840730835335 10617.0 159.255 0.0 - - - - - - - 196.71428571428572 21 14 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 269 35 C20140403_SF097_05 C20140403_SF097_05 TB148670.[MT7]-GNQHDVPVIPLDVVDNQTEK[MT7].3y6_1.heavy 835.778 / 878.434 3441.0 35.64179992675781 43 13 10 10 10 1.8478581833434997 44.02215740293251 0.0 3 0.9288055763509541 4.597571182233571 3441.0 16.868318635160154 0.0 - - - - - - - 121.9090909090909 6 11 CASP6 caspase 6, apoptosis-related cysteine peptidase 271 35 C20140403_SF097_05 C20140403_SF097_05 TB148670.[MT7]-GNQHDVPVIPLDVVDNQTEK[MT7].3b6_1.heavy 835.778 / 795.387 6596.0 35.64179992675781 43 13 10 10 10 1.8478581833434997 44.02215740293251 0.0 3 0.9288055763509541 4.597571182233571 6596.0 18.55852161785216 0.0 - - - - - - - 207.33333333333334 13 12 CASP6 caspase 6, apoptosis-related cysteine peptidase 273 35 C20140403_SF097_05 C20140403_SF097_05 TB148670.[MT7]-GNQHDVPVIPLDVVDNQTEK[MT7].3b5_1.heavy 835.778 / 696.318 4684.0 35.64179992675781 43 13 10 10 10 1.8478581833434997 44.02215740293251 0.0 3 0.9288055763509541 4.597571182233571 4684.0 17.932468619246862 0.0 - - - - - - - 299.53333333333336 9 15 CASP6 caspase 6, apoptosis-related cysteine peptidase 275 35 C20140403_SF097_05 C20140403_SF097_05 TB148670.[MT7]-GNQHDVPVIPLDVVDNQTEK[MT7].3b8_1.heavy 835.778 / 991.508 2963.0 35.64179992675781 43 13 10 10 10 1.8478581833434997 44.02215740293251 0.0 3 0.9288055763509541 4.597571182233571 2963.0 13.794236989077325 1.0 - - - - - - - 238.91666666666666 7 12 CASP6 caspase 6, apoptosis-related cysteine peptidase 277 36 C20140403_SF097_05 C20140403_SF097_05 TB148157.[MT7]-AWDEQER.2y6_1.heavy 539.258 / 862.369 1480.0 20.708133697509766 41 15 10 6 10 2.57868103237094 29.97847609706612 0.03279876708984375 3 0.9555026871182025 5.82870082676003 1480.0 46.43137254901961 0.0 - - - - - - - 92.4375 2 16 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 279 36 C20140403_SF097_05 C20140403_SF097_05 TB148157.[MT7]-AWDEQER.2y4_1.heavy 539.258 / 561.263 2808.0 20.708133697509766 41 15 10 6 10 2.57868103237094 29.97847609706612 0.03279876708984375 3 0.9555026871182025 5.82870082676003 2808.0 28.08 0.0 - - - - - - - 106.25 5 12 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 281 36 C20140403_SF097_05 C20140403_SF097_05 TB148157.[MT7]-AWDEQER.2b3_1.heavy 539.258 / 517.253 N/A 20.708133697509766 41 15 10 6 10 2.57868103237094 29.97847609706612 0.03279876708984375 3 0.9555026871182025 5.82870082676003 2501.0 26.15424836601307 0.0 - - - - - - - 134.21052631578948 5 19 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 283 36 C20140403_SF097_05 C20140403_SF097_05 TB148157.[MT7]-AWDEQER.2y5_1.heavy 539.258 / 676.29 766.0 20.708133697509766 41 15 10 6 10 2.57868103237094 29.97847609706612 0.03279876708984375 3 0.9555026871182025 5.82870082676003 766.0 5.356993464052287 0.0 - - - - - - - 0.0 1 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 285 37 C20140403_SF097_05 C20140403_SF097_05 TB148671.[MT7]-IRTEHLTEEEK[MT7].3y3_1.heavy 558.308 / 549.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 287 37 C20140403_SF097_05 C20140403_SF097_05 TB148671.[MT7]-IRTEHLTEEEK[MT7].3b4_1.heavy 558.308 / 644.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 289 37 C20140403_SF097_05 C20140403_SF097_05 TB148671.[MT7]-IRTEHLTEEEK[MT7].3b5_1.heavy 558.308 / 781.444 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 291 37 C20140403_SF097_05 C20140403_SF097_05 TB148671.[MT7]-IRTEHLTEEEK[MT7].3y5_1.heavy 558.308 / 779.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 293 38 C20140403_SF097_05 C20140403_SF097_05 TB148673.[MT7]-SPDLAPTPAPQSTPR.3y8_1.heavy 560.301 / 853.453 1698.0 24.118225574493408 39 13 10 6 10 3.7992272236226183 20.810814355576998 0.03790092468261719 3 0.9244741370909535 4.462132831249645 1698.0 40.536760563380284 0.0 - - - - - - - 106.33333333333333 3 6 EIF2A eukaryotic translation initiation factor 2A, 65kDa 295 38 C20140403_SF097_05 C20140403_SF097_05 TB148673.[MT7]-SPDLAPTPAPQSTPR.3y6_1.heavy 560.301 / 685.363 2547.0 24.118225574493408 39 13 10 6 10 3.7992272236226183 20.810814355576998 0.03790092468261719 3 0.9244741370909535 4.462132831249645 2547.0 40.835915492957746 0.0 - - - - - - - 128.54545454545453 5 11 EIF2A eukaryotic translation initiation factor 2A, 65kDa 297 38 C20140403_SF097_05 C20140403_SF097_05 TB148673.[MT7]-SPDLAPTPAPQSTPR.3b4_1.heavy 560.301 / 557.305 1061.0 24.118225574493408 39 13 10 6 10 3.7992272236226183 20.810814355576998 0.03790092468261719 3 0.9244741370909535 4.462132831249645 1061.0 7.148581560283687 0.0 - - - - - - - 135.58333333333334 2 12 EIF2A eukaryotic translation initiation factor 2A, 65kDa 299 38 C20140403_SF097_05 C20140403_SF097_05 TB148673.[MT7]-SPDLAPTPAPQSTPR.3b5_1.heavy 560.301 / 628.342 3325.0 24.118225574493408 39 13 10 6 10 3.7992272236226183 20.810814355576998 0.03790092468261719 3 0.9244741370909535 4.462132831249645 3325.0 49.28878233942663 0.0 - - - - - - - 106.3 6 10 EIF2A eukaryotic translation initiation factor 2A, 65kDa 301 39 C20140403_SF097_05 C20140403_SF097_05 TB480238.[MT7]-YFAQALK[MT7].2y6_1.heavy 564.836 / 821.5 392.0 31.624375343322754 39 13 10 6 10 5.064379261211707 15.808082004711494 0.037899017333984375 3 0.9282222594748469 4.578622925508187 392.0 6.421616854483096 1.0 - - - - - - - 0.0 0 0 TTC35 tetratricopeptide repeat domain 35 303 39 C20140403_SF097_05 C20140403_SF097_05 TB480238.[MT7]-YFAQALK[MT7].2b3_1.heavy 564.836 / 526.278 785.0 31.624375343322754 39 13 10 6 10 5.064379261211707 15.808082004711494 0.037899017333984375 3 0.9282222594748469 4.578622925508187 785.0 5.773617021276596 0.0 - - - - - - - 0.0 1 0 TTC35 tetratricopeptide repeat domain 35 305 39 C20140403_SF097_05 C20140403_SF097_05 TB480238.[MT7]-YFAQALK[MT7].2y5_1.heavy 564.836 / 674.432 1020.0 31.624375343322754 39 13 10 6 10 5.064379261211707 15.808082004711494 0.037899017333984375 3 0.9282222594748469 4.578622925508187 1020.0 4.547770700636943 0.0 - - - - - - - 182.83333333333334 2 6 TTC35 tetratricopeptide repeat domain 35 307 39 C20140403_SF097_05 C20140403_SF097_05 TB480238.[MT7]-YFAQALK[MT7].2b4_1.heavy 564.836 / 654.337 863.0 31.624375343322754 39 13 10 6 10 5.064379261211707 15.808082004711494 0.037899017333984375 3 0.9282222594748469 4.578622925508187 863.0 13.483139116202945 0.0 - - - - - - - 0.0 1 0 TTC35 tetratricopeptide repeat domain 35 309 40 C20140403_SF097_05 C20140403_SF097_05 TB148175.[MT7]-DAQVFPK[MT7].2b5_1.heavy 546.818 / 705.369 532.0 25.29246648152669 41 16 10 5 10 3.0461460907044438 25.051733755109147 0.040699005126953125 3 0.9649625989533377 6.573855550065144 532.0 6.946268656716418 1.0 - - - - - - - 0.0 1 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 311 40 C20140403_SF097_05 C20140403_SF097_05 TB148175.[MT7]-DAQVFPK[MT7].2b4_1.heavy 546.818 / 558.3 1996.0 25.29246648152669 41 16 10 5 10 3.0461460907044438 25.051733755109147 0.040699005126953125 3 0.9649625989533377 6.573855550065144 1996.0 25.51278195488722 0.0 - - - - - - - 133.25 3 8 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 313 40 C20140403_SF097_05 C20140403_SF097_05 TB148175.[MT7]-DAQVFPK[MT7].2y3_1.heavy 546.818 / 535.336 1264.0 25.29246648152669 41 16 10 5 10 3.0461460907044438 25.051733755109147 0.040699005126953125 3 0.9649625989533377 6.573855550065144 1264.0 14.621533834586467 0.0 - - - - - - - 122.33333333333333 2 12 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 315 40 C20140403_SF097_05 C20140403_SF097_05 TB148175.[MT7]-DAQVFPK[MT7].2b6_1.heavy 546.818 / 802.422 N/A 25.29246648152669 41 16 10 5 10 3.0461460907044438 25.051733755109147 0.040699005126953125 3 0.9649625989533377 6.573855550065144 67.0 0.6030075187969925 35.0 - - - - - - - 0.0 0 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 317 41 C20140403_SF097_05 C20140403_SF097_05 TB148348.[MT7]-LVFIGDTLSR.2y8_1.heavy 632.873 / 908.484 4917.0 40.04140090942383 50 20 10 10 10 15.074472288498823 6.633731389475949 0.0 3 0.9928107565427621 14.54655801366188 4917.0 99.54919099057688 0.0 - - - - - - - 121.93333333333334 9 15 BCAR1 breast cancer anti-estrogen resistance 1 319 41 C20140403_SF097_05 C20140403_SF097_05 TB148348.[MT7]-LVFIGDTLSR.2y9_1.heavy 632.873 / 1007.55 4517.0 40.04140090942383 50 20 10 10 10 15.074472288498823 6.633731389475949 0.0 3 0.9928107565427621 14.54655801366188 4517.0 86.0091994847258 0.0 - - - - - - - 155.9090909090909 9 11 BCAR1 breast cancer anti-estrogen resistance 1 321 41 C20140403_SF097_05 C20140403_SF097_05 TB148348.[MT7]-LVFIGDTLSR.2y6_1.heavy 632.873 / 648.331 2744.0 40.04140090942383 50 20 10 10 10 15.074472288498823 6.633731389475949 0.0 3 0.9928107565427621 14.54655801366188 2744.0 21.951721336447648 0.0 - - - - - - - 140.27272727272728 5 11 BCAR1 breast cancer anti-estrogen resistance 1 323 41 C20140403_SF097_05 C20140403_SF097_05 TB148348.[MT7]-LVFIGDTLSR.2y7_1.heavy 632.873 / 761.415 1772.0 40.04140090942383 50 20 10 10 10 15.074472288498823 6.633731389475949 0.0 3 0.9928107565427621 14.54655801366188 1772.0 43.39845614035087 0.0 - - - - - - - 108.4 3 10 BCAR1 breast cancer anti-estrogen resistance 1 325 42 C20140403_SF097_05 C20140403_SF097_05 TB148485.[MT7]-LEFPPGFPVK[MT7].2y4_1.heavy 709.918 / 634.404 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 327 42 C20140403_SF097_05 C20140403_SF097_05 TB148485.[MT7]-LEFPPGFPVK[MT7].2b3_1.heavy 709.918 / 534.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 329 42 C20140403_SF097_05 C20140403_SF097_05 TB148485.[MT7]-LEFPPGFPVK[MT7].2y6_1.heavy 709.918 / 788.479 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 331 42 C20140403_SF097_05 C20140403_SF097_05 TB148485.[MT7]-LEFPPGFPVK[MT7].2y7_1.heavy 709.918 / 885.531 N/A N/A - - - - - - - - - 0.0 - - - - - - - ANKRD13A ankyrin repeat domain 13A 333 43 C20140403_SF097_05 C20140403_SF097_05 TB148150.[MT7]-DFTAAFPR.2y5_1.heavy 534.783 / 561.314 5128.0 32.401474952697754 40 17 10 3 10 2.730006261636248 29.039478255140658 0.07229995727539062 3 0.9734191060365385 7.552850023885186 5128.0 31.554591945573524 0.0 - - - - - - - 186.16666666666666 10 6 HAVCR2 hepatitis A virus cellular receptor 2 335 43 C20140403_SF097_05 C20140403_SF097_05 TB148150.[MT7]-DFTAAFPR.2b4_1.heavy 534.783 / 579.289 3263.0 32.401474952697754 40 17 10 3 10 2.730006261636248 29.039478255140658 0.07229995727539062 3 0.9734191060365385 7.552850023885186 3263.0 2.8264955449968587 0.0 - - - - - - - 167.7 6 10 HAVCR2 hepatitis A virus cellular receptor 2 337 43 C20140403_SF097_05 C20140403_SF097_05 TB148150.[MT7]-DFTAAFPR.2y6_1.heavy 534.783 / 662.362 3170.0 32.401474952697754 40 17 10 3 10 2.730006261636248 29.039478255140658 0.07229995727539062 3 0.9734191060365385 7.552850023885186 3170.0 -0.5 1.0 - - - - - - - 173.0 6 7 HAVCR2 hepatitis A virus cellular receptor 2 339 43 C20140403_SF097_05 C20140403_SF097_05 TB148150.[MT7]-DFTAAFPR.2y7_1.heavy 534.783 / 809.43 4569.0 32.401474952697754 40 17 10 3 10 2.730006261636248 29.039478255140658 0.07229995727539062 3 0.9734191060365385 7.552850023885186 4569.0 47.58998428086854 1.0 - - - - - - - 130.2 9 10 HAVCR2 hepatitis A virus cellular receptor 2 341 44 C20140403_SF097_05 C20140403_SF097_05 TB148484.[MT7]-YDDAIQLYDR.2b3_1.heavy 708.35 / 538.227 15680.0 32.4556999206543 44 18 10 6 10 8.065832741536077 12.39797590706744 0.03620147705078125 3 0.9846165790315707 9.93751016639568 15680.0 89.24255319148935 0.0 - - - - - - - 263.06666666666666 31 15 TTC35 tetratricopeptide repeat domain 35 343 44 C20140403_SF097_05 C20140403_SF097_05 TB148484.[MT7]-YDDAIQLYDR.2y9_1.heavy 708.35 / 1108.53 10797.0 32.4556999206543 44 18 10 6 10 8.065832741536077 12.39797590706744 0.03620147705078125 3 0.9846165790315707 9.93751016639568 10797.0 57.845006046634666 0.0 - - - - - - - 238.3846153846154 21 13 TTC35 tetratricopeptide repeat domain 35 345 44 C20140403_SF097_05 C20140403_SF097_05 TB148484.[MT7]-YDDAIQLYDR.2b4_1.heavy 708.35 / 609.264 8732.0 32.4556999206543 44 18 10 6 10 8.065832741536077 12.39797590706744 0.03620147705078125 3 0.9846165790315707 9.93751016639568 8732.0 15.57841826801042 0.0 - - - - - - - 711.8333333333334 17 12 TTC35 tetratricopeptide repeat domain 35 347 44 C20140403_SF097_05 C20140403_SF097_05 TB148484.[MT7]-YDDAIQLYDR.2y7_1.heavy 708.35 / 878.473 12863.0 32.4556999206543 44 18 10 6 10 8.065832741536077 12.39797590706744 0.03620147705078125 3 0.9846165790315707 9.93751016639568 12863.0 144.6230728241563 0.0 - - - - - - - 177.44444444444446 25 9 TTC35 tetratricopeptide repeat domain 35 349 45 C20140403_SF097_05 C20140403_SF097_05 TPX_ECO57.AQTFTLVAK.2y7.peptide 489.78 / 779.47 448700.0 29.377500534057617 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 448700.0 4095.578419242736 0.0 - - - - - - - 651.5 897 8 351 45 C20140403_SF097_05 C20140403_SF097_05 TPX_ECO57.AQTFTLVAK.2y6.peptide 489.78 / 678.42 169067.0 29.377500534057617 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 169067.0 1014.2213728632479 0.0 - - - - - - - 671.5 338 8 353 45 C20140403_SF097_05 C20140403_SF097_05 TPX_ECO57.AQTFTLVAK.2y5.peptide 489.78 / 531.35 175874.0 29.377500534057617 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 175874.0 299.8218918642482 0.0 - - - - - - - 740.8571428571429 351 14 355 46 C20140403_SF097_05 C20140403_SF097_05 TB346622.[MT7]-LALAIDPLLDAAPVDMAAFQHGSLLQR.4y9_1.heavy 748.412 / 1085.59 8374.0 51.12722396850586 47 20 10 7 10 11.748664411617789 8.51160578738754 0.0290985107421875 3 0.9916281985579584 13.478745038137445 8374.0 -2.1750649350649347 0.0 - - - - - - - 169.78571428571428 16 14 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 357 46 C20140403_SF097_05 C20140403_SF097_05 TB346622.[MT7]-LALAIDPLLDAAPVDMAAFQHGSLLQR.4y10_1.heavy 748.412 / 1156.62 6082.0 51.12722396850586 47 20 10 7 10 11.748664411617789 8.51160578738754 0.0290985107421875 3 0.9916281985579584 13.478745038137445 6082.0 -8.293636363636363 0.0 - - - - - - - 170.26666666666668 12 15 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 359 46 C20140403_SF097_05 C20140403_SF097_05 TB346622.[MT7]-LALAIDPLLDAAPVDMAAFQHGSLLQR.4b4_1.heavy 748.412 / 513.352 26751.0 51.12722396850586 47 20 10 7 10 11.748664411617789 8.51160578738754 0.0290985107421875 3 0.9916281985579584 13.478745038137445 26751.0 -5.783999999999999 0.0 - - - - - - - 237.9 53 10 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 361 46 C20140403_SF097_05 C20140403_SF097_05 TB346622.[MT7]-LALAIDPLLDAAPVDMAAFQHGSLLQR.4b5_1.heavy 748.412 / 626.436 9828.0 51.12722396850586 47 20 10 7 10 11.748664411617789 8.51160578738754 0.0290985107421875 3 0.9916281985579584 13.478745038137445 9828.0 -6.0791752577319595 0.0 - - - - - - - 269.875 19 16 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 363 47 C20140403_SF097_05 C20140403_SF097_05 TB148488.[MT7]-GTC[CAM]ADRDNLTR.3b6_1.heavy 474.901 / 805.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - CASP6 caspase 6, apoptosis-related cysteine peptidase 365 47 C20140403_SF097_05 C20140403_SF097_05 TB148488.[MT7]-GTC[CAM]ADRDNLTR.3b5_1.heavy 474.901 / 649.273 N/A N/A - - - - - - - - - 0.0 - - - - - - - CASP6 caspase 6, apoptosis-related cysteine peptidase 367 47 C20140403_SF097_05 C20140403_SF097_05 TB148488.[MT7]-GTC[CAM]ADRDNLTR.3y4_1.heavy 474.901 / 503.294 N/A N/A - - - - - - - - - 0.0 - - - - - - - CASP6 caspase 6, apoptosis-related cysteine peptidase 369 47 C20140403_SF097_05 C20140403_SF097_05 TB148488.[MT7]-GTC[CAM]ADRDNLTR.3y5_1.heavy 474.901 / 618.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - CASP6 caspase 6, apoptosis-related cysteine peptidase 371 48 C20140403_SF097_05 C20140403_SF097_05 TB480570.[MT7]-LTPQEWLPEEFLER.3y7_1.heavy 644.339 / 919.452 11399.0 47.243374824523926 40 17 10 3 10 4.854674267974587 20.5987043579179 0.0738983154296875 3 0.9777240637959588 8.253437772424814 11399.0 300.948154126767 0.0 - - - - - - - 175.5 22 8 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 373 48 C20140403_SF097_05 C20140403_SF097_05 TB480570.[MT7]-LTPQEWLPEEFLER.3y6_1.heavy 644.339 / 822.399 2084.0 47.243374824523926 40 17 10 3 10 4.854674267974587 20.5987043579179 0.0738983154296875 3 0.9777240637959588 8.253437772424814 2084.0 40.69297316176471 0.0 - - - - - - - 121.85714285714286 4 7 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 375 48 C20140403_SF097_05 C20140403_SF097_05 TB480570.[MT7]-LTPQEWLPEEFLER.3b5_1.heavy 644.339 / 713.395 9527.0 47.243374824523926 40 17 10 3 10 4.854674267974587 20.5987043579179 0.0738983154296875 3 0.9777240637959588 8.253437772424814 9527.0 290.49387754360464 0.0 - - - - - - - 108.45454545454545 19 11 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 377 48 C20140403_SF097_05 C20140403_SF097_05 TB480570.[MT7]-LTPQEWLPEEFLER.3y5_1.heavy 644.339 / 693.357 3190.0 47.243374824523926 40 17 10 3 10 4.854674267974587 20.5987043579179 0.0738983154296875 3 0.9777240637959588 8.253437772424814 3190.0 137.9860465116279 0.0 - - - - - - - 85.5 6 6 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 379 49 C20140403_SF097_05 C20140403_SF097_05 TB148788.[MT7]-LTTFVNFPLRDLDLR.2b3_1.heavy 982.558 / 460.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 381 49 C20140403_SF097_05 C20140403_SF097_05 TB148788.[MT7]-LTTFVNFPLRDLDLR.2b4_1.heavy 982.558 / 607.357 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 383 49 C20140403_SF097_05 C20140403_SF097_05 TB148788.[MT7]-LTTFVNFPLRDLDLR.2b6_1.heavy 982.558 / 820.469 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 385 49 C20140403_SF097_05 C20140403_SF097_05 TB148788.[MT7]-LTTFVNFPLRDLDLR.2b5_1.heavy 982.558 / 706.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 387 50 C20140403_SF097_05 C20140403_SF097_05 TB148534.[MT7]-AVAASPFPAWRR.3y7_1.heavy 491.613 / 929.51 587.0 31.896049976348877 39 13 10 6 10 2.4193571345757703 41.33329410977384 0.03660011291503906 3 0.9048783178205729 3.969340732835733 587.0 6.481107142857143 1.0 - - - - - - - 0.0 1 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 389 50 C20140403_SF097_05 C20140403_SF097_05 TB148534.[MT7]-AVAASPFPAWRR.3y10_2.heavy 491.613 / 579.812 4191.0 31.896049976348877 39 13 10 6 10 2.4193571345757703 41.33329410977384 0.03660011291503906 3 0.9048783178205729 3.969340732835733 4191.0 20.892447761194028 0.0 - - - - - - - 186.33333333333334 8 9 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 391 50 C20140403_SF097_05 C20140403_SF097_05 TB148534.[MT7]-AVAASPFPAWRR.3y5_1.heavy 491.613 / 685.389 5532.0 31.896049976348877 39 13 10 6 10 2.4193571345757703 41.33329410977384 0.03660011291503906 3 0.9048783178205729 3.969340732835733 5532.0 22.55 1.0 - - - - - - - 159.4 11 10 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 393 50 C20140403_SF097_05 C20140403_SF097_05 TB148534.[MT7]-AVAASPFPAWRR.3y11_2.heavy 491.613 / 629.346 5197.0 31.896049976348877 39 13 10 6 10 2.4193571345757703 41.33329410977384 0.03660011291503906 3 0.9048783178205729 3.969340732835733 5197.0 34.19071668086012 0.0 - - - - - - - 230.5 10 12 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 395 51 C20140403_SF097_05 C20140403_SF097_05 TB148533.[MT7]-ILQEDPTNTAAR.2y10_1.heavy 736.895 / 1102.51 8238.0 25.476900100708008 43 13 10 10 10 2.6271722726476288 38.063739116438434 0.0 3 0.9235141503933452 4.433677011277707 8238.0 135.87925338390423 0.0 - - - - - - - 137.11111111111111 16 9 TTC35 tetratricopeptide repeat domain 35 397 51 C20140403_SF097_05 C20140403_SF097_05 TB148533.[MT7]-ILQEDPTNTAAR.2b5_1.heavy 736.895 / 743.406 16606.0 25.476900100708008 43 13 10 10 10 2.6271722726476288 38.063739116438434 0.0 3 0.9235141503933452 4.433677011277707 16606.0 117.97312741312743 0.0 - - - - - - - 190.6875 33 16 TTC35 tetratricopeptide repeat domain 35 399 51 C20140403_SF097_05 C20140403_SF097_05 TB148533.[MT7]-ILQEDPTNTAAR.2y11_1.heavy 736.895 / 1215.6 3568.0 25.476900100708008 43 13 10 10 10 2.6271722726476288 38.063739116438434 0.0 3 0.9235141503933452 4.433677011277707 3568.0 25.76123552123552 0.0 - - - - - - - 173.0 7 12 TTC35 tetratricopeptide repeat domain 35 401 51 C20140403_SF097_05 C20140403_SF097_05 TB148533.[MT7]-ILQEDPTNTAAR.2y7_1.heavy 736.895 / 730.384 28411.0 25.476900100708008 43 13 10 10 10 2.6271722726476288 38.063739116438434 0.0 3 0.9235141503933452 4.433677011277707 28411.0 153.02274799833936 0.0 - - - - - - - 151.58333333333334 56 12 TTC35 tetratricopeptide repeat domain 35 403 52 C20140403_SF097_05 C20140403_SF097_05 TB148532.[MT7]-RPGPGTLYDVPR.3b9_2.heavy 491.276 / 551.294 7130.0 26.739999771118164 40 10 10 10 10 0.9151847614929636 63.06138788463247 0.0 3 0.844812606368253 3.0913682090034036 7130.0 43.57757817697937 0.0 - - - - - - - 747.8571428571429 14 7 BCAR1 breast cancer anti-estrogen resistance 1 405 52 C20140403_SF097_05 C20140403_SF097_05 TB148532.[MT7]-RPGPGTLYDVPR.3y6_1.heavy 491.276 / 762.414 2340.0 26.739999771118164 40 10 10 10 10 0.9151847614929636 63.06138788463247 0.0 3 0.844812606368253 3.0913682090034036 2340.0 29.678002666343474 0.0 - - - - - - - 115.2 4 15 BCAR1 breast cancer anti-estrogen resistance 1 407 52 C20140403_SF097_05 C20140403_SF097_05 TB148532.[MT7]-RPGPGTLYDVPR.3b6_1.heavy 491.276 / 710.407 3119.0 26.739999771118164 40 10 10 10 10 0.9151847614929636 63.06138788463247 0.0 3 0.844812606368253 3.0913682090034036 3119.0 16.301010201268266 0.0 - - - - - - - 177.4375 6 16 BCAR1 breast cancer anti-estrogen resistance 1 409 52 C20140403_SF097_05 C20140403_SF097_05 TB148532.[MT7]-RPGPGTLYDVPR.3b5_1.heavy 491.276 / 609.359 2395.0 26.739999771118164 40 10 10 10 10 0.9151847614929636 63.06138788463247 0.0 3 0.844812606368253 3.0913682090034036 2395.0 25.502121476315025 0.0 - - - - - - - 177.5 4 16 BCAR1 breast cancer anti-estrogen resistance 1 411 53 C20140403_SF097_05 C20140403_SF097_05 ODP2_ECOLI.AEAPAAAPAAK.2y7.peptide 484.26 / 599.35 475393.0 14.983033180236816 23 -3 10 6 10 null 0.0 0.03769969940185547 3 0.0 0.0 475393.0 1447.3675074921325 0.0 - - - - - - - 303.3 950 10 413 53 C20140403_SF097_05 C20140403_SF097_05 ODP2_ECOLI.AEAPAAAPAAK.2y8.peptide 484.26 / 696.4 587387.0 14.983033180236816 23 -3 10 6 10 null 0.0 0.03769969940185547 3 0.0 0.0 587387.0 3086.3382831086037 0.0 - - - - - - - 649.8571428571429 1174 7 415 53 C20140403_SF097_05 C20140403_SF097_05 ODP2_ECOLI.AEAPAAAPAAK.2y6.peptide 484.26 / 528.31 392733.0 14.983033180236816 23 -3 10 6 10 null 0.0 0.03769969940185547 3 0.0 0.0 392733.0 2875.443174169931 0.0 - - - - - - - 286.8 785 10 417 54 C20140403_SF097_05 C20140403_SF097_05 TB148233.[MT7]-LDSQSDLAR.2y8_1.heavy 574.805 / 891.417 2189.0 22.096150398254395 40 14 10 6 10 1.4330421140170486 48.87363282514384 0.03289985656738281 3 0.943126104953391 5.1502195600716405 2189.0 6.973704138921531 0.0 - - - - - - - 190.14285714285714 4 14 USP2 ubiquitin specific peptidase 2 419 54 C20140403_SF097_05 C20140403_SF097_05 TB148233.[MT7]-LDSQSDLAR.2b4_1.heavy 574.805 / 588.311 592.0 22.096150398254395 40 14 10 6 10 1.4330421140170486 48.87363282514384 0.03289985656738281 3 0.943126104953391 5.1502195600716405 592.0 16.054237288135592 1.0 - - - - - - - 0.0 1 0 USP2 ubiquitin specific peptidase 2 421 54 C20140403_SF097_05 C20140403_SF097_05 TB148233.[MT7]-LDSQSDLAR.2b6_1.heavy 574.805 / 790.37 2130.0 22.096150398254395 40 14 10 6 10 1.4330421140170486 48.87363282514384 0.03289985656738281 3 0.943126104953391 5.1502195600716405 2130.0 20.924347228584516 0.0 - - - - - - - 141.7 4 10 USP2 ubiquitin specific peptidase 2 423 54 C20140403_SF097_05 C20140403_SF097_05 TB148233.[MT7]-LDSQSDLAR.2y7_1.heavy 574.805 / 776.39 1302.0 22.096150398254395 40 14 10 6 10 1.4330421140170486 48.87363282514384 0.03289985656738281 3 0.943126104953391 5.1502195600716405 1302.0 7.012071952031978 0.0 - - - - - - - 141.9 2 10 USP2 ubiquitin specific peptidase 2 425 55 C20140403_SF097_05 C20140403_SF097_05 TB148094.[MT7]-SAQGLAGLR.2y6_1.heavy 508.802 / 586.367 3976.0 25.87980079650879 45 15 10 10 10 2.3705777141759765 32.910222956400375 0.0 3 0.9537598804499751 5.7169584994175064 3976.0 45.10903777619387 0.0 - - - - - - - 135.28571428571428 7 14 USP2 ubiquitin specific peptidase 2 427 55 C20140403_SF097_05 C20140403_SF097_05 TB148094.[MT7]-SAQGLAGLR.2y8_1.heavy 508.802 / 785.463 3181.0 25.87980079650879 45 15 10 10 10 2.3705777141759765 32.910222956400375 0.0 3 0.9537598804499751 5.7169584994175064 3181.0 22.919006211180125 0.0 - - - - - - - 191.125 6 8 USP2 ubiquitin specific peptidase 2 429 55 C20140403_SF097_05 C20140403_SF097_05 TB148094.[MT7]-SAQGLAGLR.2b5_1.heavy 508.802 / 601.343 1652.0 25.87980079650879 45 15 10 10 10 2.3705777141759765 32.910222956400375 0.0 3 0.9537598804499751 5.7169584994175064 1652.0 7.987861811391224 0.0 - - - - - - - 179.94117647058823 3 17 USP2 ubiquitin specific peptidase 2 431 55 C20140403_SF097_05 C20140403_SF097_05 TB148094.[MT7]-SAQGLAGLR.2y7_1.heavy 508.802 / 714.426 1285.0 25.87980079650879 45 15 10 10 10 2.3705777141759765 32.910222956400375 0.0 3 0.9537598804499751 5.7169584994175064 1285.0 9.358152173913044 0.0 - - - - - - - 126.71428571428571 2 14 USP2 ubiquitin specific peptidase 2 433 56 C20140403_SF097_05 C20140403_SF097_05 TB480472.[MT7]-ELQGQNVEAVDPR.3y6_1.heavy 533.613 / 686.347 5664.0 24.520999908447266 44 14 10 10 10 1.289280618820517 45.33391796988166 0.0 3 0.9349433119806676 4.812085312139667 5664.0 54.17739130434782 0.0 - - - - - - - 138.0 11 10 ANKRD13A ankyrin repeat domain 13A 435 56 C20140403_SF097_05 C20140403_SF097_05 TB480472.[MT7]-ELQGQNVEAVDPR.3b6_1.heavy 533.613 / 814.417 4213.0 24.520999908447266 44 14 10 10 10 1.289280618820517 45.33391796988166 0.0 3 0.9349433119806676 4.812085312139667 4213.0 48.13403381642512 0.0 - - - - - - - 115.0 8 12 ANKRD13A ankyrin repeat domain 13A 437 56 C20140403_SF097_05 C20140403_SF097_05 TB480472.[MT7]-ELQGQNVEAVDPR.3b5_1.heavy 533.613 / 700.375 2625.0 24.520999908447266 44 14 10 10 10 1.289280618820517 45.33391796988166 0.0 3 0.9349433119806676 4.812085312139667 2625.0 12.554347826086957 0.0 - - - - - - - 207.0 5 6 ANKRD13A ankyrin repeat domain 13A 439 56 C20140403_SF097_05 C20140403_SF097_05 TB480472.[MT7]-ELQGQNVEAVDPR.3b3_1.heavy 533.613 / 515.295 N/A 24.520999908447266 44 14 10 10 10 1.289280618820517 45.33391796988166 0.0 3 0.9349433119806676 4.812085312139667 11121.0 6.251176684634098 1.0 - - - - - - - 2180.4285714285716 22 7 ANKRD13A ankyrin repeat domain 13A 441 57 C20140403_SF097_05 C20140403_SF097_05 TB148647.[MT7]-DDLALFC[CAM]LQELR.2y8_1.heavy 818.928 / 1078.57 3580.0 44.70094966888428 42 15 10 7 10 7.569074069939178 13.21165562339431 0.022998809814453125 3 0.9565125784282085 5.896495585584634 3580.0 13.25064935064935 1.0 - - - - - - - 253.73529411764707 7 34 TTC35 tetratricopeptide repeat domain 35 443 57 C20140403_SF097_05 C20140403_SF097_05 TB148647.[MT7]-DDLALFC[CAM]LQELR.2y9_1.heavy 818.928 / 1149.61 1960.0 44.70094966888428 42 15 10 7 10 7.569074069939178 13.21165562339431 0.022998809814453125 3 0.9565125784282085 5.896495585584634 1960.0 2.106194690265487 1.0 - - - - - - - 211.96875 5 32 TTC35 tetratricopeptide repeat domain 35 445 57 C20140403_SF097_05 C20140403_SF097_05 TB148647.[MT7]-DDLALFC[CAM]LQELR.2b4_1.heavy 818.928 / 559.284 5352.0 44.70094966888428 42 15 10 7 10 7.569074069939178 13.21165562339431 0.022998809814453125 3 0.9565125784282085 5.896495585584634 5352.0 18.146781979082864 0.0 - - - - - - - 259.96666666666664 10 30 TTC35 tetratricopeptide repeat domain 35 447 57 C20140403_SF097_05 C20140403_SF097_05 TB148647.[MT7]-DDLALFC[CAM]LQELR.2y7_1.heavy 818.928 / 965.487 3806.0 44.70094966888428 42 15 10 7 10 7.569074069939178 13.21165562339431 0.022998809814453125 3 0.9565125784282085 5.896495585584634 3806.0 15.265391619575645 0.0 - - - - - - - 217.61290322580646 7 31 TTC35 tetratricopeptide repeat domain 35 449 58 C20140403_SF097_05 C20140403_SF097_05 ENO_ECO24.IQLVGDDLFVTNTK.2y8.peptide 781.92 / 937.5 704055.0 39.66490173339844 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 704055.0 220.1887369094305 0.0 - - - - - - - 813.3333333333334 1408 3 451 58 C20140403_SF097_05 C20140403_SF097_05 ENO_ECO24.IQLVGDDLFVTNTK.2y6.peptide 781.92 / 709.39 878997.0 39.66490173339844 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 878997.0 535.5167093773148 0.0 - - - - - - - 793.0 1757 1 453 58 C20140403_SF097_05 C20140403_SF097_05 ENO_ECO24.IQLVGDDLFVTNTK.2y5.peptide 781.92 / 562.32 1289230.0 39.66490173339844 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1289230.0 227.45103357828157 0.0 - - - - - - - 1189.0 2578 2 455 59 C20140403_SF097_05 C20140403_SF097_05 TB480361.[MT7]-FSDLGFEVK[MT7].3y3_1.heavy 443.915 / 519.326 25201.0 36.90019989013672 39 9 10 10 10 0.907525913438298 77.01707579441128 0.0 3 0.8053045523499003 2.750250660509917 25201.0 60.41773677736778 0.0 - - - - - - - 254.54545454545453 50 11 CASP6 caspase 6, apoptosis-related cysteine peptidase 457 59 C20140403_SF097_05 C20140403_SF097_05 TB480361.[MT7]-FSDLGFEVK[MT7].3b4_1.heavy 443.915 / 607.321 11923.0 36.90019989013672 39 9 10 10 10 0.907525913438298 77.01707579441128 0.0 3 0.8053045523499003 2.750250660509917 11923.0 162.35616072160724 0.0 - - - - - - - 210.77777777777777 23 9 CASP6 caspase 6, apoptosis-related cysteine peptidase 459 59 C20140403_SF097_05 C20140403_SF097_05 TB480361.[MT7]-FSDLGFEVK[MT7].3b5_1.heavy 443.915 / 664.342 39021.0 36.90019989013672 39 9 10 10 10 0.907525913438298 77.01707579441128 0.0 3 0.8053045523499003 2.750250660509917 39021.0 173.22870720257836 0.0 - - - - - - - 207.7 78 10 CASP6 caspase 6, apoptosis-related cysteine peptidase 461 59 C20140403_SF097_05 C20140403_SF097_05 TB480361.[MT7]-FSDLGFEVK[MT7].3b3_1.heavy 443.915 / 494.237 26556.0 36.90019989013672 39 9 10 10 10 0.907525913438298 77.01707579441128 0.0 3 0.8053045523499003 2.750250660509917 26556.0 141.3602307853696 0.0 - - - - - - - 165.5 53 12 CASP6 caspase 6, apoptosis-related cysteine peptidase 463 60 C20140403_SF097_05 C20140403_SF097_05 TB148281.[MT7]-DVNYWTSR.2y6_1.heavy 592.794 / 826.384 898.0 28.689300537109375 42 15 10 7 10 2.711381289997634 29.185174942760064 0.02700042724609375 3 0.9505447533938264 5.526496328115691 898.0 18.510218724850215 0.0 - - - - - - - 0.0 1 0 HAVCR2 hepatitis A virus cellular receptor 2 465 60 C20140403_SF097_05 C20140403_SF097_05 TB148281.[MT7]-DVNYWTSR.2y5_1.heavy 592.794 / 712.341 951.0 28.689300537109375 42 15 10 7 10 2.711381289997634 29.185174942760064 0.02700042724609375 3 0.9505447533938264 5.526496328115691 951.0 8.971698113207546 0.0 - - - - - - - 0.0 1 0 HAVCR2 hepatitis A virus cellular receptor 2 467 60 C20140403_SF097_05 C20140403_SF097_05 TB148281.[MT7]-DVNYWTSR.2b4_1.heavy 592.794 / 636.311 1637.0 28.689300537109375 42 15 10 7 10 2.711381289997634 29.185174942760064 0.02700042724609375 3 0.9505447533938264 5.526496328115691 1637.0 29.36441026558169 0.0 - - - - - - - 158.57142857142858 3 14 HAVCR2 hepatitis A virus cellular receptor 2 469 60 C20140403_SF097_05 C20140403_SF097_05 TB148281.[MT7]-DVNYWTSR.2y7_1.heavy 592.794 / 925.453 2166.0 28.689300537109375 42 15 10 7 10 2.711381289997634 29.185174942760064 0.02700042724609375 3 0.9505447533938264 5.526496328115691 2166.0 44.16641151748189 1.0 - - - - - - - 132.14285714285714 4 14 HAVCR2 hepatitis A virus cellular receptor 2 471 61 C20140403_SF097_05 C20140403_SF097_05 TB148849.[MT7]-LRVDITLLGFENMSWIR.3b6_1.heavy 736.409 / 842.522 2184.0 50.22890090942383 43 13 10 10 10 1.4909731342605708 59.21797709784664 0.0 3 0.9038835225350084 3.948406894499604 2184.0 21.1575 0.0 - - - - - - - 136.04761904761904 4 21 ANKRD13A ankyrin repeat domain 13A 473 61 C20140403_SF097_05 C20140403_SF097_05 TB148849.[MT7]-LRVDITLLGFENMSWIR.3y5_1.heavy 736.409 / 692.355 1413.0 50.22890090942383 43 13 10 10 10 1.4909731342605708 59.21797709784664 0.0 3 0.9038835225350084 3.948406894499604 1413.0 7.305239224835076 0.0 - - - - - - - 158.95238095238096 2 21 ANKRD13A ankyrin repeat domain 13A 475 61 C20140403_SF097_05 C20140403_SF097_05 TB148849.[MT7]-LRVDITLLGFENMSWIR.3b4_1.heavy 736.409 / 628.39 1445.0 50.22890090942383 43 13 10 10 10 1.4909731342605708 59.21797709784664 0.0 3 0.9038835225350084 3.948406894499604 1445.0 10.898751033245297 0.0 - - - - - - - 143.76190476190476 2 21 ANKRD13A ankyrin repeat domain 13A 477 61 C20140403_SF097_05 C20140403_SF097_05 TB148849.[MT7]-LRVDITLLGFENMSWIR.3y9_1.heavy 736.409 / 1139.53 4881.0 50.22890090942383 43 13 10 10 10 1.4909731342605708 59.21797709784664 0.0 3 0.9038835225350084 3.948406894499604 4881.0 78.51969791666666 0.0 - - - - - - - 181.85714285714286 9 21 ANKRD13A ankyrin repeat domain 13A 479 62 C20140403_SF097_05 C20140403_SF097_05 TB480162.[MT7]-ETTEEIR.2y5_1.heavy 511.268 / 647.336 3471.0 17.60397481918335 42 16 10 6 10 2.7642648702964783 28.620078133455486 0.03230094909667969 3 0.9620443140373851 6.314524103866951 3471.0 128.2959613696225 0.0 - - - - - - - 107.27272727272727 6 22 DHRS3 dehydrogenase/reductase (SDR family) member 3 481 62 C20140403_SF097_05 C20140403_SF097_05 TB480162.[MT7]-ETTEEIR.2b4_1.heavy 511.268 / 605.29 3977.0 17.60397481918335 42 16 10 6 10 2.7642648702964783 28.620078133455486 0.03230094909667969 3 0.9620443140373851 6.314524103866951 3977.0 30.472857501569365 0.0 - - - - - - - 106.83333333333333 7 18 DHRS3 dehydrogenase/reductase (SDR family) member 3 483 62 C20140403_SF097_05 C20140403_SF097_05 TB480162.[MT7]-ETTEEIR.2y6_1.heavy 511.268 / 748.384 7785.0 17.60397481918335 42 16 10 6 10 2.7642648702964783 28.620078133455486 0.03230094909667969 3 0.9620443140373851 6.314524103866951 7785.0 66.43085808580858 0.0 - - - - - - - 94.66666666666667 15 21 DHRS3 dehydrogenase/reductase (SDR family) member 3 485 62 C20140403_SF097_05 C20140403_SF097_05 TB480162.[MT7]-ETTEEIR.2b5_1.heavy 511.268 / 734.333 9166.0 17.60397481918335 42 16 10 6 10 2.7642648702964783 28.620078133455486 0.03230094909667969 3 0.9620443140373851 6.314524103866951 9166.0 113.05851872711912 0.0 - - - - - - - 101.11111111111111 18 18 DHRS3 dehydrogenase/reductase (SDR family) member 3 487 63 C20140403_SF097_05 C20140403_SF097_05 TB148437.[MT7]-VATAYRPPALR.3b9_2.heavy 453.606 / 536.307 11491.0 26.664000511169434 42 16 10 6 10 3.2716852253554087 30.565287645952193 0.034801483154296875 3 0.9665991248458286 6.733907673574243 11491.0 9.414702389629705 0.0 - - - - - - - 671.875 22 8 EIF2A eukaryotic translation initiation factor 2A, 65kDa 489 63 C20140403_SF097_05 C20140403_SF097_05 TB148437.[MT7]-VATAYRPPALR.3y10_2.heavy 453.606 / 558.32 20695.0 26.664000511169434 42 16 10 6 10 3.2716852253554087 30.565287645952193 0.034801483154296875 3 0.9665991248458286 6.733907673574243 20695.0 35.56001874333651 0.0 - - - - - - - 362.0 41 3 EIF2A eukaryotic translation initiation factor 2A, 65kDa 491 63 C20140403_SF097_05 C20140403_SF097_05 TB148437.[MT7]-VATAYRPPALR.3y4_1.heavy 453.606 / 456.293 9433.0 26.664000511169434 42 16 10 6 10 3.2716852253554087 30.565287645952193 0.034801483154296875 3 0.9665991248458286 6.733907673574243 9433.0 13.544331106095811 0.0 - - - - - - - 724.25 18 12 EIF2A eukaryotic translation initiation factor 2A, 65kDa 493 63 C20140403_SF097_05 C20140403_SF097_05 TB148437.[MT7]-VATAYRPPALR.3y5_1.heavy 453.606 / 553.346 27899.0 26.664000511169434 42 16 10 6 10 3.2716852253554087 30.565287645952193 0.034801483154296875 3 0.9665991248458286 6.733907673574243 27899.0 32.6151878060993 0.0 - - - - - - - 371.5 55 6 EIF2A eukaryotic translation initiation factor 2A, 65kDa 495 64 C20140403_SF097_05 C20140403_SF097_05 TB480529.[MT7]-VLDQWFESEPLK[MT7].3y3_1.heavy 593.657 / 501.352 9148.0 42.84960174560547 45 15 10 10 10 3.449241883489758 28.99187803518881 0.0 3 0.9517659006979847 5.5965963870328626 9148.0 151.84546303369834 0.0 - - - - - - - 133.94444444444446 18 18 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 497 64 C20140403_SF097_05 C20140403_SF097_05 TB480529.[MT7]-VLDQWFESEPLK[MT7].3b4_1.heavy 593.657 / 600.347 4555.0 42.84960174560547 45 15 10 10 10 3.449241883489758 28.99187803518881 0.0 3 0.9517659006979847 5.5965963870328626 4555.0 85.93952253628724 0.0 - - - - - - - 135.3846153846154 9 13 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 499 64 C20140403_SF097_05 C20140403_SF097_05 TB480529.[MT7]-VLDQWFESEPLK[MT7].3b5_1.heavy 593.657 / 786.427 2105.0 42.84960174560547 45 15 10 10 10 3.449241883489758 28.99187803518881 0.0 3 0.9517659006979847 5.5965963870328626 2105.0 35.576996047430825 0.0 - - - - - - - 109.0 4 13 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 501 64 C20140403_SF097_05 C20140403_SF097_05 TB480529.[MT7]-VLDQWFESEPLK[MT7].3y5_1.heavy 593.657 / 717.426 1110.0 42.84960174560547 45 15 10 10 10 3.449241883489758 28.99187803518881 0.0 3 0.9517659006979847 5.5965963870328626 1110.0 46.73684210526316 0.0 - - - - - - - 127.33333333333333 2 9 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 503 65 C20140403_SF097_05 C20140403_SF097_05 TB148782.[MT7]-SQHINTLGQFWTTK[MT7].3y7_1.heavy 650.354 / 1011.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 505 65 C20140403_SF097_05 C20140403_SF097_05 TB148782.[MT7]-SQHINTLGQFWTTK[MT7].3b4_1.heavy 650.354 / 610.343 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 507 65 C20140403_SF097_05 C20140403_SF097_05 TB148782.[MT7]-SQHINTLGQFWTTK[MT7].3y4_1.heavy 650.354 / 679.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 509 65 C20140403_SF097_05 C20140403_SF097_05 TB148782.[MT7]-SQHINTLGQFWTTK[MT7].3y5_1.heavy 650.354 / 826.458 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 511 66 C20140403_SF097_05 C20140403_SF097_05 TB147857.[MT7]-DSVVGR.2y4_1.heavy 388.723 / 430.277 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 513 66 C20140403_SF097_05 C20140403_SF097_05 TB147857.[MT7]-DSVVGR.2b3_1.heavy 388.723 / 446.237 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 515 66 C20140403_SF097_05 C20140403_SF097_05 TB147857.[MT7]-DSVVGR.2y5_1.heavy 388.723 / 517.309 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 517 66 C20140403_SF097_05 C20140403_SF097_05 TB147857.[MT7]-DSVVGR.2b4_1.heavy 388.723 / 545.305 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 519 67 C20140403_SF097_05 C20140403_SF097_05 RBSB_ECOLI.LAATIAQLPDQIGAK.3y7.peptide 503.96 / 728.39 52740.0 34.8140983581543 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 52740.0 131.9228968987763 1.0 - - - - - - - 341.0 109 9 521 67 C20140403_SF097_05 C20140403_SF097_05 RBSB_ECOLI.LAATIAQLPDQIGAK.3y6.peptide 503.96 / 631.34 14348.0 34.8140983581543 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 14348.0 46.14548686868687 1.0 - - - - - - - 288.0 28 11 523 67 C20140403_SF097_05 C20140403_SF097_05 RBSB_ECOLI.LAATIAQLPDQIGAK.3y5.peptide 503.96 / 516.31 9004.0 34.8140983581543 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 9004.0 65.7110101010101 0.0 - - - - - - - 214.5 18 12 525 68 C20140403_SF097_05 C20140403_SF097_05 TB480626.[MT7]-ALYDNVAESPDELSFRK[MT7].4y8_2.heavy 561.295 / 568.315 464.0 33.28487586975098 41 16 10 5 10 2.433118153482535 41.09952484505098 0.04309844970703125 3 0.9650418869324836 6.581350411196117 464.0 2.195698924731183 5.0 - - - - - - - 0.0 0 0 BCAR1 breast cancer anti-estrogen resistance 1 527 68 C20140403_SF097_05 C20140403_SF097_05 TB480626.[MT7]-ALYDNVAESPDELSFRK[MT7].4b5_1.heavy 561.295 / 721.364 1857.0 33.28487586975098 41 16 10 5 10 2.433118153482535 41.09952484505098 0.04309844970703125 3 0.9650418869324836 6.581350411196117 1857.0 22.369035038932147 0.0 - - - - - - - 301.5 3 4 BCAR1 breast cancer anti-estrogen resistance 1 529 68 C20140403_SF097_05 C20140403_SF097_05 TB480626.[MT7]-ALYDNVAESPDELSFRK[MT7].4y9_2.heavy 561.295 / 611.831 1114.0 33.28487586975098 41 16 10 5 10 2.433118153482535 41.09952484505098 0.04309844970703125 3 0.9650418869324836 6.581350411196117 1114.0 13.424531600526032 0.0 - - - - - - - 208.75 2 4 BCAR1 breast cancer anti-estrogen resistance 1 531 68 C20140403_SF097_05 C20140403_SF097_05 TB480626.[MT7]-ALYDNVAESPDELSFRK[MT7].4b4_1.heavy 561.295 / 607.321 1857.0 33.28487586975098 41 16 10 5 10 2.433118153482535 41.09952484505098 0.04309844970703125 3 0.9650418869324836 6.581350411196117 1857.0 29.35258064516129 0.0 - - - - - - - 139.5 3 4 BCAR1 breast cancer anti-estrogen resistance 1 533 69 C20140403_SF097_05 C20140403_SF097_05 TB148538.[MT7]-INYQSC[CAM]PDWR.2b3_1.heavy 741.849 / 535.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 535 69 C20140403_SF097_05 C20140403_SF097_05 TB148538.[MT7]-INYQSC[CAM]PDWR.2y8_2.heavy 741.849 / 556.235 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 537 69 C20140403_SF097_05 C20140403_SF097_05 TB148538.[MT7]-INYQSC[CAM]PDWR.2y9_1.heavy 741.849 / 1225.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 539 69 C20140403_SF097_05 C20140403_SF097_05 TB148538.[MT7]-INYQSC[CAM]PDWR.2y7_1.heavy 741.849 / 948.399 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 541 70 C20140403_SF097_05 C20140403_SF097_05 TB480628.[MT7]-YGSSLEFTELLTLVNRK[MT7].4b4_1.heavy 565.321 / 539.258 N/A N/A - - - - - - - - - 0.0 - - - - - - - CASP6 caspase 6, apoptosis-related cysteine peptidase 543 70 C20140403_SF097_05 C20140403_SF097_05 TB480628.[MT7]-YGSSLEFTELLTLVNRK[MT7].4b5_1.heavy 565.321 / 652.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - CASP6 caspase 6, apoptosis-related cysteine peptidase 545 70 C20140403_SF097_05 C20140403_SF097_05 TB480628.[MT7]-YGSSLEFTELLTLVNRK[MT7].4y6_1.heavy 565.321 / 874.559 N/A N/A - - - - - - - - - 0.0 - - - - - - - CASP6 caspase 6, apoptosis-related cysteine peptidase 547 70 C20140403_SF097_05 C20140403_SF097_05 TB480628.[MT7]-YGSSLEFTELLTLVNRK[MT7].4b6_1.heavy 565.321 / 781.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - CASP6 caspase 6, apoptosis-related cysteine peptidase 549 71 C20140403_SF097_05 C20140403_SF097_05 TB480622.[MT7]-YRPTWDLALDPLVSC[CAM]K[MT7].4y4_1.heavy 556.302 / 637.346 1643.0 41.5703010559082 32 14 0 10 8 8.627649996656407 11.590641720370481 0.0 4 0.9365026269359955 4.8714608181674866 1643.0 42.718 0.0 - - - - - - - 104.0 3 12 RNF144A ring finger protein 144A 551 71 C20140403_SF097_05 C20140403_SF097_05 TB480622.[MT7]-YRPTWDLALDPLVSC[CAM]K[MT7].4b8_2.heavy 556.302 / 574.305 1494.0 41.5703010559082 32 14 0 10 8 8.627649996656407 11.590641720370481 0.0 4 0.9365026269359955 4.8714608181674866 1494.0 53.784 1.0 - - - - - - - 99.72727272727273 17 11 RNF144A ring finger protein 144A 553 71 C20140403_SF097_05 C20140403_SF097_05 TB480622.[MT7]-YRPTWDLALDPLVSC[CAM]K[MT7].4b6_1.heavy 556.302 / 963.481 1344.0 41.5703010559082 32 14 0 10 8 8.627649996656407 11.590641720370481 0.0 4 0.9365026269359955 4.8714608181674866 1344.0 33.6 0.0 - - - - - - - 177.11111111111111 2 9 RNF144A ring finger protein 144A 555 71 C20140403_SF097_05 C20140403_SF097_05 TB480622.[MT7]-YRPTWDLALDPLVSC[CAM]K[MT7].4b10_2.heavy 556.302 / 688.36 2639.0 41.5703010559082 32 14 0 10 8 8.627649996656407 11.590641720370481 0.0 4 0.9365026269359955 4.8714608181674866 2639.0 14.831360891935361 0.0 - - - - - - - 182.66666666666666 5 9 RNF144A ring finger protein 144A 557 72 C20140403_SF097_05 C20140403_SF097_05 TB148539.[MT7]-RFSDLGFEVK[MT7].3y3_1.heavy 495.948 / 519.326 11284.0 32.98469924926758 45 15 10 10 10 1.724930400703294 38.733931851808194 0.0 3 0.9539607911961091 5.729516633149732 11284.0 68.18184310220066 0.0 - - - - - - - 220.1 22 10 CASP6 caspase 6, apoptosis-related cysteine peptidase 559 72 C20140403_SF097_05 C20140403_SF097_05 TB148539.[MT7]-RFSDLGFEVK[MT7].3b6_1.heavy 495.948 / 820.443 9850.0 32.98469924926758 45 15 10 10 10 1.724930400703294 38.733931851808194 0.0 3 0.9539607911961091 5.729516633149732 9850.0 50.52847494502226 0.0 - - - - - - - 153.2 19 15 CASP6 caspase 6, apoptosis-related cysteine peptidase 561 72 C20140403_SF097_05 C20140403_SF097_05 TB148539.[MT7]-RFSDLGFEVK[MT7].3b4_1.heavy 495.948 / 650.338 8511.0 32.98469924926758 45 15 10 10 10 1.724930400703294 38.733931851808194 0.0 3 0.9539607911961091 5.729516633149732 8511.0 25.732930955754078 0.0 - - - - - - - 334.75 17 8 CASP6 caspase 6, apoptosis-related cysteine peptidase 563 72 C20140403_SF097_05 C20140403_SF097_05 TB148539.[MT7]-RFSDLGFEVK[MT7].3y5_1.heavy 495.948 / 723.416 3347.0 32.98469924926758 45 15 10 10 10 1.724930400703294 38.733931851808194 0.0 3 0.9539607911961091 5.729516633149732 3347.0 18.572041008565357 0.0 - - - - - - - 191.4 6 10 CASP6 caspase 6, apoptosis-related cysteine peptidase 565 73 C20140403_SF097_05 C20140403_SF097_05 TB148022.[MT7]-AYQFAGR.2b3_1.heavy 478.757 / 507.268 9187.0 23.2367000579834 50 20 10 10 10 3.3857234367889486 22.930842551050276 0.0 3 0.9919053663473761 13.707882728641408 9187.0 71.21904832316113 0.0 - - - - - - - 172.5 18 14 TTC35 tetratricopeptide repeat domain 35 567 73 C20140403_SF097_05 C20140403_SF097_05 TB148022.[MT7]-AYQFAGR.2y5_1.heavy 478.757 / 578.305 9256.0 23.2367000579834 50 20 10 10 10 3.3857234367889486 22.930842551050276 0.0 3 0.9919053663473761 13.707882728641408 9256.0 38.09264259253429 0.0 - - - - - - - 241.5625 18 16 TTC35 tetratricopeptide repeat domain 35 569 73 C20140403_SF097_05 C20140403_SF097_05 TB148022.[MT7]-AYQFAGR.2b4_1.heavy 478.757 / 654.337 5526.0 23.2367000579834 50 20 10 10 10 3.3857234367889486 22.930842551050276 0.0 3 0.9919053663473761 13.707882728641408 5526.0 23.35869565217391 0.0 - - - - - - - 226.16666666666666 11 18 TTC35 tetratricopeptide repeat domain 35 571 73 C20140403_SF097_05 C20140403_SF097_05 TB148022.[MT7]-AYQFAGR.2y6_1.heavy 478.757 / 741.368 21689.0 23.2367000579834 50 20 10 10 10 3.3857234367889486 22.930842551050276 0.0 3 0.9919053663473761 13.707882728641408 21689.0 319.53105952380946 0.0 - - - - - - - 211.11764705882354 43 17 TTC35 tetratricopeptide repeat domain 35 573 74 C20140403_SF097_05 C20140403_SF097_05 TB148907.[MT7]-NSEQIVEVGEELINEYASK[MT7].4b7_1.heavy 610.568 / 944.481 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 575 74 C20140403_SF097_05 C20140403_SF097_05 TB148907.[MT7]-NSEQIVEVGEELINEYASK[MT7].4b4_1.heavy 610.568 / 603.286 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 577 74 C20140403_SF097_05 C20140403_SF097_05 TB148907.[MT7]-NSEQIVEVGEELINEYASK[MT7].4b5_1.heavy 610.568 / 716.37 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 579 74 C20140403_SF097_05 C20140403_SF097_05 TB148907.[MT7]-NSEQIVEVGEELINEYASK[MT7].4b6_1.heavy 610.568 / 815.438 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 581 75 C20140403_SF097_05 C20140403_SF097_05 TB148320.[MT7]-RFPETVLAR.3b4_1.heavy 411.579 / 674.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 583 75 C20140403_SF097_05 C20140403_SF097_05 TB148320.[MT7]-RFPETVLAR.3b5_1.heavy 411.579 / 775.422 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 585 75 C20140403_SF097_05 C20140403_SF097_05 TB148320.[MT7]-RFPETVLAR.3y4_1.heavy 411.579 / 458.309 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 587 75 C20140403_SF097_05 C20140403_SF097_05 TB148320.[MT7]-RFPETVLAR.3y5_1.heavy 411.579 / 559.356 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 589 76 C20140403_SF097_05 C20140403_SF097_05 TB147922.[MT7]-TSDSYR.2b3_1.heavy 436.715 / 448.216 5454.0 13.604099750518799 33 17 2 6 8 3.4559145858866263 22.731943664854107 0.03040027618408203 4 0.9760226982937783 7.95409197053078 5454.0 28.22228571428571 0.0 - - - - - - - 162.33333333333334 10 27 USP2 ubiquitin specific peptidase 2 591 76 C20140403_SF097_05 C20140403_SF097_05 TB147922.[MT7]-TSDSYR.2y5_1.heavy 436.715 / 627.273 3636.0 13.604099750518799 33 17 2 6 8 3.4559145858866263 22.731943664854107 0.03040027618408203 4 0.9760226982937783 7.95409197053078 3636.0 29.6689401135179 1.0 - - - - - - - 133.66666666666666 25 27 USP2 ubiquitin specific peptidase 2 593 76 C20140403_SF097_05 C20140403_SF097_05 TB147922.[MT7]-TSDSYR.2b4_1.heavy 436.715 / 535.248 2279.0 13.604099750518799 33 17 2 6 8 3.4559145858866263 22.731943664854107 0.03040027618408203 4 0.9760226982937783 7.95409197053078 2279.0 16.234412736995623 0.0 - - - - - - - 140.69230769230768 4 26 USP2 ubiquitin specific peptidase 2 595 76 C20140403_SF097_05 C20140403_SF097_05 TB147922.[MT7]-TSDSYR.2b5_1.heavy 436.715 / 698.311 436.0 13.604099750518799 33 17 2 6 8 3.4559145858866263 22.731943664854107 0.03040027618408203 4 0.9760226982937783 7.95409197053078 436.0 2.104827586206896 10.0 - - - - - - - 0.0 1 0 USP2 ubiquitin specific peptidase 2 597 77 C20140403_SF097_05 C20140403_SF097_05 TB147921.[MT7]-DFSSLR.2b3_1.heavy 434.736 / 494.237 4130.0 25.197399139404297 45 17 10 10 8 2.6785127146891536 29.83071565758745 0.0 4 0.9794218810666739 8.588394014955124 4130.0 8.892019213860635 0.0 - - - - - - - 691.4545454545455 8 11 USP2 ubiquitin specific peptidase 2 599 77 C20140403_SF097_05 C20140403_SF097_05 TB147921.[MT7]-DFSSLR.2y4_1.heavy 434.736 / 462.267 8719.0 25.197399139404297 45 17 10 10 8 2.6785127146891536 29.83071565758745 0.0 4 0.9794218810666739 8.588394014955124 8719.0 12.082864366295663 1.0 - - - - - - - 768.7272727272727 24 11 USP2 ubiquitin specific peptidase 2 601 77 C20140403_SF097_05 C20140403_SF097_05 TB147921.[MT7]-DFSSLR.2y5_1.heavy 434.736 / 609.336 28384.0 25.197399139404297 45 17 10 10 8 2.6785127146891536 29.83071565758745 0.0 4 0.9794218810666739 8.588394014955124 28384.0 40.07659728039235 0.0 - - - - - - - 273.1666666666667 56 12 USP2 ubiquitin specific peptidase 2 603 77 C20140403_SF097_05 C20140403_SF097_05 TB147921.[MT7]-DFSSLR.2b4_1.heavy 434.736 / 581.269 11668.0 25.197399139404297 45 17 10 10 8 2.6785127146891536 29.83071565758745 0.0 4 0.9794218810666739 8.588394014955124 11668.0 29.297216739159545 0.0 - - - - - - - 245.9375 23 16 USP2 ubiquitin specific peptidase 2 605 78 C20140403_SF097_05 C20140403_SF097_05 TB147925.[MT7]-GAPSFVR.2y5_1.heavy 439.254 / 605.341 27316.0 24.365100860595703 44 14 10 10 10 2.5477946839906354 30.992317197615943 0.0 3 0.9488160992164545 5.4315732441029825 27316.0 113.03420797915244 0.0 - - - - - - - 284.0 54 12 EIF2A eukaryotic translation initiation factor 2A, 65kDa 607 78 C20140403_SF097_05 C20140403_SF097_05 TB147925.[MT7]-GAPSFVR.2b4_1.heavy 439.254 / 457.253 8727.0 24.365100860595703 44 14 10 10 10 2.5477946839906354 30.992317197615943 0.0 3 0.9488160992164545 5.4315732441029825 8727.0 18.971739130434784 0.0 - - - - - - - 769.4615384615385 17 13 EIF2A eukaryotic translation initiation factor 2A, 65kDa 609 78 C20140403_SF097_05 C20140403_SF097_05 TB147925.[MT7]-GAPSFVR.2y6_1.heavy 439.254 / 676.378 13765.0 24.365100860595703 44 14 10 10 10 2.5477946839906354 30.992317197615943 0.0 3 0.9488160992164545 5.4315732441029825 13765.0 108.73057511737088 0.0 - - - - - - - 203.53333333333333 27 15 EIF2A eukaryotic translation initiation factor 2A, 65kDa 611 78 C20140403_SF097_05 C20140403_SF097_05 TB147925.[MT7]-GAPSFVR.2b5_1.heavy 439.254 / 604.321 19796.0 24.365100860595703 44 14 10 10 10 2.5477946839906354 30.992317197615943 0.0 3 0.9488160992164545 5.4315732441029825 19796.0 46.658386443145076 0.0 - - - - - - - 736.25 39 8 EIF2A eukaryotic translation initiation factor 2A, 65kDa 613 79 C20140403_SF097_05 C20140403_SF097_05 ODP2_ECOLI.EAAPAAAPAAAAAK.2y7.peptide 590.82 / 599.35 121271.0 17.82260004679362 24 -3 10 7 10 null 0.0 0.024900436401367188 3 0.0 0.0 121271.0 3575.915125484918 0.0 - - - - - - - 233.27272727272728 242 11 615 79 C20140403_SF097_05 C20140403_SF097_05 ODP2_ECOLI.EAAPAAAPAAAAAK.2y9.peptide 590.82 / 741.43 62205.0 17.82260004679362 24 -3 10 7 10 null 0.0 0.024900436401367188 3 0.0 0.0 62205.0 518.4630759487806 0.0 - - - - - - - 121.6 124 10 617 79 C20140403_SF097_05 C20140403_SF097_05 ODP2_ECOLI.EAAPAAAPAAAAAK.2y11.peptide 590.82 / 909.52 62239.0 17.82260004679362 24 -3 10 7 10 null 0.0 0.024900436401367188 3 0.0 0.0 62239.0 1840.1310179166007 0.0 - - - - - - - 140.30769230769232 124 13 619 80 C20140403_SF097_05 C20140403_SF097_05 TB480156.[MT7]-AVPEDAK[MT7].2y6_1.heavy 509.295 / 802.443 964.0 17.29473368326823 39 20 10 3 6 3.1223432469992862 23.63467619658474 0.05679893493652344 5 0.9937402387696694 15.590379145589335 964.0 24.190375 1.0 - - - - - - - 128.45 3 20 BCAR1 breast cancer anti-estrogen resistance 1 621 80 C20140403_SF097_05 C20140403_SF097_05 TB480156.[MT7]-AVPEDAK[MT7].2y4_1.heavy 509.295 / 606.321 N/A 17.29473368326823 39 20 10 3 6 3.1223432469992862 23.63467619658474 0.05679893493652344 5 0.9937402387696694 15.590379145589335 450.0 1.7564445525291825 0.0 - - - - - - - 0.0 0 0 BCAR1 breast cancer anti-estrogen resistance 1 623 80 C20140403_SF097_05 C20140403_SF097_05 TB480156.[MT7]-AVPEDAK[MT7].2b5_1.heavy 509.295 / 656.337 546.0 17.29473368326823 39 20 10 3 6 3.1223432469992862 23.63467619658474 0.05679893493652344 5 0.9937402387696694 15.590379145589335 546.0 0.4879541689325053 2.0 - - - - - - - 0.0 1 0 BCAR1 breast cancer anti-estrogen resistance 1 625 80 C20140403_SF097_05 C20140403_SF097_05 TB480156.[MT7]-AVPEDAK[MT7].2y5_1.heavy 509.295 / 703.374 4018.0 17.29473368326823 39 20 10 3 6 3.1223432469992862 23.63467619658474 0.05679893493652344 5 0.9937402387696694 15.590379145589335 4018.0 233.54625 0.0 - - - - - - - 92.84210526315789 8 19 BCAR1 breast cancer anti-estrogen resistance 1 627 81 C20140403_SF097_05 C20140403_SF097_05 TB480092.[MT7]-ILLWSR.2b3_1.heavy 466.296 / 484.362 18725.0 38.96030044555664 50 20 10 10 10 6.997971684033152 14.289854905838496 0.0 3 0.9934982811884906 15.297226325168907 18725.0 91.08565855661637 0.0 - - - - - - - 207.86666666666667 37 15 CD38 CD38 molecule 629 81 C20140403_SF097_05 C20140403_SF097_05 TB480092.[MT7]-ILLWSR.2y4_1.heavy 466.296 / 561.314 27260.0 38.96030044555664 50 20 10 10 10 6.997971684033152 14.289854905838496 0.0 3 0.9934982811884906 15.297226325168907 27260.0 150.01572327044022 0.0 - - - - - - - 214.1818181818182 54 11 CD38 CD38 molecule 631 81 C20140403_SF097_05 C20140403_SF097_05 TB480092.[MT7]-ILLWSR.2y5_1.heavy 466.296 / 674.398 66176.0 38.96030044555664 50 20 10 10 10 6.997971684033152 14.289854905838496 0.0 3 0.9934982811884906 15.297226325168907 66176.0 144.15515023039487 0.0 - - - - - - - 179.54545454545453 132 11 CD38 CD38 molecule 633 81 C20140403_SF097_05 C20140403_SF097_05 TB480092.[MT7]-ILLWSR.2b5_1.heavy 466.296 / 757.473 2293.0 38.96030044555664 50 20 10 10 10 6.997971684033152 14.289854905838496 0.0 3 0.9934982811884906 15.297226325168907 2293.0 45.4398167539267 0.0 - - - - - - - 161.69230769230768 4 13 CD38 CD38 molecule 635 82 C20140403_SF097_05 C20140403_SF097_05 TB480298.[MT7]-AAVGLVLPAK[MT7].2y4_1.heavy 613.907 / 572.389 2744.0 33.66960144042969 44 14 10 10 10 1.400185301482724 41.022983963756495 0.0 3 0.9422976903531151 5.11275527129535 2744.0 51.8 0.0 - - - - - - - 176.4 5 5 DHRS3 dehydrogenase/reductase (SDR family) member 3 637 82 C20140403_SF097_05 C20140403_SF097_05 TB480298.[MT7]-AAVGLVLPAK[MT7].2b6_1.heavy 613.907 / 655.426 4017.0 33.66960144042969 44 14 10 10 10 1.400185301482724 41.022983963756495 0.0 3 0.9422976903531151 5.11275527129535 4017.0 50.48576530612246 0.0 - - - - - - - 156.8 8 5 DHRS3 dehydrogenase/reductase (SDR family) member 3 639 82 C20140403_SF097_05 C20140403_SF097_05 TB480298.[MT7]-AAVGLVLPAK[MT7].2b5_1.heavy 613.907 / 556.357 3038.0 33.66960144042969 44 14 10 10 10 1.400185301482724 41.022983963756495 0.0 3 0.9422976903531151 5.11275527129535 3038.0 3.5199999999999996 1.0 - - - - - - - 280.0 6 7 DHRS3 dehydrogenase/reductase (SDR family) member 3 641 82 C20140403_SF097_05 C20140403_SF097_05 TB480298.[MT7]-AAVGLVLPAK[MT7].2y7_1.heavy 613.907 / 841.563 3136.0 33.66960144042969 44 14 10 10 10 1.400185301482724 41.022983963756495 0.0 3 0.9422976903531151 5.11275527129535 3136.0 55.36 0.0 - - - - - - - 159.25 6 8 DHRS3 dehydrogenase/reductase (SDR family) member 3 643 83 C20140403_SF097_05 C20140403_SF097_05 TB480481.[MT7]-NSEQIVEVGEELINEYASK[MT7].3y6_1.heavy 813.755 / 855.433 21372.0 48.4276008605957 44 14 10 10 10 1.5989255634438029 43.010982451667665 0.0 3 0.9462599798622109 5.299673203327368 21372.0 104.00243918918919 0.0 - - - - - - - 257.85714285714283 42 14 TTC35 tetratricopeptide repeat domain 35 645 83 C20140403_SF097_05 C20140403_SF097_05 TB480481.[MT7]-NSEQIVEVGEELINEYASK[MT7].3b4_1.heavy 813.755 / 603.286 30439.0 48.4276008605957 44 14 10 10 10 1.5989255634438029 43.010982451667665 0.0 3 0.9462599798622109 5.299673203327368 30439.0 67.30725429223408 0.0 - - - - - - - 283.375 60 8 TTC35 tetratricopeptide repeat domain 35 647 83 C20140403_SF097_05 C20140403_SF097_05 TB480481.[MT7]-NSEQIVEVGEELINEYASK[MT7].3b5_1.heavy 813.755 / 716.37 28219.0 48.4276008605957 44 14 10 10 10 1.5989255634438029 43.010982451667665 0.0 3 0.9462599798622109 5.299673203327368 28219.0 83.22469892812106 0.0 - - - - - - - 324.0833333333333 56 12 TTC35 tetratricopeptide repeat domain 35 649 83 C20140403_SF097_05 C20140403_SF097_05 TB480481.[MT7]-NSEQIVEVGEELINEYASK[MT7].3b7_1.heavy 813.755 / 944.481 34371.0 48.4276008605957 44 14 10 10 10 1.5989255634438029 43.010982451667665 0.0 3 0.9462599798622109 5.299673203327368 34371.0 113.35046585138053 0.0 - - - - - - - 242.15384615384616 68 13 TTC35 tetratricopeptide repeat domain 35 651 84 C20140403_SF097_05 C20140403_SF097_05 TB480291.[MT7]-ELESIISK[MT7].2b3_1.heavy 603.863 / 516.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 653 84 C20140403_SF097_05 C20140403_SF097_05 TB480291.[MT7]-ELESIISK[MT7].2y5_1.heavy 603.863 / 691.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 655 84 C20140403_SF097_05 C20140403_SF097_05 TB480291.[MT7]-ELESIISK[MT7].2b4_1.heavy 603.863 / 603.311 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 657 84 C20140403_SF097_05 C20140403_SF097_05 TB480291.[MT7]-ELESIISK[MT7].2y7_1.heavy 603.863 / 933.574 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 659 85 C20140403_SF097_05 C20140403_SF097_05 TB148295.[MT7]-LVIK[MT7]PAK[MT7].3y6_2.heavy 400.952 / 472.331 33995.0 24.511250019073486 40 14 10 6 10 2.5040593874841974 39.935155092495215 0.03899955749511719 3 0.9370323533568211 4.89213000780396 33995.0 42.42570197952698 0.0 - - - - - - - 243.85714285714286 67 7 HAVCR2 hepatitis A virus cellular receptor 2 661 85 C20140403_SF097_05 C20140403_SF097_05 TB148295.[MT7]-LVIK[MT7]PAK[MT7].3y3_1.heavy 400.952 / 459.305 56612.0 24.511250019073486 40 14 10 6 10 2.5040593874841974 39.935155092495215 0.03899955749511719 3 0.9370323533568211 4.89213000780396 56612.0 105.5092254176436 0.0 - - - - - - - 835.5 113 8 HAVCR2 hepatitis A virus cellular receptor 2 663 85 C20140403_SF097_05 C20140403_SF097_05 TB148295.[MT7]-LVIK[MT7]PAK[MT7].3y4_1.heavy 400.952 / 731.502 4338.0 24.511250019073486 40 14 10 6 10 2.5040593874841974 39.935155092495215 0.03899955749511719 3 0.9370323533568211 4.89213000780396 4338.0 85.2325352112676 0.0 - - - - - - - 167.9090909090909 8 11 HAVCR2 hepatitis A virus cellular receptor 2 665 85 C20140403_SF097_05 C20140403_SF097_05 TB148295.[MT7]-LVIK[MT7]PAK[MT7].3y5_2.heavy 400.952 / 422.797 16073.0 24.511250019073486 40 14 10 6 10 2.5040593874841974 39.935155092495215 0.03899955749511719 3 0.9370323533568211 4.89213000780396 16073.0 174.62607826417968 0.0 - - - - - - - 284.5 32 10 HAVCR2 hepatitis A virus cellular receptor 2 667 86 C20140403_SF097_05 C20140403_SF097_05 TB480513.[MT7]-GRPLLRPDITGGGK[MT7].3y6_1.heavy 575.684 / 676.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 669 86 C20140403_SF097_05 C20140403_SF097_05 TB480513.[MT7]-GRPLLRPDITGGGK[MT7].3y8_1.heavy 575.684 / 888.491 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 671 86 C20140403_SF097_05 C20140403_SF097_05 TB480513.[MT7]-GRPLLRPDITGGGK[MT7].3y5_1.heavy 575.684 / 563.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 673 86 C20140403_SF097_05 C20140403_SF097_05 TB480513.[MT7]-GRPLLRPDITGGGK[MT7].3b8_2.heavy 575.684 / 525.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 675 87 C20140403_SF097_05 C20140403_SF097_05 TB480350.[MT7]-DILTPPDLER.3y6_1.heavy 438.246 / 726.378 7627.0 34.46839904785156 39 14 10 5 10 2.7303067049354253 36.62592184945211 0.04759979248046875 3 0.9389772029322319 4.9703010475613745 7627.0 4.057843423092571 1.0 - - - - - - - 254.57142857142858 15 7 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 677 87 C20140403_SF097_05 C20140403_SF097_05 TB480350.[MT7]-DILTPPDLER.3y4_1.heavy 438.246 / 532.273 10400.0 34.46839904785156 39 14 10 5 10 2.7303067049354253 36.62592184945211 0.04759979248046875 3 0.9389772029322319 4.9703010475613745 10400.0 34.983209725514186 0.0 - - - - - - - 237.6 20 5 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 679 87 C20140403_SF097_05 C20140403_SF097_05 TB480350.[MT7]-DILTPPDLER.3b3_1.heavy 438.246 / 486.304 18423.0 34.46839904785156 39 14 10 5 10 2.7303067049354253 36.62592184945211 0.04759979248046875 3 0.9389772029322319 4.9703010475613745 18423.0 18.006852995424822 0.0 - - - - - - - 445.5 36 2 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 681 87 C20140403_SF097_05 C20140403_SF097_05 TB480350.[MT7]-DILTPPDLER.3y5_1.heavy 438.246 / 629.325 23178.0 34.46839904785156 39 14 10 5 10 2.7303067049354253 36.62592184945211 0.04759979248046875 3 0.9389772029322319 4.9703010475613745 23178.0 97.55050505050505 0.0 - - - - - - - 247.5 46 2 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 683 88 C20140403_SF097_05 C20140403_SF097_05 TB148327.[MT7]-QIAQFSQK[MT7].3y3_1.heavy 413.243 / 506.306 49365.0 24.28700065612793 48 18 10 10 10 3.8545744581227024 20.76451268089426 0.0 3 0.9881805088380924 11.340554447692234 49365.0 164.5296241503138 0.0 - - - - - - - 268.375 98 8 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 685 88 C20140403_SF097_05 C20140403_SF097_05 TB148327.[MT7]-QIAQFSQK[MT7].3b4_1.heavy 413.243 / 585.348 42210.0 24.28700065612793 48 18 10 10 10 3.8545744581227024 20.76451268089426 0.0 3 0.9881805088380924 11.340554447692234 42210.0 96.81272152505028 0.0 - - - - - - - 196.91666666666666 84 12 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 687 88 C20140403_SF097_05 C20140403_SF097_05 TB148327.[MT7]-QIAQFSQK[MT7].3y4_1.heavy 413.243 / 653.374 10731.0 24.28700065612793 48 18 10 10 10 3.8545744581227024 20.76451268089426 0.0 3 0.9881805088380924 11.340554447692234 10731.0 73.54111888111888 0.0 - - - - - - - 189.21428571428572 21 14 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 689 88 C20140403_SF097_05 C20140403_SF097_05 TB148327.[MT7]-QIAQFSQK[MT7].3b3_1.heavy 413.243 / 457.289 44571.0 24.28700065612793 48 18 10 10 10 3.8545744581227024 20.76451268089426 0.0 3 0.9881805088380924 11.340554447692234 44571.0 38.75364832447611 0.0 - - - - - - - 1165.2857142857142 89 7 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 691 89 C20140403_SF097_05 C20140403_SF097_05 TB148654.[MT7]-FFWHLTLPERR.4y4_1.heavy 412.233 / 557.315 7059.0 38.86457443237305 41 15 10 6 10 2.6282645249826575 38.04792061433004 0.0343017578125 3 0.9523462614572116 5.630850101523894 7059.0 29.32337121212121 0.0 - - - - - - - 193.875 14 16 CASP6 caspase 6, apoptosis-related cysteine peptidase 693 89 C20140403_SF097_05 C20140403_SF097_05 TB148654.[MT7]-FFWHLTLPERR.4y8_2.heavy 412.233 / 511.299 7059.0 38.86457443237305 41 15 10 6 10 2.6282645249826575 38.04792061433004 0.0343017578125 3 0.9523462614572116 5.630850101523894 7059.0 10.202841394905132 0.0 - - - - - - - 643.5 14 8 CASP6 caspase 6, apoptosis-related cysteine peptidase 695 89 C20140403_SF097_05 C20140403_SF097_05 TB148654.[MT7]-FFWHLTLPERR.4y7_2.heavy 412.233 / 442.769 28700.0 38.86457443237305 41 15 10 6 10 2.6282645249826575 38.04792061433004 0.0343017578125 3 0.9523462614572116 5.630850101523894 28700.0 138.9030303030303 0.0 - - - - - - - 220.0 57 6 CASP6 caspase 6, apoptosis-related cysteine peptidase 697 89 C20140403_SF097_05 C20140403_SF097_05 TB148654.[MT7]-FFWHLTLPERR.4b3_1.heavy 412.233 / 625.326 2375.0 38.86457443237305 41 15 10 6 10 2.6282645249826575 38.04792061433004 0.0343017578125 3 0.9523462614572116 5.630850101523894 2375.0 8.684343434343434 0.0 - - - - - - - 257.4 4 10 CASP6 caspase 6, apoptosis-related cysteine peptidase 699 90 C20140403_SF097_05 C20140403_SF097_05 TB148198.[MT7]-RVDFC[CAM]K[MT7].3y3_1.heavy 371.542 / 598.314 8488.0 21.085100173950195 45 16 9 10 10 4.221955399100059 23.68570734340674 0.0 3 0.9671148846532162 6.786803761880651 8488.0 24.510253725332262 0.0 - - - - - - - 160.77272727272728 16 22 CASP6 caspase 6, apoptosis-related cysteine peptidase 701 90 C20140403_SF097_05 C20140403_SF097_05 TB148198.[MT7]-RVDFC[CAM]K[MT7].3b4_1.heavy 371.542 / 662.374 1146.0 21.085100173950195 45 16 9 10 10 4.221955399100059 23.68570734340674 0.0 3 0.9671148846532162 6.786803761880651 1146.0 1.4038461538461535 1.0 - - - - - - - 72.0 2 13 CASP6 caspase 6, apoptosis-related cysteine peptidase 703 90 C20140403_SF097_05 C20140403_SF097_05 TB148198.[MT7]-RVDFC[CAM]K[MT7].3b3_2.heavy 371.542 / 258.156 N/A 21.085100173950195 45 16 9 10 10 4.221955399100059 23.68570734340674 0.0 3 0.9671148846532162 6.786803761880651 47958.0 13.030287613019821 2.0 - - - - - - - 1823.0 109 1 CASP6 caspase 6, apoptosis-related cysteine peptidase 705 90 C20140403_SF097_05 C20140403_SF097_05 TB148198.[MT7]-RVDFC[CAM]K[MT7].3b3_1.heavy 371.542 / 515.306 3176.0 21.085100173950195 45 16 9 10 10 4.221955399100059 23.68570734340674 0.0 3 0.9671148846532162 6.786803761880651 3176.0 57.41230769230769 0.0 - - - - - - - 156.04761904761904 6 21 CASP6 caspase 6, apoptosis-related cysteine peptidase 707 91 C20140403_SF097_05 C20140403_SF097_05 TB480151.[MT7]-ILGAQLPR.2y5_1.heavy 506.325 / 584.352 3456.0 31.69260025024414 48 18 10 10 10 5.4772100926724905 18.257470191581987 0.0 3 0.9865742055178252 10.639109437128056 3456.0 8.261340748896908 0.0 - - - - - - - 216.30769230769232 6 13 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 709 91 C20140403_SF097_05 C20140403_SF097_05 TB480151.[MT7]-ILGAQLPR.2y6_1.heavy 506.325 / 641.373 18086.0 31.69260025024414 48 18 10 10 10 5.4772100926724905 18.257470191581987 0.0 3 0.9865742055178252 10.639109437128056 18086.0 72.2212192587908 0.0 - - - - - - - 270.3636363636364 36 11 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 711 91 C20140403_SF097_05 C20140403_SF097_05 TB480151.[MT7]-ILGAQLPR.2b5_1.heavy 506.325 / 627.395 5225.0 31.69260025024414 48 18 10 10 10 5.4772100926724905 18.257470191581987 0.0 3 0.9865742055178252 10.639109437128056 5225.0 30.506211180124225 0.0 - - - - - - - 174.94117647058823 10 17 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 713 91 C20140403_SF097_05 C20140403_SF097_05 TB480151.[MT7]-ILGAQLPR.2y7_1.heavy 506.325 / 754.457 27490.0 31.69260025024414 48 18 10 10 10 5.4772100926724905 18.257470191581987 0.0 3 0.9865742055178252 10.639109437128056 27490.0 116.59543483090715 0.0 - - - - - - - 160.83333333333334 54 12 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 715 92 C20140403_SF097_05 C20140403_SF097_05 TB148856.[MT7]-ALYDNVAESPDELSFRK[MT7].3b4_1.heavy 748.058 / 607.321 9357.0 33.27410125732422 46 16 10 10 10 4.385398510415544 22.80294476374152 0.0 3 0.9683830759766029 6.922319117695272 9357.0 7.438471488368901 0.0 - - - - - - - 270.77777777777777 18 9 BCAR1 breast cancer anti-estrogen resistance 1 717 92 C20140403_SF097_05 C20140403_SF097_05 TB148856.[MT7]-ALYDNVAESPDELSFRK[MT7].3b5_1.heavy 748.058 / 721.364 10137.0 33.27410125732422 46 16 10 10 10 4.385398510415544 22.80294476374152 0.0 3 0.9683830759766029 6.922319117695272 10137.0 45.469082796545806 0.0 - - - - - - - 292.26666666666665 20 15 BCAR1 breast cancer anti-estrogen resistance 1 719 92 C20140403_SF097_05 C20140403_SF097_05 TB148856.[MT7]-ALYDNVAESPDELSFRK[MT7].3y8_1.heavy 748.058 / 1135.62 5946.0 33.27410125732422 46 16 10 10 10 4.385398510415544 22.80294476374152 0.0 3 0.9683830759766029 6.922319117695272 5946.0 72.79095400475813 0.0 - - - - - - - 217.23076923076923 11 13 BCAR1 breast cancer anti-estrogen resistance 1 721 92 C20140403_SF097_05 C20140403_SF097_05 TB148856.[MT7]-ALYDNVAESPDELSFRK[MT7].3y9_1.heavy 748.058 / 1222.65 1949.0 33.27410125732422 46 16 10 10 10 4.385398510415544 22.80294476374152 0.0 3 0.9683830759766029 6.922319117695272 1949.0 21.413952831520973 2.0 - - - - - - - 215.5 4 14 BCAR1 breast cancer anti-estrogen resistance 1 723 93 C20140403_SF097_05 C20140403_SF097_05 TB480355.[MT7]-AVAASPFPAWR.2y8_1.heavy 658.865 / 931.479 6176.0 36.86460018157959 41 18 10 3 10 2.483550006017814 28.41164745030737 0.07120132446289062 3 0.9829502285239723 9.438089663045314 6176.0 130.3068131868132 0.0 - - - - - - - 166.66666666666666 12 6 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 725 93 C20140403_SF097_05 C20140403_SF097_05 TB480355.[MT7]-AVAASPFPAWR.2y9_1.heavy 658.865 / 1002.52 5904.0 36.86460018157959 41 18 10 3 10 2.483550006017814 28.41164745030737 0.07120132446289062 3 0.9829502285239723 9.438089663045314 5904.0 83.69406593406593 0.0 - - - - - - - 181.66666666666666 11 12 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 727 93 C20140403_SF097_05 C20140403_SF097_05 TB480355.[MT7]-AVAASPFPAWR.2y6_1.heavy 658.865 / 773.409 4995.0 36.86460018157959 41 18 10 3 10 2.483550006017814 28.41164745030737 0.07120132446289062 3 0.9829502285239723 9.438089663045314 4995.0 34.051212663988 0.0 - - - - - - - 246.42857142857142 9 7 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 729 93 C20140403_SF097_05 C20140403_SF097_05 TB480355.[MT7]-AVAASPFPAWR.2y10_1.heavy 658.865 / 1101.58 4632.0 36.86460018157959 41 18 10 3 10 2.483550006017814 28.41164745030737 0.07120132446289062 3 0.9829502285239723 9.438089663045314 4632.0 22.466324878575286 0.0 - - - - - - - 259.42857142857144 9 7 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 731 94 C20140403_SF097_05 C20140403_SF097_05 TB147999.[MT7]-DLFLQR.2y4_1.heavy 468.275 / 563.33 4371.0 31.98533312479655 34 18 2 6 8 4.651952599426077 21.496349729001373 0.037700653076171875 4 0.9898929989939166 12.265485716335828 4371.0 12.026314126790316 0.0 - - - - - - - 210.0 8 13 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 733 94 C20140403_SF097_05 C20140403_SF097_05 TB147999.[MT7]-DLFLQR.2b3_1.heavy 468.275 / 520.289 7649.0 31.98533312479655 34 18 2 6 8 4.651952599426077 21.496349729001373 0.037700653076171875 4 0.9898929989939166 12.265485716335828 7649.0 18.652312408150728 1.0 - - - - - - - 257.8333333333333 33 12 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 735 94 C20140403_SF097_05 C20140403_SF097_05 TB147999.[MT7]-DLFLQR.2y5_1.heavy 468.275 / 676.414 N/A 31.98533312479655 34 18 2 6 8 4.651952599426077 21.496349729001373 0.037700653076171875 4 0.9898929989939166 12.265485716335828 8287.0 42.81062407294533 1.0 - - - - - - - 265.4166666666667 24 12 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 737 94 C20140403_SF097_05 C20140403_SF097_05 TB147999.[MT7]-DLFLQR.2b4_1.heavy 468.275 / 633.373 3278.0 31.98533312479655 34 18 2 6 8 4.651952599426077 21.496349729001373 0.037700653076171875 4 0.9898929989939166 12.265485716335828 3278.0 12.96649946132299 0.0 - - - - - - - 182.0 6 13 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 739 95 C20140403_SF097_05 C20140403_SF097_05 TB148193.[MT7]-K[MT7]LQFER.3y3_1.heavy 370.229 / 451.23 8815.0 22.549999237060547 40 10 10 10 10 0.6156793490484774 83.79584768586838 0.0 3 0.8374203024117842 3.0182942588717654 8815.0 168.90677419354842 0.0 - - - - - - - 172.78571428571428 17 14 RNF144A ring finger protein 144A 741 95 C20140403_SF097_05 C20140403_SF097_05 TB148193.[MT7]-K[MT7]LQFER.3b3_1.heavy 370.229 / 658.449 559.0 22.549999237060547 40 10 10 10 10 0.6156793490484774 83.79584768586838 0.0 3 0.8374203024117842 3.0182942588717654 559.0 17.491290322580646 0.0 - - - - - - - 0.0 1 0 RNF144A ring finger protein 144A 743 95 C20140403_SF097_05 C20140403_SF097_05 TB148193.[MT7]-K[MT7]LQFER.3y4_1.heavy 370.229 / 579.289 5897.0 22.549999237060547 40 10 10 10 10 0.6156793490484774 83.79584768586838 0.0 3 0.8374203024117842 3.0182942588717654 5897.0 70.8591129032258 0.0 - - - - - - - 210.9 11 10 RNF144A ring finger protein 144A 745 95 C20140403_SF097_05 C20140403_SF097_05 TB148193.[MT7]-K[MT7]LQFER.3y5_1.heavy 370.229 / 692.373 2049.0 22.549999237060547 40 10 10 10 10 0.6156793490484774 83.79584768586838 0.0 3 0.8374203024117842 3.0182942588717654 2049.0 20.93064516129032 0.0 - - - - - - - 103.33333333333333 4 3 RNF144A ring finger protein 144A 747 96 C20140403_SF097_05 C20140403_SF097_05 TB148034.[MT7]-TGTC[CAM]LK[MT7].2y5_1.heavy 484.278 / 722.399 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 749 97 C20140403_SF097_05 C20140403_SF097_05 TB147997.[MT7]-DIVDGK[MT7].2y4_1.heavy 467.776 / 562.332 N/A 20.19813283284505 35 13 6 6 10 1.016331891694792 59.16896821983002 0.031398773193359375 3 0.9243220915390862 4.457590014208874 2493.0 9.871112688085608 2.0 - - - - - - - 222.7391304347826 8 23 BCAS1 breast carcinoma amplified sequence 1 751 97 C20140403_SF097_05 C20140403_SF097_05 TB147997.[MT7]-DIVDGK[MT7].2y5_1.heavy 467.776 / 675.416 1317.0 20.19813283284505 35 13 6 6 10 1.016331891694792 59.16896821983002 0.031398773193359375 3 0.9243220915390862 4.457590014208874 1317.0 9.977772215269086 0.0 - - - - - - - 172.33333333333334 2 24 BCAS1 breast carcinoma amplified sequence 1 753 97 C20140403_SF097_05 C20140403_SF097_05 TB147997.[MT7]-DIVDGK[MT7].2b4_1.heavy 467.776 / 587.316 2917.0 20.19813283284505 35 13 6 6 10 1.016331891694792 59.16896821983002 0.031398773193359375 3 0.9243220915390862 4.457590014208874 2917.0 14.017559270516717 1.0 - - - - - - - 235.0 5 22 BCAS1 breast carcinoma amplified sequence 1 755 97 C20140403_SF097_05 C20140403_SF097_05 TB147997.[MT7]-DIVDGK[MT7].2y3_1.heavy 467.776 / 463.263 2729.0 20.19813283284505 35 13 6 6 10 1.016331891694792 59.16896821983002 0.031398773193359375 3 0.9243220915390862 4.457590014208874 2729.0 8.29105672682659 0.0 - - - - - - - 659.0 5 9 BCAS1 breast carcinoma amplified sequence 1 757 98 C20140403_SF097_05 C20140403_SF097_05 TB148130.[MT7]-VLLESAK[MT7].2y4_1.heavy 524.336 / 578.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 759 98 C20140403_SF097_05 C20140403_SF097_05 TB148130.[MT7]-VLLESAK[MT7].2y5_1.heavy 524.336 / 691.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 761 98 C20140403_SF097_05 C20140403_SF097_05 TB148130.[MT7]-VLLESAK[MT7].2b6_1.heavy 524.336 / 757.458 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 763 98 C20140403_SF097_05 C20140403_SF097_05 TB148130.[MT7]-VLLESAK[MT7].2y6_1.heavy 524.336 / 804.495 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 765 99 C20140403_SF097_05 C20140403_SF097_05 TB480495.[MT7]-WEFTSWVPLVSR.2b3_1.heavy 825.942 / 607.3 13096.0 48.07939910888672 48 18 10 10 10 4.874993191795507 20.512849160137804 0.0 3 0.985858487668796 10.365763858444708 13096.0 76.14701378493929 0.0 - - - - - - - 217.0 26 17 ANKRD13A ankyrin repeat domain 13A 767 99 C20140403_SF097_05 C20140403_SF097_05 TB480495.[MT7]-WEFTSWVPLVSR.2y8_1.heavy 825.942 / 943.536 16185.0 48.07939910888672 48 18 10 10 10 4.874993191795507 20.512849160137804 0.0 3 0.985858487668796 10.365763858444708 16185.0 81.82519591441401 0.0 - - - - - - - 207.4375 32 16 ANKRD13A ankyrin repeat domain 13A 769 99 C20140403_SF097_05 C20140403_SF097_05 TB480495.[MT7]-WEFTSWVPLVSR.2y5_1.heavy 825.942 / 571.356 21027.0 48.07939910888672 48 18 10 10 10 4.874993191795507 20.512849160137804 0.0 3 0.985858487668796 10.365763858444708 21027.0 6.903448493894254 1.0 - - - - - - - 169.0 44 3 ANKRD13A ankyrin repeat domain 13A 771 99 C20140403_SF097_05 C20140403_SF097_05 TB480495.[MT7]-WEFTSWVPLVSR.2y7_1.heavy 825.942 / 856.504 6179.0 48.07939910888672 48 18 10 10 10 4.874993191795507 20.512849160137804 0.0 3 0.985858487668796 10.365763858444708 6179.0 30.889418005478106 0.0 - - - - - - - 176.75 12 12 ANKRD13A ankyrin repeat domain 13A 773 100 C20140403_SF097_05 C20140403_SF097_05 OPPA_ECOLI.LAIAASSLWK.2y7.peptide 530.31 / 762.41 96376.0 37.4718017578125 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 96376.0 1293.097658431794 0.0 - - - - - - - 164.91666666666666 192 12 775 100 C20140403_SF097_05 C20140403_SF097_05 OPPA_ECOLI.LAIAASSLWK.2y8.peptide 530.31 / 875.5 59168.0 37.4718017578125 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 59168.0 403.8803866809881 0.0 - - - - - - - 196.75 118 12 777 100 C20140403_SF097_05 C20140403_SF097_05 OPPA_ECOLI.LAIAASSLWK.2y6.peptide 530.31 / 691.38 94851.0 37.4718017578125 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 94851.0 242.17281421960755 0.0 - - - - - - - 205.6 189 10 779 101 C20140403_SF097_05 C20140403_SF097_05 TB148398.[MT7]-QQPSQPLGC[CAM]R.2y8_1.heavy 657.839 / 914.451 1577.0 18.438924312591553 39 16 10 3 10 3.397521951306635 29.433216748324913 0.062000274658203125 3 0.9689501470996824 6.985579064658725 1577.0 76.59714285714286 0.0 - - - - - - - 77.5 3 14 HAVCR2 hepatitis A virus cellular receptor 2 781 101 C20140403_SF097_05 C20140403_SF097_05 TB148398.[MT7]-QQPSQPLGC[CAM]R.2y5_1.heavy 657.839 / 602.308 491.0 18.438924312591553 39 16 10 3 10 3.397521951306635 29.433216748324913 0.062000274658203125 3 0.9689501470996824 6.985579064658725 491.0 13.638888888888888 0.0 - - - - - - - 0.0 0 0 HAVCR2 hepatitis A virus cellular receptor 2 783 101 C20140403_SF097_05 C20140403_SF097_05 TB148398.[MT7]-QQPSQPLGC[CAM]R.2y9_1.heavy 657.839 / 1042.51 1087.0 18.438924312591553 39 16 10 3 10 3.397521951306635 29.433216748324913 0.062000274658203125 3 0.9689501470996824 6.985579064658725 1087.0 24.845714285714287 0.0 - - - - - - - 137.71428571428572 2 14 HAVCR2 hepatitis A virus cellular receptor 2 785 101 C20140403_SF097_05 C20140403_SF097_05 TB148398.[MT7]-QQPSQPLGC[CAM]R.2b4_1.heavy 657.839 / 585.311 280.0 18.438924312591553 39 16 10 3 10 3.397521951306635 29.433216748324913 0.062000274658203125 3 0.9689501470996824 6.985579064658725 280.0 6.68 1.0 - - - - - - - 0.0 0 0 HAVCR2 hepatitis A virus cellular receptor 2 787 102 C20140403_SF097_05 C20140403_SF097_05 TB148397.[MT7]-GIALIFNHER.3b4_1.heavy 438.586 / 499.336 62387.0 35.143798828125 48 18 10 10 10 3.158763670671977 25.079149540871207 0.0 3 0.9873123839649005 10.944907719483037 62387.0 415.7822131147541 0.0 - - - - - - - 230.9090909090909 124 11 CASP6 caspase 6, apoptosis-related cysteine peptidase 789 102 C20140403_SF097_05 C20140403_SF097_05 TB148397.[MT7]-GIALIFNHER.3b5_1.heavy 438.586 / 612.42 14254.0 35.143798828125 48 18 10 10 10 3.158763670671977 25.079149540871207 0.0 3 0.9873123839649005 10.944907719483037 14254.0 45.07083803374697 0.0 - - - - - - - 284.1818181818182 28 11 CASP6 caspase 6, apoptosis-related cysteine peptidase 791 102 C20140403_SF097_05 C20140403_SF097_05 TB148397.[MT7]-GIALIFNHER.3y4_1.heavy 438.586 / 555.263 45790.0 35.143798828125 48 18 10 10 10 3.158763670671977 25.079149540871207 0.0 3 0.9873123839649005 10.944907719483037 45790.0 139.91531220276391 0.0 - - - - - - - 299.85714285714283 91 14 CASP6 caspase 6, apoptosis-related cysteine peptidase 793 102 C20140403_SF097_05 C20140403_SF097_05 TB148397.[MT7]-GIALIFNHER.3y5_1.heavy 438.586 / 702.332 37686.0 35.143798828125 48 18 10 10 10 3.158763670671977 25.079149540871207 0.0 3 0.9873123839649005 10.944907719483037 37686.0 471.5094245315874 0.0 - - - - - - - 173.77777777777777 75 9 CASP6 caspase 6, apoptosis-related cysteine peptidase 795 103 C20140403_SF097_05 C20140403_SF097_05 TB148072.[MT7]-DYC[CAM]LQR.2y4_1.heavy 499.746 / 576.292 2140.0 21.203899383544922 48 18 10 10 10 5.522560507881252 18.10754266201156 0.0 3 0.9844964374782762 9.898831301877252 2140.0 10.566903519668738 0.0 - - - - - - - 147.4 4 20 USP2 ubiquitin specific peptidase 2 797 103 C20140403_SF097_05 C20140403_SF097_05 TB148072.[MT7]-DYC[CAM]LQR.2b3_1.heavy 499.746 / 583.23 3532.0 21.203899383544922 48 18 10 10 10 5.522560507881252 18.10754266201156 0.0 3 0.9844964374782762 9.898831301877252 3532.0 34.04473210657689 0.0 - - - - - - - 155.05263157894737 7 19 USP2 ubiquitin specific peptidase 2 799 103 C20140403_SF097_05 C20140403_SF097_05 TB148072.[MT7]-DYC[CAM]LQR.2y5_1.heavy 499.746 / 739.356 4977.0 21.203899383544922 48 18 10 10 10 5.522560507881252 18.10754266201156 0.0 3 0.9844964374782762 9.898831301877252 4977.0 97.79296019900498 0.0 - - - - - - - 171.4 9 20 USP2 ubiquitin specific peptidase 2 801 103 C20140403_SF097_05 C20140403_SF097_05 TB148072.[MT7]-DYC[CAM]LQR.2b4_1.heavy 499.746 / 696.314 1124.0 21.203899383544922 48 18 10 10 10 5.522560507881252 18.10754266201156 0.0 3 0.9844964374782762 9.898831301877252 1124.0 27.7517895465559 0.0 - - - - - - - 118.06666666666666 2 15 USP2 ubiquitin specific peptidase 2 803 104 C20140403_SF097_05 C20140403_SF097_05 TB148935.[MT7]-LQQGVSATVAHLLDLAGSAGATGSWR.3b10_1.heavy 904.151 / 1099.62 2980.0 50.4995002746582 43 13 10 10 10 2.073218144806377 38.630386986118104 0.0 3 0.9207085286823554 4.353482729746574 2980.0 40.53932584269663 0.0 - - - - - - - 177.5 5 22 BCAR1 breast cancer anti-estrogen resistance 1 805 104 C20140403_SF097_05 C20140403_SF097_05 TB148935.[MT7]-LQQGVSATVAHLLDLAGSAGATGSWR.3b5_1.heavy 904.151 / 670.4 2235.0 50.4995002746582 43 13 10 10 10 2.073218144806377 38.630386986118104 0.0 3 0.9207085286823554 4.353482729746574 2235.0 25.525210084033617 0.0 - - - - - - - 133.42857142857142 4 21 BCAR1 breast cancer anti-estrogen resistance 1 807 104 C20140403_SF097_05 C20140403_SF097_05 TB148935.[MT7]-LQQGVSATVAHLLDLAGSAGATGSWR.3y12_1.heavy 904.151 / 1133.57 2861.0 50.4995002746582 43 13 10 10 10 2.073218144806377 38.630386986118104 0.0 3 0.9207085286823554 4.353482729746574 2861.0 42.21095078299776 0.0 - - - - - - - 119.33333333333333 5 24 BCAR1 breast cancer anti-estrogen resistance 1 809 104 C20140403_SF097_05 C20140403_SF097_05 TB148935.[MT7]-LQQGVSATVAHLLDLAGSAGATGSWR.3y10_1.heavy 904.151 / 949.449 5662.0 50.4995002746582 43 13 10 10 10 2.073218144806377 38.630386986118104 0.0 3 0.9207085286823554 4.353482729746574 5662.0 50.935080446812876 0.0 - - - - - - - 170.94736842105263 11 19 BCAR1 breast cancer anti-estrogen resistance 1 811 105 C20140403_SF097_05 C20140403_SF097_05 TB148839.[MT7]-INVAVDRLPSFLAAPNAPR.3y18_2.heavy 722.415 / 954.526 32876.0 40.53220176696777 36 10 10 6 10 0.889568730117867 73.86983516192987 0.03639984130859375 3 0.822705288645279 2.886546679667683 32876.0 236.06552851263962 0.0 - - - - - - - 191.5 65 12 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 813 105 C20140403_SF097_05 C20140403_SF097_05 TB148839.[MT7]-INVAVDRLPSFLAAPNAPR.3y7_1.heavy 722.415 / 696.379 11445.0 40.53220176696777 36 10 10 6 10 0.889568730117867 73.86983516192987 0.03639984130859375 3 0.822705288645279 2.886546679667683 11445.0 50.537757973733584 0.0 - - - - - - - 181.35294117647058 22 17 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 815 105 C20140403_SF097_05 C20140403_SF097_05 TB148839.[MT7]-INVAVDRLPSFLAAPNAPR.3y11_1.heavy 722.415 / 1140.62 15540.0 40.53220176696777 36 10 10 6 10 0.889568730117867 73.86983516192987 0.03639984130859375 3 0.822705288645279 2.886546679667683 15540.0 105.19862595419846 0.0 - - - - - - - 159.85 31 20 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 817 105 C20140403_SF097_05 C20140403_SF097_05 TB148839.[MT7]-INVAVDRLPSFLAAPNAPR.3y5_1.heavy 722.415 / 554.305 12006.0 40.53220176696777 36 10 10 6 10 0.889568730117867 73.86983516192987 0.03639984130859375 3 0.822705288645279 2.886546679667683 12006.0 56.37714034036855 0.0 - - - - - - - 245.76190476190476 24 21 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 819 106 C20140403_SF097_05 C20140403_SF097_05 TB148253.[MT7]-IFIIQAC[CAM]R.2b3_1.heavy 582.838 / 518.346 4905.0 36.241600036621094 50 20 10 10 10 3.364024061897443 23.16771193247523 0.0 3 0.990252124205962 12.489756077888076 4905.0 25.808677685950414 0.0 - - - - - - - 232.11111111111111 9 9 CASP6 caspase 6, apoptosis-related cysteine peptidase 821 106 C20140403_SF097_05 C20140403_SF097_05 TB148253.[MT7]-IFIIQAC[CAM]R.2y5_1.heavy 582.838 / 647.329 4723.0 36.241600036621094 50 20 10 10 10 3.364024061897443 23.16771193247523 0.0 3 0.990252124205962 12.489756077888076 4723.0 48.69123755032845 0.0 - - - - - - - 172.7 9 10 CASP6 caspase 6, apoptosis-related cysteine peptidase 823 106 C20140403_SF097_05 C20140403_SF097_05 TB148253.[MT7]-IFIIQAC[CAM]R.2y6_1.heavy 582.838 / 760.413 3906.0 36.241600036621094 50 20 10 10 10 3.364024061897443 23.16771193247523 0.0 3 0.990252124205962 12.489756077888076 3906.0 56.22923076923076 0.0 - - - - - - - 161.55555555555554 7 9 CASP6 caspase 6, apoptosis-related cysteine peptidase 825 106 C20140403_SF097_05 C20140403_SF097_05 TB148253.[MT7]-IFIIQAC[CAM]R.2y7_1.heavy 582.838 / 907.482 11989.0 36.241600036621094 50 20 10 10 10 3.364024061897443 23.16771193247523 0.0 3 0.990252124205962 12.489756077888076 11989.0 56.38363148479428 0.0 - - - - - - - 194.71428571428572 23 7 CASP6 caspase 6, apoptosis-related cysteine peptidase 827 107 C20140403_SF097_05 C20140403_SF097_05 TB480318.[MT7]-LGVNTAVFER.2y9_1.heavy 625.355 / 992.516 4208.0 33.60210037231445 45 20 10 5 10 12.83331456986005 7.792219185124402 0.0449981689453125 3 0.9965917027680273 21.133440784216486 4208.0 82.0989387755102 0.0 - - - - - - - 110.25 8 8 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 829 107 C20140403_SF097_05 C20140403_SF097_05 TB480318.[MT7]-LGVNTAVFER.2b4_1.heavy 625.355 / 528.326 881.0 33.60210037231445 45 20 10 5 10 12.83331456986005 7.792219185124402 0.0449981689453125 3 0.9965917027680273 21.133440784216486 881.0 8.090816326530613 1.0 - - - - - - - 0.0 1 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 831 107 C20140403_SF097_05 C20140403_SF097_05 TB480318.[MT7]-LGVNTAVFER.2b6_1.heavy 625.355 / 700.411 881.0 33.60210037231445 45 20 10 5 10 12.83331456986005 7.792219185124402 0.0449981689453125 3 0.9965917027680273 21.133440784216486 881.0 11.716700680272108 0.0 - - - - - - - 0.0 1 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 833 107 C20140403_SF097_05 C20140403_SF097_05 TB480318.[MT7]-LGVNTAVFER.2y7_1.heavy 625.355 / 836.426 1272.0 33.60210037231445 45 20 10 5 10 12.83331456986005 7.792219185124402 0.0449981689453125 3 0.9965917027680273 21.133440784216486 1272.0 25.569795918367348 0.0 - - - - - - - 196.0 2 3 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 835 108 C20140403_SF097_05 C20140403_SF097_05 TB148729.[MT7]-VSELYDVTWEEMR.2b3_1.heavy 900.933 / 460.252 7814.0 41.27330017089844 47 17 10 10 10 5.992168041069439 16.688450543211523 0.0 3 0.9721871630965959 7.382916775203639 7814.0 33.414006508459096 0.0 - - - - - - - 163.875 15 24 TTC35 tetratricopeptide repeat domain 35 837 108 C20140403_SF097_05 C20140403_SF097_05 TB148729.[MT7]-VSELYDVTWEEMR.2y8_1.heavy 900.933 / 1065.47 5475.0 41.27330017089844 47 17 10 10 10 5.992168041069439 16.688450543211523 0.0 3 0.9721871630965959 7.382916775203639 5475.0 25.139337530796606 0.0 - - - - - - - 205.04761904761904 10 21 TTC35 tetratricopeptide repeat domain 35 839 108 C20140403_SF097_05 C20140403_SF097_05 TB148729.[MT7]-VSELYDVTWEEMR.2b4_1.heavy 900.933 / 573.336 5428.0 41.27330017089844 47 17 10 10 10 5.992168041069439 16.688450543211523 0.0 3 0.9721871630965959 7.382916775203639 5428.0 41.77865533159651 0.0 - - - - - - - 156.0 10 21 TTC35 tetratricopeptide repeat domain 35 841 108 C20140403_SF097_05 C20140403_SF097_05 TB148729.[MT7]-VSELYDVTWEEMR.2y9_1.heavy 900.933 / 1228.53 3229.0 41.27330017089844 47 17 10 10 10 5.992168041069439 16.688450543211523 0.0 3 0.9721871630965959 7.382916775203639 3229.0 38.08235634507505 0.0 - - - - - - - 204.79166666666666 6 24 TTC35 tetratricopeptide repeat domain 35 843 109 C20140403_SF097_05 C20140403_SF097_05 TB148394.[MT7]-DILTPPDLER.2y8_1.heavy 656.865 / 940.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 845 109 C20140403_SF097_05 C20140403_SF097_05 TB148394.[MT7]-DILTPPDLER.2y9_1.heavy 656.865 / 1053.59 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 847 109 C20140403_SF097_05 C20140403_SF097_05 TB148394.[MT7]-DILTPPDLER.2y6_1.heavy 656.865 / 726.378 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 849 109 C20140403_SF097_05 C20140403_SF097_05 TB148394.[MT7]-DILTPPDLER.2y7_1.heavy 656.865 / 827.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 851 110 C20140403_SF097_05 C20140403_SF097_05 TB480316.[MT7]-ELEEWELR.2b3_1.heavy 624.323 / 516.279 1273.0 35.202975273132324 42 17 10 5 10 3.3659321615315125 29.709452003482923 0.045497894287109375 3 0.9719343196352124 7.349428757912606 1273.0 8.865535714285715 0.0 - - - - - - - 236.83333333333334 2 12 ANKRD13A ankyrin repeat domain 13A 853 110 C20140403_SF097_05 C20140403_SF097_05 TB480316.[MT7]-ELEEWELR.2y4_1.heavy 624.323 / 603.325 881.0 35.202975273132324 42 17 10 5 10 3.3659321615315125 29.709452003482923 0.045497894287109375 3 0.9719343196352124 7.349428757912606 881.0 8.290816326530612 1.0 - - - - - - - 0.0 1 0 ANKRD13A ankyrin repeat domain 13A 855 110 C20140403_SF097_05 C20140403_SF097_05 TB480316.[MT7]-ELEEWELR.2b4_1.heavy 624.323 / 645.321 2448.0 35.202975273132324 42 17 10 5 10 3.3659321615315125 29.709452003482923 0.045497894287109375 3 0.9719343196352124 7.349428757912606 2448.0 19.3615763546798 0.0 - - - - - - - 232.75 4 8 ANKRD13A ankyrin repeat domain 13A 857 110 C20140403_SF097_05 C20140403_SF097_05 TB480316.[MT7]-ELEEWELR.2y7_1.heavy 624.323 / 974.494 3721.0 35.202975273132324 42 17 10 5 10 3.3659321615315125 29.709452003482923 0.045497894287109375 3 0.9719343196352124 7.349428757912606 3721.0 20.56675170068027 0.0 - - - - - - - 196.0 7 6 ANKRD13A ankyrin repeat domain 13A 859 111 C20140403_SF097_05 C20140403_SF097_05 TB148832.[MT7]-GHGPAETQTLGSLPDINLTQISTLANELR.3y8_1.heavy 1064.23 / 903.489 1333.0 48.14469909667969 40 15 10 5 10 2.7207412786080662 29.19931674146052 0.04360198974609375 3 0.9553291837972938 5.817284843680389 1333.0 22.651340579710144 0.0 - - - - - - - 99.66666666666667 2 12 HAVCR2 hepatitis A virus cellular receptor 2 861 111 C20140403_SF097_05 C20140403_SF097_05 TB148832.[MT7]-GHGPAETQTLGSLPDINLTQISTLANELR.3b6_1.heavy 1064.23 / 693.344 781.0 48.14469909667969 40 15 10 5 10 2.7207412786080662 29.19931674146052 0.04360198974609375 3 0.9553291837972938 5.817284843680389 781.0 24.95804347826087 0.0 - - - - - - - 0.0 1 0 HAVCR2 hepatitis A virus cellular receptor 2 863 111 C20140403_SF097_05 C20140403_SF097_05 TB148832.[MT7]-GHGPAETQTLGSLPDINLTQISTLANELR.3y11_1.heavy 1064.23 / 1245.68 735.0 48.14469909667969 40 15 10 5 10 2.7207412786080662 29.19931674146052 0.04360198974609375 3 0.9553291837972938 5.817284843680389 735.0 17.043478260869566 0.0 - - - - - - - 0.0 1 0 HAVCR2 hepatitis A virus cellular receptor 2 865 111 C20140403_SF097_05 C20140403_SF097_05 TB148832.[MT7]-GHGPAETQTLGSLPDINLTQISTLANELR.3y9_1.heavy 1064.23 / 1016.57 1103.0 48.14469909667969 40 15 10 5 10 2.7207412786080662 29.19931674146052 0.04360198974609375 3 0.9553291837972938 5.817284843680389 1103.0 21.22076086956522 0.0 - - - - - - - 111.16666666666667 2 12 HAVCR2 hepatitis A virus cellular receptor 2 867 112 C20140403_SF097_05 C20140403_SF097_05 TB480688.[MT7]-TVEAVQLNQALLLLPWTMHALVILK[MT7].4b4_1.heavy 776.464 / 545.305 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 869 112 C20140403_SF097_05 C20140403_SF097_05 TB480688.[MT7]-TVEAVQLNQALLLLPWTMHALVILK[MT7].4b5_1.heavy 776.464 / 644.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 871 112 C20140403_SF097_05 C20140403_SF097_05 TB480688.[MT7]-TVEAVQLNQALLLLPWTMHALVILK[MT7].4y6_1.heavy 776.464 / 800.573 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 873 112 C20140403_SF097_05 C20140403_SF097_05 TB480688.[MT7]-TVEAVQLNQALLLLPWTMHALVILK[MT7].4b6_1.heavy 776.464 / 772.432 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 875 113 C20140403_SF097_05 C20140403_SF097_05 TB148450.[MT7]-DLC[CAM]QDPTIK[MT7].2y4_1.heavy 689.368 / 602.399 7914.0 24.118225574493408 41 20 9 6 6 5.963683276917093 16.768160775247388 0.03790092468261719 6 0.9923980554914121 14.145702313837914 7914.0 51.926947368421054 0.0 - - - - - - - 166.38888888888889 15 18 CD38 CD38 molecule 877 113 C20140403_SF097_05 C20140403_SF097_05 TB148450.[MT7]-DLC[CAM]QDPTIK[MT7].2b3_1.heavy 689.368 / 533.251 1283.0 24.118225574493408 41 20 9 6 6 5.963683276917093 16.768160775247388 0.03790092468261719 6 0.9923980554914121 14.145702313837914 1283.0 11.226053245000614 1.0 - - - - - - - 175.3846153846154 2 13 CD38 CD38 molecule 879 113 C20140403_SF097_05 C20140403_SF097_05 TB148450.[MT7]-DLC[CAM]QDPTIK[MT7].2b5_1.heavy 689.368 / 776.336 6131.0 24.118225574493408 41 20 9 6 6 5.963683276917093 16.768160775247388 0.03790092468261719 6 0.9923980554914121 14.145702313837914 6131.0 54.93153355416513 0.0 - - - - - - - 169.5 12 8 CD38 CD38 molecule 881 113 C20140403_SF097_05 C20140403_SF097_05 TB148450.[MT7]-DLC[CAM]QDPTIK[MT7].2b4_1.heavy 689.368 / 661.31 1854.0 24.118225574493408 41 20 9 6 6 5.963683276917093 16.768160775247388 0.03790092468261719 6 0.9923980554914121 14.145702313837914 1854.0 2.990208633208487 4.0 - - - - - - - 719.4545454545455 17 11 CD38 CD38 molecule 883 114 C20140403_SF097_05 C20140403_SF097_05 TB148314.[MT7]-ILVGMYDK[MT7].2y5_1.heavy 613.857 / 757.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 885 114 C20140403_SF097_05 C20140403_SF097_05 TB148314.[MT7]-ILVGMYDK[MT7].2y3_1.heavy 613.857 / 569.305 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 887 114 C20140403_SF097_05 C20140403_SF097_05 TB148314.[MT7]-ILVGMYDK[MT7].2y6_1.heavy 613.857 / 856.435 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 889 114 C20140403_SF097_05 C20140403_SF097_05 TB148314.[MT7]-ILVGMYDK[MT7].2y7_1.heavy 613.857 / 969.52 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 891 115 C20140403_SF097_05 C20140403_SF097_05 TB148451.[MT7]-IGDLFVGQLK[MT7].2y4_1.heavy 689.421 / 589.379 1527.0 40.70979881286621 44 18 10 6 10 3.4691923617494047 23.039910590283956 0.032199859619140625 3 0.9884391837033473 11.466974061403146 1527.0 8.992169720347155 0.0 - - - - - - - 167.38095238095238 3 21 USP2 ubiquitin specific peptidase 2 893 115 C20140403_SF097_05 C20140403_SF097_05 TB148451.[MT7]-IGDLFVGQLK[MT7].2b4_1.heavy 689.421 / 543.326 1273.0 40.70979881286621 44 18 10 6 10 3.4691923617494047 23.039910590283956 0.032199859619140625 3 0.9884391837033473 11.466974061403146 1273.0 13.229215686274511 0.0 - - - - - - - 195.29166666666666 2 24 USP2 ubiquitin specific peptidase 2 895 115 C20140403_SF097_05 C20140403_SF097_05 TB148451.[MT7]-IGDLFVGQLK[MT7].2y9_1.heavy 689.421 / 1120.65 967.0 40.70979881286621 44 18 10 6 10 3.4691923617494047 23.039910590283956 0.032199859619140625 3 0.9884391837033473 11.466974061403146 967.0 6.992177756348441 0.0 - - - - - - - 0.0 1 0 USP2 ubiquitin specific peptidase 2 897 115 C20140403_SF097_05 C20140403_SF097_05 TB148451.[MT7]-IGDLFVGQLK[MT7].2y7_1.heavy 689.421 / 948.6 1374.0 40.70979881286621 44 18 10 6 10 3.4691923617494047 23.039910590283956 0.032199859619140625 3 0.9884391837033473 11.466974061403146 1374.0 25.86352941176471 0.0 - - - - - - - 145.25 2 20 USP2 ubiquitin specific peptidase 2 899 116 C20140403_SF097_05 C20140403_SF097_05 TB480544.[MT7]-VFDC[CAM]IEVYAPGFK[MT7].2y4_1.heavy 916.978 / 592.357 15793.0 41.811326026916504 44 18 10 6 10 1.5380039354148514 38.43675860371506 0.033298492431640625 3 0.9835559311496189 9.610827745547956 15793.0 128.320658658042 0.0 - - - - - - - 174.94444444444446 31 18 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 901 116 C20140403_SF097_05 C20140403_SF097_05 TB480544.[MT7]-VFDC[CAM]IEVYAPGFK[MT7].2y5_1.heavy 916.978 / 663.395 2977.0 41.811326026916504 44 18 10 6 10 1.5380039354148514 38.43675860371506 0.033298492431640625 3 0.9835559311496189 9.610827745547956 2977.0 41.53953488372093 0.0 - - - - - - - 88.8125 5 16 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 903 116 C20140403_SF097_05 C20140403_SF097_05 TB480544.[MT7]-VFDC[CAM]IEVYAPGFK[MT7].2b6_1.heavy 916.978 / 908.43 3970.0 41.811326026916504 44 18 10 6 10 1.5380039354148514 38.43675860371506 0.033298492431640625 3 0.9835559311496189 9.610827745547956 3970.0 39.445238461933364 0.0 - - - - - - - 205.47058823529412 7 17 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 905 116 C20140403_SF097_05 C20140403_SF097_05 TB480544.[MT7]-VFDC[CAM]IEVYAPGFK[MT7].2b7_1.heavy 916.978 / 1007.5 5264.0 41.811326026916504 44 18 10 6 10 1.5380039354148514 38.43675860371506 0.033298492431640625 3 0.9835559311496189 9.610827745547956 5264.0 50.66995225627599 0.0 - - - - - - - 123.0952380952381 10 21 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 907 117 C20140403_SF097_05 C20140403_SF097_05 TB148453.[MT7]-GQMEVWDVK[MT7].2b4_1.heavy 690.365 / 590.273 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 909 117 C20140403_SF097_05 C20140403_SF097_05 TB148453.[MT7]-GQMEVWDVK[MT7].2b7_1.heavy 690.365 / 990.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 911 117 C20140403_SF097_05 C20140403_SF097_05 TB148453.[MT7]-GQMEVWDVK[MT7].2b5_1.heavy 690.365 / 689.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 913 117 C20140403_SF097_05 C20140403_SF097_05 TB148453.[MT7]-GQMEVWDVK[MT7].2y7_1.heavy 690.365 / 1050.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 915 118 C20140403_SF097_05 C20140403_SF097_05 TB148514.[MT7]-EAK[MT7]PEAPAAK[MT7].3y7_1.heavy 481.956 / 827.474 816.0 16.40767526626587 37 13 10 6 8 2.049962883058789 48.78137103184428 0.03529930114746094 4 0.9298993976931441 4.633735281835157 816.0 15.82 1.0 - - - - - - - 0.0 1 0 BCAS1 breast carcinoma amplified sequence 1 917 118 C20140403_SF097_05 C20140403_SF097_05 TB148514.[MT7]-EAK[MT7]PEAPAAK[MT7].3y5_1.heavy 481.956 / 601.379 3507.0 16.40767526626587 37 13 10 6 8 2.049962883058789 48.78137103184428 0.03529930114746094 4 0.9298993976931441 4.633735281835157 3507.0 20.24017758046615 0.0 - - - - - - - 146.24 7 25 BCAS1 breast carcinoma amplified sequence 1 919 118 C20140403_SF097_05 C20140403_SF097_05 TB148514.[MT7]-EAK[MT7]PEAPAAK[MT7].3y4_1.heavy 481.956 / 530.342 5442.0 16.40767526626587 37 13 10 6 8 2.049962883058789 48.78137103184428 0.03529930114746094 4 0.9298993976931441 4.633735281835157 5442.0 26.615079372808726 0.0 - - - - - - - 234.76923076923077 10 26 BCAS1 breast carcinoma amplified sequence 1 921 118 C20140403_SF097_05 C20140403_SF097_05 TB148514.[MT7]-EAK[MT7]PEAPAAK[MT7].3b3_1.heavy 481.956 / 617.386 907.0 16.40767526626587 37 13 10 6 8 2.049962883058789 48.78137103184428 0.03529930114746094 4 0.9298993976931441 4.633735281835157 907.0 4.602949500554939 2.0 - - - - - - - 148.73076923076923 4 26 BCAS1 breast carcinoma amplified sequence 1 923 119 C20140403_SF097_05 C20140403_SF097_05 TB147971.[MT7]-GQAPGPSR.2y6_1.heavy 457.252 / 584.315 2244.0 12.677749872207642 44 18 10 6 10 5.769729566158588 17.331834855230262 0.03859996795654297 3 0.9838962818630611 9.712135841864415 2244.0 19.946666666666665 0.0 - - - - - - - 84.9 4 20 USP2 ubiquitin specific peptidase 2 925 119 C20140403_SF097_05 C20140403_SF097_05 TB147971.[MT7]-GQAPGPSR.2b5_1.heavy 457.252 / 555.301 1662.0 12.677749872207642 44 18 10 6 10 5.769729566158588 17.331834855230262 0.03859996795654297 3 0.9838962818630611 9.712135841864415 1662.0 16.74963903410505 0.0 - - - - - - - 147.35 3 20 USP2 ubiquitin specific peptidase 2 927 119 C20140403_SF097_05 C20140403_SF097_05 TB147971.[MT7]-GQAPGPSR.2y5_1.heavy 457.252 / 513.278 7846.0 12.677749872207642 44 18 10 6 10 5.769729566158588 17.331834855230262 0.03859996795654297 3 0.9838962818630611 9.712135841864415 7846.0 57.05452085938388 0.0 - - - - - - - 158.4 15 20 USP2 ubiquitin specific peptidase 2 929 119 C20140403_SF097_05 C20140403_SF097_05 TB147971.[MT7]-GQAPGPSR.2y7_1.heavy 457.252 / 712.374 1662.0 12.677749872207642 44 18 10 6 10 5.769729566158588 17.331834855230262 0.03859996795654297 3 0.9838962818630611 9.712135841864415 1662.0 40.663933018462856 0.0 - - - - - - - 82.33333333333333 3 21 USP2 ubiquitin specific peptidase 2 931 120 C20140403_SF097_05 C20140403_SF097_05 TB148104.[MT7]-RYTESAR.2y5_1.heavy 513.776 / 563.278 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 933 120 C20140403_SF097_05 C20140403_SF097_05 TB148104.[MT7]-RYTESAR.2b4_1.heavy 513.776 / 694.364 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 935 120 C20140403_SF097_05 C20140403_SF097_05 TB148104.[MT7]-RYTESAR.2b6_1.heavy 513.776 / 852.433 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 937 120 C20140403_SF097_05 C20140403_SF097_05 TB148104.[MT7]-RYTESAR.2y6_1.heavy 513.776 / 726.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 939 121 C20140403_SF097_05 C20140403_SF097_05 TB148102.[MT7]-VDFDIK[MT7].2y4_1.heavy 512.799 / 666.394 1549.0 31.80084991455078 42 17 9 6 10 2.0571449191964457 38.362219082235114 0.03820037841796875 3 0.9745698449128123 7.722593874477585 1549.0 6.773229789590253 0.0 - - - - - - - 177.73333333333332 3 15 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 941 121 C20140403_SF097_05 C20140403_SF097_05 TB148102.[MT7]-VDFDIK[MT7].2y5_1.heavy 512.799 / 781.421 946.0 31.80084991455078 42 17 9 6 10 2.0571449191964457 38.362219082235114 0.03820037841796875 3 0.9745698449128123 7.722593874477585 946.0 9.9 0.0 - - - - - - - 0.0 1 0 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 943 121 C20140403_SF097_05 C20140403_SF097_05 TB148102.[MT7]-VDFDIK[MT7].2b4_1.heavy 512.799 / 621.3 2237.0 31.80084991455078 42 17 9 6 10 2.0571449191964457 38.362219082235114 0.03820037841796875 3 0.9745698449128123 7.722593874477585 2237.0 22.760174418604652 0.0 - - - - - - - 126.13333333333334 4 15 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 945 121 C20140403_SF097_05 C20140403_SF097_05 TB148102.[MT7]-VDFDIK[MT7].2y3_1.heavy 512.799 / 519.326 516.0 31.80084991455078 42 17 9 6 10 2.0571449191964457 38.362219082235114 0.03820037841796875 3 0.9745698449128123 7.722593874477585 516.0 1.0499999999999998 11.0 - - - - - - - 188.38095238095238 5 21 HS6ST2 heparan sulfate 6-O-sulfotransferase 2 947 122 C20140403_SF097_05 C20140403_SF097_05 TB148622.[MT7]-ELQGQNVEAVDPR.2b3_1.heavy 799.916 / 515.295 11893.0 24.520999908447266 41 11 10 10 10 0.7371438882580132 70.67985713985574 0.0 3 0.8741183847861801 3.441251894553901 11893.0 73.40240207917672 0.0 - - - - - - - 227.93333333333334 23 15 ANKRD13A ankyrin repeat domain 13A 949 122 C20140403_SF097_05 C20140403_SF097_05 TB148622.[MT7]-ELQGQNVEAVDPR.2b4_1.heavy 799.916 / 572.316 2991.0 24.520999908447266 41 11 10 10 10 0.7371438882580132 70.67985713985574 0.0 3 0.8741183847861801 3.441251894553901 2991.0 24.504471460340994 0.0 - - - - - - - 213.63636363636363 5 11 ANKRD13A ankyrin repeat domain 13A 951 122 C20140403_SF097_05 C20140403_SF097_05 TB148622.[MT7]-ELQGQNVEAVDPR.2b6_1.heavy 799.916 / 814.417 4629.0 24.520999908447266 41 11 10 10 10 0.7371438882580132 70.67985713985574 0.0 3 0.8741183847861801 3.441251894553901 4629.0 81.18267934711069 0.0 - - - - - - - 126.44444444444444 9 9 ANKRD13A ankyrin repeat domain 13A 953 122 C20140403_SF097_05 C20140403_SF097_05 TB148622.[MT7]-ELQGQNVEAVDPR.2b7_1.heavy 799.916 / 913.486 8332.0 24.520999908447266 41 11 10 10 10 0.7371438882580132 70.67985713985574 0.0 3 0.8741183847861801 3.441251894553901 8332.0 167.22676056338025 0.0 - - - - - - - 116.36363636363636 16 11 ANKRD13A ankyrin repeat domain 13A 955 123 C20140403_SF097_05 C20140403_SF097_05 TB148593.[MT7]-IQIPGIMNDEK[MT7].3y3_1.heavy 515.956 / 535.284 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 957 123 C20140403_SF097_05 C20140403_SF097_05 TB148593.[MT7]-IQIPGIMNDEK[MT7].3b5_1.heavy 515.956 / 653.41 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 959 123 C20140403_SF097_05 C20140403_SF097_05 TB148593.[MT7]-IQIPGIMNDEK[MT7].3y4_1.heavy 515.956 / 649.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 961 123 C20140403_SF097_05 C20140403_SF097_05 TB148593.[MT7]-IQIPGIMNDEK[MT7].3y5_1.heavy 515.956 / 780.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 963 124 C20140403_SF097_05 C20140403_SF097_05 TB346479.[MT7]-VLDQWFESEPLK[MT7].2y5_1.heavy 889.982 / 717.426 3057.0 42.84960174560547 47 17 10 10 10 2.6294086131756704 38.03136549371264 0.0 3 0.9706310896750026 7.183726461725834 3057.0 31.232890464748284 0.0 - - - - - - - 133.42307692307693 6 26 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 965 124 C20140403_SF097_05 C20140403_SF097_05 TB346479.[MT7]-VLDQWFESEPLK[MT7].2b4_1.heavy 889.982 / 600.347 9323.0 42.84960174560547 47 17 10 10 10 2.6294086131756704 38.03136549371264 0.0 3 0.9706310896750026 7.183726461725834 9323.0 44.61921539437047 0.0 - - - - - - - 142.7391304347826 18 23 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 967 124 C20140403_SF097_05 C20140403_SF097_05 TB346479.[MT7]-VLDQWFESEPLK[MT7].2y3_1.heavy 889.982 / 501.352 21666.0 42.84960174560547 47 17 10 10 10 2.6294086131756704 38.03136549371264 0.0 3 0.9706310896750026 7.183726461725834 21666.0 99.42222811671087 0.0 - - - - - - - 196.41666666666666 43 24 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 969 124 C20140403_SF097_05 C20140403_SF097_05 TB346479.[MT7]-VLDQWFESEPLK[MT7].2y7_1.heavy 889.982 / 993.537 8530.0 42.84960174560547 47 17 10 10 10 2.6294086131756704 38.03136549371264 0.0 3 0.9706310896750026 7.183726461725834 8530.0 51.6969696969697 0.0 - - - - - - - 162.3913043478261 17 23 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 971 125 C20140403_SF097_05 C20140403_SF097_05 TB148594.[MT7]-IEIQTLTGLFK[MT7].2y4_1.heavy 775.973 / 608.389 13615.0 45.91524887084961 45 18 10 7 10 2.934225850092092 27.20695487930376 0.0298004150390625 3 0.9848543436646051 10.015408155337228 13615.0 75.15645406226272 0.0 - - - - - - - 638.875 27 8 CASP6 caspase 6, apoptosis-related cysteine peptidase 973 125 C20140403_SF097_05 C20140403_SF097_05 TB148594.[MT7]-IEIQTLTGLFK[MT7].2b3_1.heavy 775.973 / 500.32 21082.0 45.91524887084961 45 18 10 7 10 2.934225850092092 27.20695487930376 0.0298004150390625 3 0.9848543436646051 10.015408155337228 21082.0 88.03407526119813 0.0 - - - - - - - 264.15384615384613 42 26 CASP6 caspase 6, apoptosis-related cysteine peptidase 975 125 C20140403_SF097_05 C20140403_SF097_05 TB148594.[MT7]-IEIQTLTGLFK[MT7].2y5_1.heavy 775.973 / 709.437 14214.0 45.91524887084961 45 18 10 7 10 2.934225850092092 27.20695487930376 0.0298004150390625 3 0.9848543436646051 10.015408155337228 14214.0 138.29037499999998 0.0 - - - - - - - 189.875 28 24 CASP6 caspase 6, apoptosis-related cysteine peptidase 977 125 C20140403_SF097_05 C20140403_SF097_05 TB148594.[MT7]-IEIQTLTGLFK[MT7].2y7_1.heavy 775.973 / 923.568 16490.0 45.91524887084961 45 18 10 7 10 2.934225850092092 27.20695487930376 0.0298004150390625 3 0.9848543436646051 10.015408155337228 16490.0 131.2532630979499 0.0 - - - - - - - 208.96153846153845 32 26 CASP6 caspase 6, apoptosis-related cysteine peptidase 979 126 C20140403_SF097_05 C20140403_SF097_05 TB346349.[MT7]-DLC[CAM]QDPTIK[MT7].3b4_1.heavy 459.914 / 661.31 N/A 24.11506716410319 35 17 2 6 10 3.1022913895625672 27.20322281638194 0.03790092468261719 3 0.9782037270770394 8.344095123546118 10144.0 8.433245406565083 3.0 - - - - - - - 821.75 161 8 CD38 CD38 molecule 981 126 C20140403_SF097_05 C20140403_SF097_05 TB346349.[MT7]-DLC[CAM]QDPTIK[MT7].3b5_1.heavy 459.914 / 776.336 16645.0 24.11506716410319 35 17 2 6 10 3.1022913895625672 27.20322281638194 0.03790092468261719 3 0.9782037270770394 8.344095123546118 16645.0 74.57385044970582 0.0 - - - - - - - 205.76470588235293 33 17 CD38 CD38 molecule 983 126 C20140403_SF097_05 C20140403_SF097_05 TB346349.[MT7]-DLC[CAM]QDPTIK[MT7].3b3_1.heavy 459.914 / 533.251 34719.0 24.11506716410319 35 17 2 6 10 3.1022913895625672 27.20322281638194 0.03790092468261719 3 0.9782037270770394 8.344095123546118 34719.0 61.01273236813438 0.0 - - - - - - - 257.1 69 10 CD38 CD38 molecule 985 126 C20140403_SF097_05 C20140403_SF097_05 TB346349.[MT7]-DLC[CAM]QDPTIK[MT7].3y4_1.heavy 459.914 / 602.399 25146.0 24.11506716410319 35 17 2 6 10 3.1022913895625672 27.20322281638194 0.03790092468261719 3 0.9782037270770394 8.344095123546118 25146.0 77.57636977099237 0.0 - - - - - - - 375.25 50 12 CD38 CD38 molecule 987 127 C20140403_SF097_05 C20140403_SF097_05 TB480687.[MT7]-LALAIDPLLDAAPVDMAAFQHGSLLQR.3y7_1.heavy 997.547 / 810.458 1013.0 51.12722396850586 45 18 10 7 10 7.704830873973881 12.978870222549547 0.0290985107421875 3 0.9879583642282573 11.235253084177991 1013.0 7.7227113237639555 0.0 - - - - - - - 92.88888888888889 2 18 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 989 127 C20140403_SF097_05 C20140403_SF097_05 TB480687.[MT7]-LALAIDPLLDAAPVDMAAFQHGSLLQR.3y6_1.heavy 997.547 / 673.399 1013.0 51.12722396850586 45 18 10 7 10 7.704830873973881 12.978870222549547 0.0290985107421875 3 0.9879583642282573 11.235253084177991 1013.0 3.7968388395103134 0.0 - - - - - - - 92.33333333333333 2 21 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 991 127 C20140403_SF097_05 C20140403_SF097_05 TB480687.[MT7]-LALAIDPLLDAAPVDMAAFQHGSLLQR.3b4_1.heavy 997.547 / 513.352 3844.0 51.12722396850586 45 18 10 7 10 7.704830873973881 12.978870222549547 0.0290985107421875 3 0.9879583642282573 11.235253084177991 3844.0 32.29818509954317 0.0 - - - - - - - 95.91304347826087 7 23 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 993 127 C20140403_SF097_05 C20140403_SF097_05 TB480687.[MT7]-LALAIDPLLDAAPVDMAAFQHGSLLQR.3y10_1.heavy 997.547 / 1156.62 685.0 51.12722396850586 45 18 10 7 10 7.704830873973881 12.978870222549547 0.0290985107421875 3 0.9879583642282573 11.235253084177991 685.0 5.568737607402511 0.0 - - - - - - - 0.0 1 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 995 128 C20140403_SF097_05 C20140403_SF097_05 TB148920.[MT7]-AQQGLYQVPGPSPQFQSPPAK[MT7].3b6_1.heavy 838.451 / 805.432 3662.0 31.69260025024414 47 17 10 10 10 2.3597955951399916 33.5235109736938 0.0 3 0.9745406619830582 7.718147622136985 3662.0 52.4919950011361 0.0 - - - - - - - 187.1 7 10 BCAR1 breast cancer anti-estrogen resistance 1 997 128 C20140403_SF097_05 C20140403_SF097_05 TB148920.[MT7]-AQQGLYQVPGPSPQFQSPPAK[MT7].3b4_1.heavy 838.451 / 529.285 5290.0 31.69260025024414 47 17 10 10 10 2.3597955951399916 33.5235109736938 0.0 3 0.9745406619830582 7.718147622136985 5290.0 44.94877300613497 0.0 - - - - - - - 213.5625 10 16 BCAR1 breast cancer anti-estrogen resistance 1 999 128 C20140403_SF097_05 C20140403_SF097_05 TB148920.[MT7]-AQQGLYQVPGPSPQFQSPPAK[MT7].3y4_1.heavy 838.451 / 556.357 11394.0 31.69260025024414 47 17 10 10 10 2.3597955951399916 33.5235109736938 0.0 3 0.9745406619830582 7.718147622136985 11394.0 85.58401238302564 0.0 - - - - - - - 215.2941176470588 22 17 BCAR1 breast cancer anti-estrogen resistance 1 1001 128 C20140403_SF097_05 C20140403_SF097_05 TB148920.[MT7]-AQQGLYQVPGPSPQFQSPPAK[MT7].3b7_1.heavy 838.451 / 933.491 6348.0 31.69260025024414 47 17 10 10 10 2.3597955951399916 33.5235109736938 0.0 3 0.9745406619830582 7.718147622136985 6348.0 34.775245901639344 0.0 - - - - - - - 207.1818181818182 12 11 BCAR1 breast cancer anti-estrogen resistance 1 1003 129 C20140403_SF097_05 C20140403_SF097_05 TB148923.[MT7]-ASYLLSLLRPQIYTDLELK[MT7].3b4_1.heavy 842.159 / 579.326 N/A 49.506900787353516 39 11 10 10 8 0.7532371807770986 82.43530581634303 0.0 4 0.8705207756747746 3.3920397602979824 5723.0 25.973543192571995 1.0 - - - - - - - 189.0 16 17 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1005 129 C20140403_SF097_05 C20140403_SF097_05 TB148923.[MT7]-ASYLLSLLRPQIYTDLELK[MT7].3y4_1.heavy 842.159 / 646.426 5353.0 49.506900787353516 39 11 10 10 8 0.7532371807770986 82.43530581634303 0.0 4 0.8705207756747746 3.3920397602979824 5353.0 5.128652865091408 2.0 - - - - - - - 221.3125 12 16 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1007 129 C20140403_SF097_05 C20140403_SF097_05 TB148923.[MT7]-ASYLLSLLRPQIYTDLELK[MT7].3y5_1.heavy 842.159 / 761.453 1688.0 49.506900787353516 39 11 10 10 8 0.7532371807770986 82.43530581634303 0.0 4 0.8705207756747746 3.3920397602979824 1688.0 13.516438058395504 0.0 - - - - - - - 150.88888888888889 3 18 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1009 129 C20140403_SF097_05 C20140403_SF097_05 TB148923.[MT7]-ASYLLSLLRPQIYTDLELK[MT7].3y16_2.heavy 842.159 / 1030.12 5394.0 49.506900787353516 39 11 10 10 8 0.7532371807770986 82.43530581634303 0.0 4 0.8705207756747746 3.3920397602979824 5394.0 41.20432142119397 0.0 - - - - - - - 197.66666666666666 10 15 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1011 130 C20140403_SF097_05 C20140403_SF097_05 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y7.peptide 661.38 / 836.43 46340.0 43.72013473510742 24 -3 10 7 10 null 0.0 0.027099609375 3 0.0 0.0 46340.0 289.2503167980219 0.0 - - - - - - - 120.66666666666667 92 21 1013 130 C20140403_SF097_05 C20140403_SF097_05 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y9.peptide 661.38 / 502.76 54473.0 43.72013473510742 24 -3 10 7 10 null 0.0 0.027099609375 3 0.0 0.0 54473.0 221.25154651511662 0.0 - - - - - - - 285.6 108 20 1015 130 C20140403_SF097_05 C20140403_SF097_05 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y17.peptide 661.38 / 906.51 55268.0 43.72013473510742 24 -3 10 7 10 null 0.0 0.027099609375 3 0.0 0.0 55268.0 203.8355101039025 0.0 - - - - - - - 200.8125 110 16 1017 131 C20140403_SF097_05 C20140403_SF097_05 TB148924.[MT7]-LIQTIWTSSPNDVVSPSEFK[MT7].3y7_1.heavy 846.123 / 937.511 9700.0 43.516273498535156 44 17 10 7 10 3.112553640272416 32.12796036865981 0.0251007080078125 3 0.9774219948589641 8.1978328154375 9700.0 13.755255147502945 1.0 - - - - - - - 828.2857142857143 19 7 USP2 ubiquitin specific peptidase 2 1019 131 C20140403_SF097_05 C20140403_SF097_05 TB148924.[MT7]-LIQTIWTSSPNDVVSPSEFK[MT7].3y6_1.heavy 846.123 / 838.443 11330.0 43.516273498535156 44 17 10 7 10 3.112553640272416 32.12796036865981 0.0251007080078125 3 0.9774219948589641 8.1978328154375 11330.0 51.53208220354463 0.0 - - - - - - - 199.47368421052633 22 19 USP2 ubiquitin specific peptidase 2 1021 131 C20140403_SF097_05 C20140403_SF097_05 TB148924.[MT7]-LIQTIWTSSPNDVVSPSEFK[MT7].3b4_1.heavy 846.123 / 600.384 7540.0 43.516273498535156 44 17 10 7 10 3.112553640272416 32.12796036865981 0.0251007080078125 3 0.9774219948589641 8.1978328154375 7540.0 12.412456162743347 0.0 - - - - - - - 677.6666666666666 15 9 USP2 ubiquitin specific peptidase 2 1023 131 C20140403_SF097_05 C20140403_SF097_05 TB148924.[MT7]-LIQTIWTSSPNDVVSPSEFK[MT7].3y5_1.heavy 846.123 / 751.411 11481.0 43.516273498535156 44 17 10 7 10 3.112553640272416 32.12796036865981 0.0251007080078125 3 0.9774219948589641 8.1978328154375 11481.0 28.837570474608953 0.0 - - - - - - - 209.47368421052633 22 19 USP2 ubiquitin specific peptidase 2 1025 132 C20140403_SF097_05 C20140403_SF097_05 TB148639.[MT7]-YTQGGLENLELSR.2b3_1.heavy 812.427 / 537.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 1027 132 C20140403_SF097_05 C20140403_SF097_05 TB148639.[MT7]-YTQGGLENLELSR.2y6_1.heavy 812.427 / 731.405 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 1029 132 C20140403_SF097_05 C20140403_SF097_05 TB148639.[MT7]-YTQGGLENLELSR.2y10_1.heavy 812.427 / 1087.57 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 1031 132 C20140403_SF097_05 C20140403_SF097_05 TB148639.[MT7]-YTQGGLENLELSR.2y11_1.heavy 812.427 / 1215.63 N/A N/A - - - - - - - - - 0.0 - - - - - - - TTC35 tetratricopeptide repeat domain 35 1033 133 C20140403_SF097_05 C20140403_SF097_05 TB148064.[MT7]-EQAATGK[MT7].2y4_1.heavy 496.784 / 520.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1035 133 C20140403_SF097_05 C20140403_SF097_05 TB148064.[MT7]-EQAATGK[MT7].2y5_1.heavy 496.784 / 591.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1037 133 C20140403_SF097_05 C20140403_SF097_05 TB148064.[MT7]-EQAATGK[MT7].2b6_1.heavy 496.784 / 702.354 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1039 133 C20140403_SF097_05 C20140403_SF097_05 TB148064.[MT7]-EQAATGK[MT7].2y6_1.heavy 496.784 / 719.417 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1041 134 C20140403_SF097_05 C20140403_SF097_05 TB148825.[MT7]-VQTLEAWVIHGGREDSR.4y9_2.heavy 525.029 / 513.757 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 1043 134 C20140403_SF097_05 C20140403_SF097_05 TB148825.[MT7]-VQTLEAWVIHGGREDSR.4b4_1.heavy 525.029 / 586.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 1045 134 C20140403_SF097_05 C20140403_SF097_05 TB148825.[MT7]-VQTLEAWVIHGGREDSR.4b5_1.heavy 525.029 / 715.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 1047 134 C20140403_SF097_05 C20140403_SF097_05 TB148825.[MT7]-VQTLEAWVIHGGREDSR.4b6_1.heavy 525.029 / 786.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 1049 135 C20140403_SF097_05 C20140403_SF097_05 TB148739.[MT7]-VFDC[CAM]IEVYAPGFK[MT7].3b6_1.heavy 611.655 / 908.43 1726.0 41.811326026916504 43 17 10 6 10 4.053289326180692 24.671320488791107 0.033298492431640625 3 0.976397965849595 8.017329745851354 1726.0 44.15348837209302 0.0 - - - - - - - 64.5 3 10 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1051 135 C20140403_SF097_05 C20140403_SF097_05 TB148739.[MT7]-VFDC[CAM]IEVYAPGFK[MT7].3b7_1.heavy 611.655 / 1007.5 992.0 41.811326026916504 43 17 10 6 10 4.053289326180692 24.671320488791107 0.033298492431640625 3 0.976397965849595 8.017329745851354 992.0 31.374883720930228 0.0 - - - - - - - 0.0 1 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1053 135 C20140403_SF097_05 C20140403_SF097_05 TB148739.[MT7]-VFDC[CAM]IEVYAPGFK[MT7].3b5_1.heavy 611.655 / 779.388 388.0 41.811326026916504 43 17 10 6 10 4.053289326180692 24.671320488791107 0.033298492431640625 3 0.976397965849595 8.017329745851354 388.0 7.981860465116279 1.0 - - - - - - - 0.0 0 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1055 135 C20140403_SF097_05 C20140403_SF097_05 TB148739.[MT7]-VFDC[CAM]IEVYAPGFK[MT7].3y4_1.heavy 611.655 / 592.357 3366.0 41.811326026916504 43 17 10 6 10 4.053289326180692 24.671320488791107 0.033298492431640625 3 0.976397965849595 8.017329745851354 3366.0 113.66120930232557 0.0 - - - - - - - 139.30769230769232 6 13 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1057 136 C20140403_SF097_05 C20140403_SF097_05 TB148380.[MT7]-FDLSQEMER.2y6_1.heavy 649.812 / 779.335 1262.0 32.06999969482422 43 13 10 10 10 1.727123181699536 45.959779215404325 0.0 3 0.927289460438364 4.548795423371272 1262.0 7.291555555555556 0.0 - - - - - - - 236.375 2 8 ANKRD13A ankyrin repeat domain 13A 1059 136 C20140403_SF097_05 C20140403_SF097_05 TB148380.[MT7]-FDLSQEMER.2b3_1.heavy 649.812 / 520.289 N/A 32.06999969482422 43 13 10 10 10 1.727123181699536 45.959779215404325 0.0 3 0.927289460438364 4.548795423371272 901.0 7.007777777777777 0.0 - - - - - - - 0.0 1 0 ANKRD13A ankyrin repeat domain 13A 1061 136 C20140403_SF097_05 C20140403_SF097_05 TB148380.[MT7]-FDLSQEMER.2y8_1.heavy 649.812 / 1007.45 2523.0 32.06999969482422 43 13 10 10 10 1.727123181699536 45.959779215404325 0.0 3 0.927289460438364 4.548795423371272 2523.0 12.615000000000002 0.0 - - - - - - - 135.0 5 8 ANKRD13A ankyrin repeat domain 13A 1063 136 C20140403_SF097_05 C20140403_SF097_05 TB148380.[MT7]-FDLSQEMER.2y7_1.heavy 649.812 / 892.419 1532.0 32.06999969482422 43 13 10 10 10 1.727123181699536 45.959779215404325 0.0 3 0.927289460438364 4.548795423371272 1532.0 1.5813096559378468 1.0 - - - - - - - 207.84615384615384 3 13 ANKRD13A ankyrin repeat domain 13A 1065 137 C20140403_SF097_05 C20140403_SF097_05 TB148823.[MT7]-LGFK[MT7]PVPTSSFLTRPR.4y5_1.heavy 523.563 / 642.405 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 1067 137 C20140403_SF097_05 C20140403_SF097_05 TB148823.[MT7]-LGFK[MT7]PVPTSSFLTRPR.4y10_2.heavy 523.563 / 581.322 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 1069 137 C20140403_SF097_05 C20140403_SF097_05 TB148823.[MT7]-LGFK[MT7]PVPTSSFLTRPR.4y12_2.heavy 523.563 / 679.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 1071 137 C20140403_SF097_05 C20140403_SF097_05 TB148823.[MT7]-LGFK[MT7]PVPTSSFLTRPR.4y10_1.heavy 523.563 / 1161.64 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 1073 138 C20140403_SF097_05 C20140403_SF097_05 TB480276.[MT7]-IC[CAM]PNDVC[CAM]R.2y6_1.heavy 589.282 / 760.341 2322.0 22.440150260925293 46 20 10 6 10 6.578059422717364 15.202051786678828 0.037799835205078125 3 0.9906457451568169 12.750248441348722 2322.0 53.48397051597052 0.0 - - - - - - - 117.375 4 8 ANKRD13A ankyrin repeat domain 13A 1075 138 C20140403_SF097_05 C20140403_SF097_05 TB480276.[MT7]-IC[CAM]PNDVC[CAM]R.2y4_1.heavy 589.282 / 549.245 221.0 22.440150260925293 46 20 10 6 10 6.578059422717364 15.202051786678828 0.037799835205078125 3 0.9906457451568169 12.750248441348722 221.0 7.433636363636364 6.0 - - - - - - - 0.0 0 0 ANKRD13A ankyrin repeat domain 13A 1077 138 C20140403_SF097_05 C20140403_SF097_05 TB480276.[MT7]-IC[CAM]PNDVC[CAM]R.2b5_1.heavy 589.282 / 744.347 663.0 22.440150260925293 46 20 10 6 10 6.578059422717364 15.202051786678828 0.037799835205078125 3 0.9906457451568169 12.750248441348722 663.0 5.614594594594594 0.0 - - - - - - - 0.0 1 0 ANKRD13A ankyrin repeat domain 13A 1079 138 C20140403_SF097_05 C20140403_SF097_05 TB480276.[MT7]-IC[CAM]PNDVC[CAM]R.2y7_1.heavy 589.282 / 920.371 3648.0 22.440150260925293 46 20 10 6 10 6.578059422717364 15.202051786678828 0.037799835205078125 3 0.9906457451568169 12.750248441348722 3648.0 89.33267813267813 0.0 - - - - - - - 96.625 7 8 ANKRD13A ankyrin repeat domain 13A 1081 139 C20140403_SF097_05 C20140403_SF097_05 TB148301.[MT7]-VAVYVPGSK[MT7].2y4_1.heavy 604.368 / 532.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1083 139 C20140403_SF097_05 C20140403_SF097_05 TB148301.[MT7]-VAVYVPGSK[MT7].2y5_1.heavy 604.368 / 631.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1085 139 C20140403_SF097_05 C20140403_SF097_05 TB148301.[MT7]-VAVYVPGSK[MT7].2b4_1.heavy 604.368 / 577.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1087 139 C20140403_SF097_05 C20140403_SF097_05 TB148301.[MT7]-VAVYVPGSK[MT7].2y6_1.heavy 604.368 / 794.453 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1089 140 C20140403_SF097_05 C20140403_SF097_05 TB480179.[MT7]-VC[CAM]IFSK[MT7].2b3_1.heavy 521.304 / 517.292 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1091 140 C20140403_SF097_05 C20140403_SF097_05 TB480179.[MT7]-VC[CAM]IFSK[MT7].2y4_1.heavy 521.304 / 638.399 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1093 140 C20140403_SF097_05 C20140403_SF097_05 TB480179.[MT7]-VC[CAM]IFSK[MT7].2y5_1.heavy 521.304 / 798.43 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1095 140 C20140403_SF097_05 C20140403_SF097_05 TB480179.[MT7]-VC[CAM]IFSK[MT7].2y3_1.heavy 521.304 / 525.315 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1097 141 C20140403_SF097_05 C20140403_SF097_05 TB480174.[MT7]-Y[MT7]ASWAASQINR.3y7_1.heavy 518.947 / 759.411 1467.0 27.35972547531128 41 15 10 6 10 1.648423305383681 42.25921994254564 0.03750038146972656 3 0.9539334261961796 5.727801336785778 1467.0 7.4184659090909095 1.0 - - - - - - - 134.21428571428572 2 14 TTC35 tetratricopeptide repeat domain 35 1099 141 C20140403_SF097_05 C20140403_SF097_05 TB480174.[MT7]-Y[MT7]ASWAASQINR.3y8_1.heavy 518.947 / 945.49 293.0 27.35972547531128 41 15 10 6 10 1.648423305383681 42.25921994254564 0.03750038146972656 3 0.9539334261961796 5.727801336785778 293.0 7.230304505287556 2.0 - - - - - - - 0.0 0 0 TTC35 tetratricopeptide repeat domain 35 1101 141 C20140403_SF097_05 C20140403_SF097_05 TB480174.[MT7]-Y[MT7]ASWAASQINR.3y6_1.heavy 518.947 / 688.374 2582.0 27.35972547531128 41 15 10 6 10 1.648423305383681 42.25921994254564 0.03750038146972656 3 0.9539334261961796 5.727801336785778 2582.0 23.13892707765048 0.0 - - - - - - - 161.4375 5 16 TTC35 tetratricopeptide repeat domain 35 1103 141 C20140403_SF097_05 C20140403_SF097_05 TB480174.[MT7]-Y[MT7]ASWAASQINR.3y5_1.heavy 518.947 / 617.336 2171.0 27.35972547531128 41 15 10 6 10 1.648423305383681 42.25921994254564 0.03750038146972656 3 0.9539334261961796 5.727801336785778 2171.0 14.799271455430215 0.0 - - - - - - - 172.06666666666666 4 15 TTC35 tetratricopeptide repeat domain 35 1105 142 C20140403_SF097_05 C20140403_SF097_05 TB480278.[MT7]-EVLFDPC[CAM]R.2y5_1.heavy 590.301 / 694.298 2461.0 32.4195499420166 39 13 10 6 10 2.3982769869991447 41.69660157775415 0.036098480224609375 3 0.9070161525786429 4.015452870818835 2461.0 32.837657524091924 0.0 - - - - - - - 208.4 4 5 RNF144A ring finger protein 144A 1107 142 C20140403_SF097_05 C20140403_SF097_05 TB480278.[MT7]-EVLFDPC[CAM]R.2y6_1.heavy 590.301 / 807.382 1704.0 32.4195499420166 39 13 10 6 10 2.3982769869991447 41.69660157775415 0.036098480224609375 3 0.9070161525786429 4.015452870818835 1704.0 16.76952380952381 0.0 - - - - - - - 202.85714285714286 3 7 RNF144A ring finger protein 144A 1109 142 C20140403_SF097_05 C20140403_SF097_05 TB480278.[MT7]-EVLFDPC[CAM]R.2b5_1.heavy 590.301 / 748.4 17132.0 32.4195499420166 39 13 10 6 10 2.3982769869991447 41.69660157775415 0.036098480224609375 3 0.9070161525786429 4.015452870818835 17132.0 73.99737089201878 0.0 - - - - - - - 189.5 34 12 RNF144A ring finger protein 144A 1111 142 C20140403_SF097_05 C20140403_SF097_05 TB480278.[MT7]-EVLFDPC[CAM]R.2y7_1.heavy 590.301 / 906.45 3597.0 32.4195499420166 39 13 10 6 10 2.3982769869991447 41.69660157775415 0.036098480224609375 3 0.9070161525786429 4.015452870818835 3597.0 21.686147338442854 0.0 - - - - - - - 321.8 7 5 RNF144A ring finger protein 144A 1113 143 C20140403_SF097_05 C20140403_SF097_05 TB148504.[MT7]-GLLHSFDLLK[MT7].3y6_1.heavy 477.625 / 866.51 3004.0 40.080101013183594 47 17 10 10 10 3.6463061264205456 27.425014941948 0.0 3 0.9727215345351197 7.455215242181535 3004.0 57.27966101694915 0.0 - - - - - - - 151.57142857142858 6 7 EIF2A eukaryotic translation initiation factor 2A, 65kDa 1115 143 C20140403_SF097_05 C20140403_SF097_05 TB148504.[MT7]-GLLHSFDLLK[MT7].3y3_1.heavy 477.625 / 517.383 14962.0 40.080101013183594 47 17 10 10 10 3.6463061264205456 27.425014941948 0.0 3 0.9727215345351197 7.455215242181535 14962.0 104.0210681164055 0.0 - - - - - - - 268.44444444444446 29 18 EIF2A eukaryotic translation initiation factor 2A, 65kDa 1117 143 C20140403_SF097_05 C20140403_SF097_05 TB148504.[MT7]-GLLHSFDLLK[MT7].3b3_1.heavy 477.625 / 428.299 25153.0 40.080101013183594 47 17 10 10 10 3.6463061264205456 27.425014941948 0.0 3 0.9727215345351197 7.455215242181535 25153.0 47.219883644721364 0.0 - - - - - - - 209.66666666666666 50 9 EIF2A eukaryotic translation initiation factor 2A, 65kDa 1119 143 C20140403_SF097_05 C20140403_SF097_05 TB148504.[MT7]-GLLHSFDLLK[MT7].3y4_1.heavy 477.625 / 632.41 12017.0 40.080101013183594 47 17 10 10 10 3.6463061264205456 27.425014941948 0.0 3 0.9727215345351197 7.455215242181535 12017.0 79.01176057521486 0.0 - - - - - - - 210.42857142857142 24 14 EIF2A eukaryotic translation initiation factor 2A, 65kDa 1121 144 C20140403_SF097_05 C20140403_SF097_05 TB147900.[MT7]-LVAC[CAM]SR.2b3_1.heavy 425.24 / 428.299 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 1123 144 C20140403_SF097_05 C20140403_SF097_05 TB147900.[MT7]-LVAC[CAM]SR.2y4_1.heavy 425.24 / 493.219 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 1125 144 C20140403_SF097_05 C20140403_SF097_05 TB147900.[MT7]-LVAC[CAM]SR.2y5_1.heavy 425.24 / 592.287 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 1127 144 C20140403_SF097_05 C20140403_SF097_05 TB147900.[MT7]-LVAC[CAM]SR.2y3_1.heavy 425.24 / 422.182 N/A N/A - - - - - - - - - 0.0 - - - - - - - BCAR1 breast cancer anti-estrogen resistance 1 1129 145 C20140403_SF097_05 C20140403_SF097_05 TB147984.[MT7]-FEAMER.2y4_1.heavy 463.73 / 506.239 6369.0 24.98940086364746 32 16 0 10 6 2.033075700926374 35.07274133553202 0.0 5 0.9610517201167155 6.2330192590829006 6369.0 6.658436861608966 3.0 - - - - - - - 282.5833333333333 69 12 TTC35 tetratricopeptide repeat domain 35 1131 145 C20140403_SF097_05 C20140403_SF097_05 TB147984.[MT7]-FEAMER.2b3_1.heavy 463.73 / 492.258 5556.0 24.98940086364746 32 16 0 10 6 2.033075700926374 35.07274133553202 0.0 5 0.9610517201167155 6.2330192590829006 5556.0 12.905061425061424 1.0 - - - - - - - 286.6923076923077 11 13 TTC35 tetratricopeptide repeat domain 35 1133 145 C20140403_SF097_05 C20140403_SF097_05 TB147984.[MT7]-FEAMER.2y5_1.heavy 463.73 / 635.282 9757.0 24.98940086364746 32 16 0 10 6 2.033075700926374 35.07274133553202 0.0 5 0.9610517201167155 6.2330192590829006 9757.0 34.36024460781607 0.0 - - - - - - - 254.25 19 12 TTC35 tetratricopeptide repeat domain 35 1135 145 C20140403_SF097_05 C20140403_SF097_05 TB147984.[MT7]-FEAMER.2b4_1.heavy 463.73 / 623.298 3049.0 24.98940086364746 32 16 0 10 6 2.033075700926374 35.07274133553202 0.0 5 0.9610517201167155 6.2330192590829006 3049.0 6.115001961597368 2.0 - - - - - - - 725.1 6 10 TTC35 tetratricopeptide repeat domain 35 1137 146 C20140403_SF097_05 C20140403_SF097_05 TB480672.[MT7]-LQQGVSATVAHLLDLAGSAGATGSWR.4y4_1.heavy 678.365 / 505.252 2414.0 50.50890064239502 44 18 10 6 10 3.9666099852780086 25.210444276384106 0.037601470947265625 3 0.9815731442051535 9.07752798771164 2414.0 26.39925641025641 0.0 - - - - - - - 119.71428571428571 4 14 BCAR1 breast cancer anti-estrogen resistance 1 1139 146 C20140403_SF097_05 C20140403_SF097_05 TB480672.[MT7]-LQQGVSATVAHLLDLAGSAGATGSWR.4y5_1.heavy 678.365 / 606.299 2609.0 50.50890064239502 44 18 10 6 10 3.9666099852780086 25.210444276384106 0.037601470947265625 3 0.9815731442051535 9.07752798771164 2609.0 24.975042735042734 0.0 - - - - - - - 134.27777777777777 5 18 BCAR1 breast cancer anti-estrogen resistance 1 1141 146 C20140403_SF097_05 C20140403_SF097_05 TB480672.[MT7]-LQQGVSATVAHLLDLAGSAGATGSWR.4b14_2.heavy 678.365 / 789.442 3738.0 50.50890064239502 44 18 10 6 10 3.9666099852780086 25.210444276384106 0.037601470947265625 3 0.9815731442051535 9.07752798771164 3738.0 106.77261538461538 0.0 - - - - - - - 152.76923076923077 7 13 BCAR1 breast cancer anti-estrogen resistance 1 1143 146 C20140403_SF097_05 C20140403_SF097_05 TB480672.[MT7]-LQQGVSATVAHLLDLAGSAGATGSWR.4y7_1.heavy 678.365 / 734.358 3193.0 50.50890064239502 44 18 10 6 10 3.9666099852780086 25.210444276384106 0.037601470947265625 3 0.9815731442051535 9.07752798771164 3193.0 43.392051282051284 0.0 - - - - - - - 181.83333333333334 6 12 BCAR1 breast cancer anti-estrogen resistance 1 1145 147 C20140403_SF097_05 C20140403_SF097_05 EFTU1_ECO24.FESEVYILSK.2y8.peptide 607.82 / 938.52 111413.0 34.19620132446289 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 111413.0 1058.2335989782246 0.0 - - - - - - - 245.83333333333334 222 6 1147 147 C20140403_SF097_05 C20140403_SF097_05 EFTU1_ECO24.FESEVYILSK.2y6.peptide 607.82 / 722.44 25491.0 34.19620132446289 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 25491.0 274.4793651694987 0.0 - - - - - - - 168.57142857142858 50 7 1149 147 C20140403_SF097_05 C20140403_SF097_05 EFTU1_ECO24.FESEVYILSK.2y5.peptide 607.82 / 623.38 28936.0 34.19620132446289 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 28936.0 143.95397975023897 0.0 - - - - - - - 196.85714285714286 57 7 1151 148 C20140403_SF097_05 C20140403_SF097_05 TB148110.[MT7]-NAAHVAFR.2y5_1.heavy 515.289 / 629.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1153 148 C20140403_SF097_05 C20140403_SF097_05 TB148110.[MT7]-NAAHVAFR.2b4_1.heavy 515.289 / 538.285 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1155 148 C20140403_SF097_05 C20140403_SF097_05 TB148110.[MT7]-NAAHVAFR.2y6_1.heavy 515.289 / 700.389 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1157 148 C20140403_SF097_05 C20140403_SF097_05 TB148110.[MT7]-NAAHVAFR.2y7_1.heavy 515.289 / 771.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1159 149 C20140403_SF097_05 C20140403_SF097_05 TB148631.[MT7]-VQTLEAWVIHGGR.3y6_1.heavy 537.303 / 638.373 3947.0 39.98550033569336 46 20 10 6 10 7.881835267772435 12.68740040899916 0.037200927734375 3 0.9910721831136572 13.05167028792357 3947.0 32.4456779661017 0.0 - - - - - - - 122.53846153846153 7 13 CD38 CD38 molecule 1161 149 C20140403_SF097_05 C20140403_SF097_05 TB148631.[MT7]-VQTLEAWVIHGGR.3b6_1.heavy 537.303 / 786.448 4830.0 39.98550033569336 46 20 10 6 10 7.881835267772435 12.68740040899916 0.037200927734375 3 0.9910721831136572 13.05167028792357 4830.0 121.89610169491525 0.0 - - - - - - - 118.0 9 4 CD38 CD38 molecule 1163 149 C20140403_SF097_05 C20140403_SF097_05 TB148631.[MT7]-VQTLEAWVIHGGR.3b5_1.heavy 537.303 / 715.411 4536.0 39.98550033569336 46 20 10 6 10 7.881835267772435 12.68740040899916 0.037200927734375 3 0.9910721831136572 13.05167028792357 4536.0 52.509966101694914 0.0 - - - - - - - 117.9 9 10 CD38 CD38 molecule 1165 149 C20140403_SF097_05 C20140403_SF097_05 TB148631.[MT7]-VQTLEAWVIHGGR.3y5_1.heavy 537.303 / 539.305 6303.0 39.98550033569336 46 20 10 6 10 7.881835267772435 12.68740040899916 0.037200927734375 3 0.9910721831136572 13.05167028792357 6303.0 133.53813559322035 0.0 - - - - - - - 88.5 12 6 CD38 CD38 molecule 1167 150 C20140403_SF097_05 C20140403_SF097_05 TB148630.[MT7]-VQTLEAWVIHGGR.2y8_1.heavy 805.45 / 895.49 3067.0 39.98550033569336 35 9 10 6 10 0.6929926185856313 81.4047755757953 0.037200927734375 3 0.8012840955761568 2.7213031775384096 3067.0 13.255677966101695 0.0 - - - - - - - 192.52631578947367 6 19 CD38 CD38 molecule 1169 150 C20140403_SF097_05 C20140403_SF097_05 TB148630.[MT7]-VQTLEAWVIHGGR.2y9_1.heavy 805.45 / 1024.53 6547.0 39.98550033569336 35 9 10 6 10 0.6929926185856313 81.4047755757953 0.037200927734375 3 0.8012840955761568 2.7213031775384096 6547.0 39.49087736789632 0.0 - - - - - - - 202.28571428571428 13 14 CD38 CD38 molecule 1171 150 C20140403_SF097_05 C20140403_SF097_05 TB148630.[MT7]-VQTLEAWVIHGGR.2b6_1.heavy 805.45 / 786.448 3480.0 39.98550033569336 35 9 10 6 10 0.6929926185856313 81.4047755757953 0.037200927734375 3 0.8012840955761568 2.7213031775384096 3480.0 7.453902030173216 0.0 - - - - - - - 276.5625 6 16 CD38 CD38 molecule 1173 150 C20140403_SF097_05 C20140403_SF097_05 TB148630.[MT7]-VQTLEAWVIHGGR.2y6_1.heavy 805.45 / 638.373 2006.0 39.98550033569336 35 9 10 6 10 0.6929926185856313 81.4047755757953 0.037200927734375 3 0.8012840955761568 2.7213031775384096 2006.0 6.460000000000001 1.0 - - - - - - - 227.57142857142858 4 21 CD38 CD38 molecule 1175 151 C20140403_SF097_05 C20140403_SF097_05 TB148585.[MT7]-SWEGTK[MT7]PPAK[MT7].3y3_1.heavy 511.631 / 459.305 N/A 20.65336736043294 46 20 10 6 10 12.25160430135488 8.162196357332665 0.03280067443847656 3 0.9985789943271357 32.73505105448968 1725.0 6.470749304589708 3.0 - - - - - - - 645.0 5 13 BCAR1 breast cancer anti-estrogen resistance 1 1177 151 C20140403_SF097_05 C20140403_SF097_05 TB148585.[MT7]-SWEGTK[MT7]PPAK[MT7].3y9_2.heavy 511.631 / 651.376 383.0 20.65336736043294 46 20 10 6 10 12.25160430135488 8.162196357332665 0.03280067443847656 3 0.9985789943271357 32.73505105448968 383.0 7.580208333333333 7.0 - - - - - - - 0.0 0 0 BCAR1 breast cancer anti-estrogen resistance 1 1179 151 C20140403_SF097_05 C20140403_SF097_05 TB148585.[MT7]-SWEGTK[MT7]PPAK[MT7].3y4_1.heavy 511.631 / 556.357 3067.0 20.65336736043294 46 20 10 6 10 12.25160430135488 8.162196357332665 0.03280067443847656 3 0.9985789943271357 32.73505105448968 3067.0 31.947916666666664 0.0 - - - - - - - 123.57692307692308 6 26 BCAR1 breast cancer anti-estrogen resistance 1 1181 151 C20140403_SF097_05 C20140403_SF097_05 TB148585.[MT7]-SWEGTK[MT7]PPAK[MT7].3b3_1.heavy 511.631 / 547.263 527.0 20.65336736043294 46 20 10 6 10 12.25160430135488 8.162196357332665 0.03280067443847656 3 0.9985789943271357 32.73505105448968 527.0 2.9277777777777776 2.0 - - - - - - - 0.0 1 0 BCAR1 breast cancer anti-estrogen resistance 1 1183 152 C20140403_SF097_05 C20140403_SF097_05 TB480537.[MT7]-VSELYDVTWEEMR.3y5_1.heavy 600.958 / 750.324 1315.0 41.26504993438721 44 18 10 6 10 4.5022652506650145 22.211041427474612 0.033000946044921875 3 0.9828818412924735 9.419164142423805 1315.0 41.59693877551021 0.0 - - - - - - - 170.33333333333334 2 6 TTC35 tetratricopeptide repeat domain 35 1185 152 C20140403_SF097_05 C20140403_SF097_05 TB480537.[MT7]-VSELYDVTWEEMR.3b4_1.heavy 600.958 / 573.336 1509.0 41.26504993438721 44 18 10 6 10 4.5022652506650145 22.211041427474612 0.033000946044921875 3 0.9828818412924735 9.419164142423805 1509.0 23.335051546391753 0.0 - - - - - - - 80.0 3 14 TTC35 tetratricopeptide repeat domain 35 1187 152 C20140403_SF097_05 C20140403_SF097_05 TB480537.[MT7]-VSELYDVTWEEMR.3b5_1.heavy 600.958 / 736.4 390.0 41.26504993438721 44 18 10 6 10 4.5022652506650145 22.211041427474612 0.033000946044921875 3 0.9828818412924735 9.419164142423805 390.0 8.763307384809593 0.0 - - - - - - - 0.0 0 0 TTC35 tetratricopeptide repeat domain 35 1189 152 C20140403_SF097_05 C20140403_SF097_05 TB480537.[MT7]-VSELYDVTWEEMR.3y4_1.heavy 600.958 / 564.245 1120.0 41.26504993438721 44 18 10 6 10 4.5022652506650145 22.211041427474612 0.033000946044921875 3 0.9828818412924735 9.419164142423805 1120.0 6.49025641025641 0.0 - - - - - - - 112.3076923076923 2 13 TTC35 tetratricopeptide repeat domain 35 1191 153 C20140403_SF097_05 C20140403_SF097_05 TB147908.[MT7]-DAYADR.2b3_1.heavy 427.71 / 494.237 2797.0 14.71049976348877 48 20 10 10 8 4.629562772729267 17.61903764402463 0.0 4 0.9913474572697671 13.257964429933871 2797.0 19.164351752503578 3.0 - - - - - - - 176.52173913043478 5 23 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1193 153 C20140403_SF097_05 C20140403_SF097_05 TB147908.[MT7]-DAYADR.2y5_1.heavy 427.71 / 595.284 5867.0 14.71049976348877 48 20 10 10 8 4.629562772729267 17.61903764402463 0.0 4 0.9913474572697671 13.257964429933871 5867.0 32.13883086369475 1.0 - - - - - - - 189.05263157894737 12 19 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1195 153 C20140403_SF097_05 C20140403_SF097_05 TB147908.[MT7]-DAYADR.2b4_1.heavy 427.71 / 565.274 1727.0 14.71049976348877 48 20 10 10 8 4.629562772729267 17.61903764402463 0.0 4 0.9913474572697671 13.257964429933871 1727.0 6.0450826585695 0.0 - - - - - - - 182.08 3 25 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1197 153 C20140403_SF097_05 C20140403_SF097_05 TB147908.[MT7]-DAYADR.2b5_1.heavy 427.71 / 680.301 3646.0 14.71049976348877 48 20 10 10 8 4.629562772729267 17.61903764402463 0.0 4 0.9913474572697671 13.257964429933871 3646.0 18.276120991145174 0.0 - - - - - - - 208.13636363636363 7 22 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1199 154 C20140403_SF097_05 C20140403_SF097_05 TB147957.[MT7]-LRDLSR.2y4_1.heavy 452.278 / 490.262 2228.0 19.846799850463867 38 18 2 10 8 6.356696625263349 15.73144132796445 0.0 4 0.9883848808132927 11.440085526169577 2228.0 8.340412254587934 1.0 - - - - - - - 279.46153846153845 4 26 DHRS3 dehydrogenase/reductase (SDR family) member 3 1201 154 C20140403_SF097_05 C20140403_SF097_05 TB147957.[MT7]-LRDLSR.2b3_1.heavy 452.278 / 529.321 4591.0 19.846799850463867 38 18 2 10 8 6.356696625263349 15.73144132796445 0.0 4 0.9883848808132927 11.440085526169577 4591.0 10.503363622605754 0.0 - - - - - - - 681.4285714285714 9 7 DHRS3 dehydrogenase/reductase (SDR family) member 3 1203 154 C20140403_SF097_05 C20140403_SF097_05 TB147957.[MT7]-LRDLSR.2y5_1.heavy 452.278 / 646.363 N/A 19.846799850463867 38 18 2 10 8 6.356696625263349 15.73144132796445 0.0 4 0.9883848808132927 11.440085526169577 2451.0 9.54167352028093 4.0 - - - - - - - 290.89473684210526 30 19 DHRS3 dehydrogenase/reductase (SDR family) member 3 1205 154 C20140403_SF097_05 C20140403_SF097_05 TB147957.[MT7]-LRDLSR.2b5_1.heavy 452.278 / 729.438 1649.0 19.846799850463867 38 18 2 10 8 6.356696625263349 15.73144132796445 0.0 4 0.9883848808132927 11.440085526169577 1649.0 10.143900195469703 2.0 - - - - - - - 190.26923076923077 10 26 DHRS3 dehydrogenase/reductase (SDR family) member 3 1207 155 C20140403_SF097_05 C20140403_SF097_05 TB148746.[MT7]-IQNLSLISLANLPPSGLANAVAEGIR.3b4_1.heavy 925.866 / 613.379 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 1209 155 C20140403_SF097_05 C20140403_SF097_05 TB148746.[MT7]-IQNLSLISLANLPPSGLANAVAEGIR.3b5_1.heavy 925.866 / 700.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 1211 155 C20140403_SF097_05 C20140403_SF097_05 TB148746.[MT7]-IQNLSLISLANLPPSGLANAVAEGIR.3b3_1.heavy 925.866 / 500.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 1213 155 C20140403_SF097_05 C20140403_SF097_05 TB148746.[MT7]-IQNLSLISLANLPPSGLANAVAEGIR.3y12_1.heavy 925.866 / 1157.63 N/A N/A - - - - - - - - - 0.0 - - - - - - - HAVCR2 hepatitis A virus cellular receptor 2 1215 156 C20140403_SF097_05 C20140403_SF097_05 TB148811.[MT7]-HVIGGAAVTEEIIPGFK[MT7].4y4_1.heavy 507.295 / 592.357 6595.0 37.42717456817627 43 17 10 6 10 4.13661896388601 24.174331953953605 0.035701751708984375 3 0.9706989624708534 7.192082947158152 6595.0 82.87138157894736 0.0 - - - - - - - 151.9 13 10 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1217 156 C20140403_SF097_05 C20140403_SF097_05 TB148811.[MT7]-HVIGGAAVTEEIIPGFK[MT7].4b7_1.heavy 507.295 / 750.438 2881.0 37.42717456817627 43 17 10 6 10 4.13661896388601 24.174331953953605 0.035701751708984375 3 0.9706989624708534 7.192082947158152 2881.0 40.9545292320511 0.0 - - - - - - - 161.125 5 8 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1219 156 C20140403_SF097_05 C20140403_SF097_05 TB148811.[MT7]-HVIGGAAVTEEIIPGFK[MT7].4b5_1.heavy 507.295 / 608.364 1213.0 37.42717456817627 43 17 10 6 10 4.13661896388601 24.174331953953605 0.035701751708984375 3 0.9706989624708534 7.192082947158152 1213.0 17.34096444938203 0.0 - - - - - - - 189.6 2 10 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1221 156 C20140403_SF097_05 C20140403_SF097_05 TB148811.[MT7]-HVIGGAAVTEEIIPGFK[MT7].4b6_1.heavy 507.295 / 679.401 2047.0 37.42717456817627 43 17 10 6 10 4.13661896388601 24.174331953953605 0.035701751708984375 3 0.9706989624708534 7.192082947158152 2047.0 25.166282170183166 0.0 - - - - - - - 164.33333333333334 4 12 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1223 157 C20140403_SF097_05 C20140403_SF097_05 TB148059.[MT7]-EAPAEGK[MT7].2y6_1.heavy 495.279 / 716.406 2526.0 14.076800346374512 50 20 10 10 10 5.081128905570726 19.6806658241566 0.0 3 0.9927512570634343 14.486662100946027 2526.0 76.66209523809525 0.0 - - - - - - - 85.04545454545455 5 22 BCAR1 breast cancer anti-estrogen resistance 1 1225 157 C20140403_SF097_05 C20140403_SF097_05 TB148059.[MT7]-EAPAEGK[MT7].2y4_1.heavy 495.279 / 548.316 1187.0 14.076800346374512 50 20 10 10 10 5.081128905570726 19.6806658241566 0.0 3 0.9927512570634343 14.486662100946027 1187.0 8.467400715226802 0.0 - - - - - - - 102.17391304347827 2 23 BCAR1 breast cancer anti-estrogen resistance 1 1227 157 C20140403_SF097_05 C20140403_SF097_05 TB148059.[MT7]-EAPAEGK[MT7].2b5_1.heavy 495.279 / 642.321 808.0 14.076800346374512 50 20 10 10 10 5.081128905570726 19.6806658241566 0.0 3 0.9927512570634343 14.486662100946027 808.0 13.635421888053468 0.0 - - - - - - - 0.0 1 0 BCAR1 breast cancer anti-estrogen resistance 1 1229 157 C20140403_SF097_05 C20140403_SF097_05 TB148059.[MT7]-EAPAEGK[MT7].2y5_1.heavy 495.279 / 645.369 5861.0 14.076800346374512 50 20 10 10 10 5.081128905570726 19.6806658241566 0.0 3 0.9927512570634343 14.486662100946027 5861.0 248.2831238095238 0.0 - - - - - - - 74.66666666666667 11 21 BCAR1 breast cancer anti-estrogen resistance 1 1231 158 C20140403_SF097_05 C20140403_SF097_05 TB148277.[MT7]-VTMLWNK[MT7].2y4_1.heavy 590.344 / 704.421 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1233 158 C20140403_SF097_05 C20140403_SF097_05 TB148277.[MT7]-VTMLWNK[MT7].2y5_1.heavy 590.344 / 835.462 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1235 158 C20140403_SF097_05 C20140403_SF097_05 TB148277.[MT7]-VTMLWNK[MT7].2b4_1.heavy 590.344 / 589.35 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1237 158 C20140403_SF097_05 C20140403_SF097_05 TB148277.[MT7]-VTMLWNK[MT7].2y6_1.heavy 590.344 / 936.509 N/A N/A - - - - - - - - - 0.0 - - - - - - - EIF2A eukaryotic translation initiation factor 2A, 65kDa 1239 159 C20140403_SF097_05 C20140403_SF097_05 TB148749.[MT7]-FVGYNQQDAQEFLR.3y7_1.heavy 620.312 / 878.437 2129.0 36.04309844970703 42 12 10 10 10 1.2692961624896146 53.187571543096894 0.0 3 0.8983174046208492 3.836970423003939 2129.0 27.965940133682068 0.0 - - - - - - - 139.0 4 2 USP2 ubiquitin specific peptidase 2 1241 159 C20140403_SF097_05 C20140403_SF097_05 TB148749.[MT7]-FVGYNQQDAQEFLR.3y6_1.heavy 620.312 / 763.41 2221.0 36.04309844970703 42 12 10 10 10 1.2692961624896146 53.187571543096894 0.0 3 0.8983174046208492 3.836970423003939 2221.0 20.40918918918919 0.0 - - - - - - - 129.8 4 5 USP2 ubiquitin specific peptidase 2 1243 159 C20140403_SF097_05 C20140403_SF097_05 TB148749.[MT7]-FVGYNQQDAQEFLR.3b4_1.heavy 620.312 / 611.331 3332.0 36.04309844970703 42 12 10 10 10 1.2692961624896146 53.187571543096894 0.0 3 0.8983174046208492 3.836970423003939 3332.0 17.407871094053483 0.0 - - - - - - - 250.2 6 10 USP2 ubiquitin specific peptidase 2 1245 159 C20140403_SF097_05 C20140403_SF097_05 TB148749.[MT7]-FVGYNQQDAQEFLR.3b5_1.heavy 620.312 / 725.374 833.0 36.04309844970703 42 12 10 10 10 1.2692961624896146 53.187571543096894 0.0 3 0.8983174046208492 3.836970423003939 833.0 4.003999370942014 1.0 - - - - - - - 166.8 2 10 USP2 ubiquitin specific peptidase 2 1247 160 C20140403_SF097_05 C20140403_SF097_05 TB148478.[MT7]-YASWAASQINR.2y8_1.heavy 705.866 / 945.49 7437.0 31.614900588989258 47 17 10 10 10 3.0279473716308494 27.600238826438186 0.0 3 0.9788065107488937 8.462352697660602 7437.0 61.82197530864197 0.0 - - - - - - - 138.78571428571428 14 14 TTC35 tetratricopeptide repeat domain 35 1249 160 C20140403_SF097_05 C20140403_SF097_05 TB148478.[MT7]-YASWAASQINR.2y9_1.heavy 705.866 / 1032.52 12369.0 31.614900588989258 47 17 10 10 10 3.0279473716308494 27.600238826438186 0.0 3 0.9788065107488937 8.462352697660602 12369.0 100.08896222955629 0.0 - - - - - - - 199.8235294117647 24 17 TTC35 tetratricopeptide repeat domain 35 1251 160 C20140403_SF097_05 C20140403_SF097_05 TB148478.[MT7]-YASWAASQINR.2y10_1.heavy 705.866 / 1103.56 12692.0 31.614900588989258 47 17 10 10 10 3.0279473716308494 27.600238826438186 0.0 3 0.9788065107488937 8.462352697660602 12692.0 85.9037327523602 0.0 - - - - - - - 204.7058823529412 25 17 TTC35 tetratricopeptide repeat domain 35 1253 160 C20140403_SF097_05 C20140403_SF097_05 TB148478.[MT7]-YASWAASQINR.2y7_1.heavy 705.866 / 759.411 8812.0 31.614900588989258 47 17 10 10 10 3.0279473716308494 27.600238826438186 0.0 3 0.9788065107488937 8.462352697660602 8812.0 44.48157576220871 0.0 - - - - - - - 156.07142857142858 17 14 TTC35 tetratricopeptide repeat domain 35 1255 161 C20140403_SF097_05 C20140403_SF097_05 TB148479.[MT7]-REMFDPAEK[MT7].3b4_1.heavy 470.914 / 708.362 1407.0 24.705774784088135 41 15 10 6 10 4.311991783794197 23.191138808712726 0.03890037536621094 3 0.954975940161584 5.794246251284617 1407.0 9.558886870783601 1.0 - - - - - - - 200.85714285714286 2 14 CASP6 caspase 6, apoptosis-related cysteine peptidase 1257 161 C20140403_SF097_05 C20140403_SF097_05 TB148479.[MT7]-REMFDPAEK[MT7].3b5_1.heavy 470.914 / 823.389 5908.0 24.705774784088135 41 15 10 6 10 4.311991783794197 23.191138808712726 0.03890037536621094 3 0.954975940161584 5.794246251284617 5908.0 76.67829787234044 0.0 - - - - - - - 121.36363636363636 11 11 CASP6 caspase 6, apoptosis-related cysteine peptidase 1259 161 C20140403_SF097_05 C20140403_SF097_05 TB148479.[MT7]-REMFDPAEK[MT7].3y4_1.heavy 470.914 / 588.347 15474.0 24.705774784088135 41 15 10 6 10 4.311991783794197 23.191138808712726 0.03890037536621094 3 0.954975940161584 5.794246251284617 15474.0 26.746250348480622 0.0 - - - - - - - 210.91666666666666 30 12 CASP6 caspase 6, apoptosis-related cysteine peptidase 1261 161 C20140403_SF097_05 C20140403_SF097_05 TB148479.[MT7]-REMFDPAEK[MT7].3b3_1.heavy 470.914 / 561.294 1688.0 24.705774784088135 41 15 10 6 10 4.311991783794197 23.191138808712726 0.03890037536621094 3 0.954975940161584 5.794246251284617 1688.0 1.9181818181818184 1.0 - - - - - - - 254.9375 3 16 CASP6 caspase 6, apoptosis-related cysteine peptidase 1263 162 C20140403_SF097_05 C20140403_SF097_05 TB480263.[MT7]-ENVLITGGGR.2b4_1.heavy 580.331 / 600.347 3684.0 25.988524913787842 44 18 10 6 10 4.86830786463876 20.54101810741179 0.03949928283691406 3 0.98855390138572 11.52440488759914 3684.0 38.47609756097561 0.0 - - - - - - - 122.72727272727273 7 11 DHRS3 dehydrogenase/reductase (SDR family) member 3 1265 162 C20140403_SF097_05 C20140403_SF097_05 TB480263.[MT7]-ENVLITGGGR.2y9_1.heavy 580.331 / 886.51 5220.0 25.988524913787842 44 18 10 6 10 4.86830786463876 20.54101810741179 0.03949928283691406 3 0.98855390138572 11.52440488759914 5220.0 43.81831822688004 0.0 - - - - - - - 136.22222222222223 10 9 DHRS3 dehydrogenase/reductase (SDR family) member 3 1267 162 C20140403_SF097_05 C20140403_SF097_05 TB480263.[MT7]-ENVLITGGGR.2y6_1.heavy 580.331 / 560.315 5220.0 25.988524913787842 44 18 10 6 10 4.86830786463876 20.54101810741179 0.03949928283691406 3 0.98855390138572 11.52440488759914 5220.0 47.83211405991349 0.0 - - - - - - - 150.63636363636363 10 11 DHRS3 dehydrogenase/reductase (SDR family) member 3 1269 162 C20140403_SF097_05 C20140403_SF097_05 TB480263.[MT7]-ENVLITGGGR.2y7_1.heavy 580.331 / 673.399 5649.0 25.988524913787842 44 18 10 6 10 4.86830786463876 20.54101810741179 0.03949928283691406 3 0.98855390138572 11.52440488759914 5649.0 61.93689203146103 0.0 - - - - - - - 156.77777777777777 11 9 DHRS3 dehydrogenase/reductase (SDR family) member 3 1271 163 C20140403_SF097_05 C20140403_SF097_05 TB148474.[MT7]-LGTQTVPC[CAM]NK[MT7].3y3_1.heavy 469.262 / 565.288 4551.0 22.138225078582764 38 15 10 3 10 2.871228252459616 27.831023340198954 0.06830024719238281 3 0.9530278793515632 5.671885776919383 4551.0 11.761983083273078 0.0 - - - - - - - 226.8125 9 16 CD38 CD38 molecule 1273 163 C20140403_SF097_05 C20140403_SF097_05 TB148474.[MT7]-LGTQTVPC[CAM]NK[MT7].3b4_1.heavy 469.262 / 544.321 6106.0 22.138225078582764 38 15 10 3 10 2.871228252459616 27.831023340198954 0.06830024719238281 3 0.9530278793515632 5.671885776919383 6106.0 23.62014464247484 0.0 - - - - - - - 793.5555555555555 12 9 CD38 CD38 molecule 1275 163 C20140403_SF097_05 C20140403_SF097_05 TB148474.[MT7]-LGTQTVPC[CAM]NK[MT7].3b5_1.heavy 469.262 / 645.369 6624.0 22.138225078582764 38 15 10 3 10 2.871228252459616 27.831023340198954 0.06830024719238281 3 0.9530278793515632 5.671885776919383 6624.0 35.417341040462425 0.0 - - - - - - - 265.06666666666666 13 15 CD38 CD38 molecule 1277 163 C20140403_SF097_05 C20140403_SF097_05 TB148474.[MT7]-LGTQTVPC[CAM]NK[MT7].3y4_1.heavy 469.262 / 662.341 18490.0 22.138225078582764 38 15 10 3 10 2.871228252459616 27.831023340198954 0.06830024719238281 3 0.9530278793515632 5.671885776919383 18490.0 101.91771350289496 0.0 - - - - - - - 287.94736842105266 36 19 CD38 CD38 molecule 1279 164 C20140403_SF097_05 C20140403_SF097_05 TB148952.[MT7]-LEQEVSRPIDHDLANWTPAQPLAPGR.4b12_2.heavy 764.402 / 782.398 3282.0 36.08319854736328 48 18 10 10 10 3.179636536624395 27.463833207065864 0.0 3 0.9809239377188655 8.921239342661762 3282.0 35.56559235792646 0.0 - - - - - - - 187.75 6 12 BCAR1 breast cancer anti-estrogen resistance 1 1281 164 C20140403_SF097_05 C20140403_SF097_05 TB148952.[MT7]-LEQEVSRPIDHDLANWTPAQPLAPGR.4y9_1.heavy 764.402 / 906.516 11908.0 36.08319854736328 48 18 10 10 10 3.179636536624395 27.463833207065864 0.0 3 0.9809239377188655 8.921239342661762 11908.0 51.82523637651583 0.0 - - - - - - - 196.27272727272728 23 11 BCAR1 breast cancer anti-estrogen resistance 1 1283 164 C20140403_SF097_05 C20140403_SF097_05 TB148952.[MT7]-LEQEVSRPIDHDLANWTPAQPLAPGR.4b4_1.heavy 764.402 / 644.337 3000.0 36.08319854736328 48 18 10 10 10 3.179636536624395 27.463833207065864 0.0 3 0.9809239377188655 8.921239342661762 3000.0 7.467620715157109 0.0 - - - - - - - 224.11111111111111 6 18 BCAR1 breast cancer anti-estrogen resistance 1 1285 164 C20140403_SF097_05 C20140403_SF097_05 TB148952.[MT7]-LEQEVSRPIDHDLANWTPAQPLAPGR.4y6_1.heavy 764.402 / 610.367 12470.0 36.08319854736328 48 18 10 10 10 3.179636536624395 27.463833207065864 0.0 3 0.9809239377188655 8.921239342661762 12470.0 15.663776991068591 0.0 - - - - - - - 324.09090909090907 24 11 BCAR1 breast cancer anti-estrogen resistance 1 1287 165 C20140403_SF097_05 C20140403_SF097_05 SUCC_ECO24.LVQQFTK.2y4.peptide 432.25 / 523.29 380067.0 21.666099548339844 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 380067.0 476.6478321831845 0.0 - - - - - - - 661.1428571428571 760 14 1289 165 C20140403_SF097_05 C20140403_SF097_05 SUCC_ECO24.LVQQFTK.2y6.peptide 432.25 / 750.41 574442.0 21.666099548339844 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 574442.0 612.6727559554398 0.0 - - - - - - - 613.4545454545455 1148 11 1291 165 C20140403_SF097_05 C20140403_SF097_05 SUCC_ECO24.LVQQFTK.2y5.peptide 432.25 / 651.35 1781460.0 21.666099548339844 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1781460.0 881.0852880941816 0.0 - - - - - - - 756.7142857142857 3562 7 1293 166 C20140403_SF097_05 C20140403_SF097_05 TB480660.[MT7]-GNQHDVPVIPLDVVDNQTEK[MT7].4b8_1.heavy 627.085 / 991.508 1171.0 35.62987518310547 33 8 10 5 10 2.8444105460215026 35.15666897659015 0.047698974609375 3 0.7874718822247966 2.6281125118909023 1171.0 17.54759738356881 0.0 - - - - - - - 211.5 2 6 CASP6 caspase 6, apoptosis-related cysteine peptidase 1295 166 C20140403_SF097_05 C20140403_SF097_05 TB480660.[MT7]-GNQHDVPVIPLDVVDNQTEK[MT7].4b5_1.heavy 627.085 / 696.318 781.0 35.62987518310547 33 8 10 5 10 2.8444105460215026 35.15666897659015 0.047698974609375 3 0.7874718822247966 2.6281125118909023 781.0 8.586504447933018 0.0 - - - - - - - 0.0 1 0 CASP6 caspase 6, apoptosis-related cysteine peptidase 1297 166 C20140403_SF097_05 C20140403_SF097_05 TB480660.[MT7]-GNQHDVPVIPLDVVDNQTEK[MT7].4y3_1.heavy 627.085 / 521.305 1952.0 35.62987518310547 33 8 10 5 10 2.8444105460215026 35.15666897659015 0.047698974609375 3 0.7874718822247966 2.6281125118909023 1952.0 23.028697017268446 0.0 - - - - - - - 177.63636363636363 3 11 CASP6 caspase 6, apoptosis-related cysteine peptidase 1299 166 C20140403_SF097_05 C20140403_SF097_05 TB480660.[MT7]-GNQHDVPVIPLDVVDNQTEK[MT7].4b6_1.heavy 627.085 / 795.387 1952.0 35.62987518310547 33 8 10 5 10 2.8444105460215026 35.15666897659015 0.047698974609375 3 0.7874718822247966 2.6281125118909023 1952.0 29.628316064887493 0.0 - - - - - - - 153.57142857142858 3 7 CASP6 caspase 6, apoptosis-related cysteine peptidase 1301 167 C20140403_SF097_05 C20140403_SF097_05 TB147951.[MT7]-RNIQFSC[CAM]K[MT7].3y3_1.heavy 447.583 / 538.278 69103.0 20.758399963378906 47 17 10 10 10 3.521093773062092 28.40026606648302 0.0 3 0.9713933954822412 7.279280139483657 69103.0 265.52588472168327 0.0 - - - - - - - 251.88888888888889 138 18 CD38 CD38 molecule 1303 167 C20140403_SF097_05 C20140403_SF097_05 TB147951.[MT7]-RNIQFSC[CAM]K[MT7].3b4_1.heavy 447.583 / 656.396 18434.0 20.758399963378906 47 17 10 10 10 3.521093773062092 28.40026606648302 0.0 3 0.9713933954822412 7.279280139483657 18434.0 119.5989898989899 0.0 - - - - - - - 173.66666666666666 36 21 CD38 CD38 molecule 1305 167 C20140403_SF097_05 C20140403_SF097_05 TB147951.[MT7]-RNIQFSC[CAM]K[MT7].3b3_1.heavy 447.583 / 528.337 12322.0 20.758399963378906 47 17 10 10 10 3.521093773062092 28.40026606648302 0.0 3 0.9713933954822412 7.279280139483657 12322.0 37.68851105395567 0.0 - - - - - - - 237.5 24 22 CD38 CD38 molecule 1307 167 C20140403_SF097_05 C20140403_SF097_05 TB147951.[MT7]-RNIQFSC[CAM]K[MT7].3y4_1.heavy 447.583 / 685.346 25630.0 20.758399963378906 47 17 10 10 10 3.521093773062092 28.40026606648302 0.0 3 0.9713933954822412 7.279280139483657 25630.0 133.34527027027028 0.0 - - - - - - - 170.13636363636363 51 22 CD38 CD38 molecule 1309 168 C20140403_SF097_05 C20140403_SF097_05 TB480661.[MT7]-ASYLLSLLRPQIYTDLELK[MT7].4y5_1.heavy 631.871 / 761.453 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1311 168 C20140403_SF097_05 C20140403_SF097_05 TB480661.[MT7]-ASYLLSLLRPQIYTDLELK[MT7].4b11_2.heavy 631.871 / 693.915 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1313 168 C20140403_SF097_05 C20140403_SF097_05 TB480661.[MT7]-ASYLLSLLRPQIYTDLELK[MT7].4b4_1.heavy 631.871 / 579.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1315 168 C20140403_SF097_05 C20140403_SF097_05 TB480661.[MT7]-ASYLLSLLRPQIYTDLELK[MT7].4y3_1.heavy 631.871 / 533.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1317 169 C20140403_SF097_05 C20140403_SF097_05 TB148578.[MT7]-TYGPSSLLDYDR.2y4_1.heavy 765.881 / 568.236 2178.0 35.59410095214844 46 16 10 10 10 3.450916843524926 22.164676818210072 0.0 3 0.9680022420456934 6.880780501245752 2178.0 6.8969089888847765 0.0 - - - - - - - 290.3333333333333 4 15 USP2 ubiquitin specific peptidase 2 1319 169 C20140403_SF097_05 C20140403_SF097_05 TB148578.[MT7]-TYGPSSLLDYDR.2y9_1.heavy 765.881 / 1065.52 7669.0 35.59410095214844 46 16 10 10 10 3.450916843524926 22.164676818210072 0.0 3 0.9680022420456934 6.880780501245752 7669.0 45.821911628079825 0.0 - - - - - - - 236.7 15 10 USP2 ubiquitin specific peptidase 2 1321 169 C20140403_SF097_05 C20140403_SF097_05 TB148578.[MT7]-TYGPSSLLDYDR.2y6_1.heavy 765.881 / 794.404 1041.0 35.59410095214844 46 16 10 10 10 3.450916843524926 22.164676818210072 0.0 3 0.9680022420456934 6.880780501245752 1041.0 2.015537552491731 2.0 - - - - - - - 262.3076923076923 6 13 USP2 ubiquitin specific peptidase 2 1323 169 C20140403_SF097_05 C20140403_SF097_05 TB148578.[MT7]-TYGPSSLLDYDR.2y10_1.heavy 765.881 / 1122.54 6154.0 35.59410095214844 46 16 10 10 10 3.450916843524926 22.164676818210072 0.0 3 0.9680022420456934 6.880780501245752 6154.0 15.559165623634735 1.0 - - - - - - - 215.0909090909091 12 11 USP2 ubiquitin specific peptidase 2 1325 170 C20140403_SF097_05 C20140403_SF097_05 TB148691.[MT7]-GAC[CAM]PVFEC[CAM]GNVVLR.2y8_1.heavy 861.433 / 946.477 6238.0 34.57357597351074 43 18 10 5 10 9.216634016166106 10.849948020567876 0.04650115966796875 3 0.988798679450972 11.649882162879955 6238.0 79.39272727272727 0.0 - - - - - - - 209.0 12 9 HAVCR2 hepatitis A virus cellular receptor 2 1327 170 C20140403_SF097_05 C20140403_SF097_05 TB148691.[MT7]-GAC[CAM]PVFEC[CAM]GNVVLR.2y9_1.heavy 861.433 / 1093.55 12873.0 34.57357597351074 43 18 10 5 10 9.216634016166106 10.849948020567876 0.04650115966796875 3 0.988798679450972 11.649882162879955 12873.0 102.72393939393939 0.0 - - - - - - - 222.75 25 12 HAVCR2 hepatitis A virus cellular receptor 2 1329 170 C20140403_SF097_05 C20140403_SF097_05 TB148691.[MT7]-GAC[CAM]PVFEC[CAM]GNVVLR.2b5_1.heavy 861.433 / 629.32 5149.0 34.57357597351074 43 18 10 5 10 9.216634016166106 10.849948020567876 0.04650115966796875 3 0.988798679450972 11.649882162879955 5149.0 27.30530303030303 0.0 - - - - - - - 225.0 10 11 HAVCR2 hepatitis A virus cellular receptor 2 1331 170 C20140403_SF097_05 C20140403_SF097_05 TB148691.[MT7]-GAC[CAM]PVFEC[CAM]GNVVLR.2y7_1.heavy 861.433 / 817.435 5050.0 34.57357597351074 43 18 10 5 10 9.216634016166106 10.849948020567876 0.04650115966796875 3 0.988798679450972 11.649882162879955 5050.0 10.202020202020202 1.0 - - - - - - - 316.8 11 15 HAVCR2 hepatitis A virus cellular receptor 2 1333 171 C20140403_SF097_05 C20140403_SF097_05 TB346330.[MT7]-SAVGNAAHTSDR.3b6_1.heavy 443.892 / 644.348 8137.0 13.447600364685059 44 14 10 10 10 2.345906268318968 34.83218535757602 0.0 3 0.9340142760625906 4.777710681138441 8137.0 69.26532698002715 0.0 - - - - - - - 132.07692307692307 16 26 BCAR1 breast cancer anti-estrogen resistance 1 1335 171 C20140403_SF097_05 C20140403_SF097_05 TB346330.[MT7]-SAVGNAAHTSDR.3b4_1.heavy 443.892 / 459.268 4434.0 13.447600364685059 44 14 10 10 10 2.345906268318968 34.83218535757602 0.0 3 0.9340142760625906 4.777710681138441 4434.0 7.781501133380662 1.0 - - - - - - - 219.34782608695653 12 23 BCAR1 breast cancer anti-estrogen resistance 1 1337 171 C20140403_SF097_05 C20140403_SF097_05 TB346330.[MT7]-SAVGNAAHTSDR.3b5_1.heavy 443.892 / 573.311 14300.0 13.447600364685059 44 14 10 10 10 2.345906268318968 34.83218535757602 0.0 3 0.9340142760625906 4.777710681138441 14300.0 65.73301349006833 0.0 - - - - - - - 179.55555555555554 28 27 BCAR1 breast cancer anti-estrogen resistance 1 1339 171 C20140403_SF097_05 C20140403_SF097_05 TB346330.[MT7]-SAVGNAAHTSDR.3y5_1.heavy 443.892 / 615.284 11645.0 13.447600364685059 44 14 10 10 10 2.345906268318968 34.83218535757602 0.0 3 0.9340142760625906 4.777710681138441 11645.0 43.84769933263084 0.0 - - - - - - - 162.71428571428572 23 28 BCAR1 breast cancer anti-estrogen resistance 1 1341 172 C20140403_SF097_05 C20140403_SF097_05 TB148041.[MT7]-DPSAIGK[MT7].2y4_1.heavy 488.289 / 532.357 2581.0 18.960350036621094 40 17 10 3 10 2.8297720184295447 35.338535878059034 0.05989837646484375 3 0.9767295845516495 8.074478839517779 2581.0 18.481451744820067 0.0 - - - - - - - 188.3846153846154 5 26 CASP6 caspase 6, apoptosis-related cysteine peptidase 1343 172 C20140403_SF097_05 C20140403_SF097_05 TB148041.[MT7]-DPSAIGK[MT7].2y5_1.heavy 488.289 / 619.39 1197.0 18.960350036621094 40 17 10 3 10 2.8297720184295447 35.338535878059034 0.05989837646484375 3 0.9767295845516495 8.074478839517779 1197.0 9.88325668896321 1.0 - - - - - - - 152.21428571428572 2 28 CASP6 caspase 6, apoptosis-related cysteine peptidase 1345 172 C20140403_SF097_05 C20140403_SF097_05 TB148041.[MT7]-DPSAIGK[MT7].2b4_1.heavy 488.289 / 515.258 2469.0 18.960350036621094 40 17 10 3 10 2.8297720184295447 35.338535878059034 0.05989837646484375 3 0.9767295845516495 8.074478839517779 2469.0 16.957870989304812 0.0 - - - - - - - 189.96 4 25 CASP6 caspase 6, apoptosis-related cysteine peptidase 1347 172 C20140403_SF097_05 C20140403_SF097_05 TB148041.[MT7]-DPSAIGK[MT7].2y6_1.heavy 488.289 / 716.442 7818.0 18.960350036621094 40 17 10 3 10 2.8297720184295447 35.338535878059034 0.05989837646484375 3 0.9767295845516495 8.074478839517779 7818.0 83.29537622682662 0.0 - - - - - - - 118.12 15 25 CASP6 caspase 6, apoptosis-related cysteine peptidase 1349 173 C20140403_SF097_05 C20140403_SF097_05 TB148362.[MT7]-YTLWETGK[MT7].2y4_1.heavy 643.355 / 578.327 979.0 33.16775131225586 41 16 10 5 10 2.2019448107511477 37.400246927791336 0.0420989990234375 3 0.9639063163353351 6.4763716208809585 979.0 8.59122448979592 1.0 - - - - - - - 0.0 1 0 USP2 ubiquitin specific peptidase 2 1351 173 C20140403_SF097_05 C20140403_SF097_05 TB148362.[MT7]-YTLWETGK[MT7].2b3_1.heavy 643.355 / 522.304 881.0 33.16775131225586 41 16 10 5 10 2.2019448107511477 37.400246927791336 0.0420989990234375 3 0.9639063163353351 6.4763716208809585 881.0 12.57672448979592 0.0 - - - - - - - 0.0 1 0 USP2 ubiquitin specific peptidase 2 1353 173 C20140403_SF097_05 C20140403_SF097_05 TB148362.[MT7]-YTLWETGK[MT7].2y5_1.heavy 643.355 / 764.406 1174.0 33.16775131225586 41 16 10 5 10 2.2019448107511477 37.400246927791336 0.0420989990234375 3 0.9639063163353351 6.4763716208809585 1174.0 8.543042173391095 0.0 - - - - - - - 171.375 2 8 USP2 ubiquitin specific peptidase 2 1355 173 C20140403_SF097_05 C20140403_SF097_05 TB148362.[MT7]-YTLWETGK[MT7].2y7_1.heavy 643.355 / 978.538 1077.0 33.16775131225586 41 16 10 5 10 2.2019448107511477 37.400246927791336 0.0420989990234375 3 0.9639063163353351 6.4763716208809585 1077.0 11.100592838362338 0.0 - - - - - - - 232.5 2 8 USP2 ubiquitin specific peptidase 2 1357 174 C20140403_SF097_05 C20140403_SF097_05 TB148612.[MT7]-YYEVLTAPITK[MT7].3y3_1.heavy 529.307 / 505.347 4153.0 37.032225608825684 39 13 10 6 10 1.18334517050619 56.337464611571626 0.034702301025390625 3 0.9194546618900682 4.318999020633451 4153.0 47.96422535211268 0.0 - - - - - - - 151.9 8 10 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1359 174 C20140403_SF097_05 C20140403_SF097_05 TB148612.[MT7]-YYEVLTAPITK[MT7].3b4_1.heavy 529.307 / 699.347 7986.0 37.032225608825684 39 13 10 6 10 1.18334517050619 56.337464611571626 0.034702301025390625 3 0.9194546618900682 4.318999020633451 7986.0 46.647586206896555 0.0 - - - - - - - 209.0 15 13 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1361 174 C20140403_SF097_05 C20140403_SF097_05 TB148612.[MT7]-YYEVLTAPITK[MT7].3y4_1.heavy 529.307 / 602.399 11659.0 37.032225608825684 39 13 10 6 10 1.18334517050619 56.337464611571626 0.034702301025390625 3 0.9194546618900682 4.318999020633451 11659.0 99.92155897335424 0.0 - - - - - - - 210.63636363636363 23 11 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1363 174 C20140403_SF097_05 C20140403_SF097_05 TB148612.[MT7]-YYEVLTAPITK[MT7].3b3_1.heavy 529.307 / 600.279 6708.0 37.032225608825684 39 13 10 6 10 1.18334517050619 56.337464611571626 0.034702301025390625 3 0.9194546618900682 4.318999020633451 6708.0 92.794 0.0 - - - - - - - 152.63636363636363 13 11 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1365 175 C20140403_SF097_05 C20140403_SF097_05 TB147969.[MT7]-GAFISK[MT7].2y4_1.heavy 455.784 / 638.399 9444.0 24.127700805664062 47 17 10 10 10 2.7844507429977745 35.913725624874495 0.0 3 0.9703133741646672 7.144990567870749 9444.0 25.128965034965034 0.0 - - - - - - - 702.3636363636364 18 11 CD38 CD38 molecule 1367 175 C20140403_SF097_05 C20140403_SF097_05 TB147969.[MT7]-GAFISK[MT7].2y5_1.heavy 455.784 / 709.437 5151.0 24.127700805664062 47 17 10 10 10 2.7844507429977745 35.913725624874495 0.0 3 0.9703133741646672 7.144990567870749 5151.0 25.46273397261421 0.0 - - - - - - - 221.1818181818182 10 11 CD38 CD38 molecule 1369 175 C20140403_SF097_05 C20140403_SF097_05 TB147969.[MT7]-GAFISK[MT7].2b4_1.heavy 455.784 / 533.32 7083.0 24.127700805664062 47 17 10 10 10 2.7844507429977745 35.913725624874495 0.0 3 0.9703133741646672 7.144990567870749 7083.0 22.360936979188473 0.0 - - - - - - - 654.0 14 7 CD38 CD38 molecule 1371 175 C20140403_SF097_05 C20140403_SF097_05 TB147969.[MT7]-GAFISK[MT7].2y3_1.heavy 455.784 / 491.331 10374.0 24.127700805664062 47 17 10 10 10 2.7844507429977745 35.913725624874495 0.0 3 0.9703133741646672 7.144990567870749 10374.0 21.432450592885374 0.0 - - - - - - - 629.5 20 10 CD38 CD38 molecule 1373 176 C20140403_SF097_05 C20140403_SF097_05 TB148892.[MT7]-NLGNTC[CAM]FMNSILQC[CAM]LSNTR.3y7_1.heavy 796.384 / 878.415 4510.0 48.773799896240234 44 14 10 10 10 2.7326397944941214 30.649727000897983 0.0 3 0.9384872589643738 4.9502606785942715 4510.0 47.11564245810056 0.0 - - - - - - - 149.8235294117647 9 17 USP2 ubiquitin specific peptidase 2 1375 176 C20140403_SF097_05 C20140403_SF097_05 TB148892.[MT7]-NLGNTC[CAM]FMNSILQC[CAM]LSNTR.3b6_1.heavy 796.384 / 804.379 1563.0 48.773799896240234 44 14 10 10 10 2.7326397944941214 30.649727000897983 0.0 3 0.9384872589643738 4.9502606785942715 1563.0 2.527238805970149 1.0 - - - - - - - 165.52941176470588 3 17 USP2 ubiquitin specific peptidase 2 1377 176 C20140403_SF097_05 C20140403_SF097_05 TB148892.[MT7]-NLGNTC[CAM]FMNSILQC[CAM]LSNTR.3b4_1.heavy 796.384 / 543.301 3126.0 48.773799896240234 44 14 10 10 10 2.7326397944941214 30.649727000897983 0.0 3 0.9384872589643738 4.9502606785942715 3126.0 11.61064899534912 1.0 - - - - - - - 304.8235294117647 6 17 USP2 ubiquitin specific peptidase 2 1379 176 C20140403_SF097_05 C20140403_SF097_05 TB148892.[MT7]-NLGNTC[CAM]FMNSILQC[CAM]LSNTR.3y8_1.heavy 796.384 / 991.499 9645.0 48.773799896240234 44 14 10 10 10 2.7326397944941214 30.649727000897983 0.0 3 0.9384872589643738 4.9502606785942715 9645.0 36.47751302213763 0.0 - - - - - - - 215.47058823529412 19 17 USP2 ubiquitin specific peptidase 2 1381 177 C20140403_SF097_05 C20140403_SF097_05 TB148699.[MT7]-ILQEDPTNTAARK[MT7].3y8_1.heavy 582.331 / 1002.58 2286.0 23.568833033243816 44 18 10 6 10 3.908311350767405 25.58649785676998 0.0391998291015625 3 0.9856592743524283 10.29334260026442 2286.0 44.31136065060995 0.0 - - - - - - - 110.8 4 5 TTC35 tetratricopeptide repeat domain 35 1383 177 C20140403_SF097_05 C20140403_SF097_05 TB148699.[MT7]-ILQEDPTNTAARK[MT7].3y6_1.heavy 582.331 / 804.481 N/A 23.568833033243816 44 18 10 6 10 3.908311350767405 25.58649785676998 0.0391998291015625 3 0.9856592743524283 10.29334260026442 208.0 3.0144927536231885 2.0 - - - - - - - 0.0 0 0 TTC35 tetratricopeptide repeat domain 35 1385 177 C20140403_SF097_05 C20140403_SF097_05 TB148699.[MT7]-ILQEDPTNTAARK[MT7].3y8_2.heavy 582.331 / 501.794 2840.0 23.568833033243816 44 18 10 6 10 3.908311350767405 25.58649785676998 0.0391998291015625 3 0.9856592743524283 10.29334260026442 2840.0 28.55913115661317 0.0 - - - - - - - 173.5 5 6 TTC35 tetratricopeptide repeat domain 35 1387 177 C20140403_SF097_05 C20140403_SF097_05 TB148699.[MT7]-ILQEDPTNTAARK[MT7].3b5_1.heavy 582.331 / 743.406 1177.0 23.568833033243816 44 18 10 6 10 3.908311350767405 25.58649785676998 0.0391998291015625 3 0.9856592743524283 10.29334260026442 1177.0 23.811332186424774 0.0 - - - - - - - 97.0 2 5 TTC35 tetratricopeptide repeat domain 35 1389 178 C20140403_SF097_05 C20140403_SF097_05 TB148697.[MT7]-DC[CAM]SNNPVSVFWK[MT7].3y3_1.heavy 580.959 / 624.363 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 1391 178 C20140403_SF097_05 C20140403_SF097_05 TB148697.[MT7]-DC[CAM]SNNPVSVFWK[MT7].3b4_1.heavy 580.959 / 621.242 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 1393 178 C20140403_SF097_05 C20140403_SF097_05 TB148697.[MT7]-DC[CAM]SNNPVSVFWK[MT7].3b5_1.heavy 580.959 / 735.285 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 1395 178 C20140403_SF097_05 C20140403_SF097_05 TB148697.[MT7]-DC[CAM]SNNPVSVFWK[MT7].3y5_1.heavy 580.959 / 810.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD38 CD38 molecule 1397 179 C20140403_SF097_05 C20140403_SF097_05 TB148804.[MT7]-EGLETAISC[CAM]PDAAC[CAM]PK[MT7].3y7_1.heavy 669.664 / 902.452 2334.0 28.98925018310547 41 14 10 7 10 2.9553018645292615 33.83749091767606 0.02339935302734375 3 0.9467901136400445 5.326248291403214 2334.0 8.388140161725069 0.0 - - - - - - - 124.70588235294117 4 17 RNF144A ring finger protein 144A 1399 179 C20140403_SF097_05 C20140403_SF097_05 TB148804.[MT7]-EGLETAISC[CAM]PDAAC[CAM]PK[MT7].3b6_1.heavy 669.664 / 745.385 2493.0 28.98925018310547 41 14 10 7 10 2.9553018645292615 33.83749091767606 0.02339935302734375 3 0.9467901136400445 5.326248291403214 2493.0 51.741509433962264 0.0 - - - - - - - 143.1 4 20 RNF144A ring finger protein 144A 1401 179 C20140403_SF097_05 C20140403_SF097_05 TB148804.[MT7]-EGLETAISC[CAM]PDAAC[CAM]PK[MT7].3b4_1.heavy 669.664 / 573.3 1379.0 28.98925018310547 41 14 10 7 10 2.9553018645292615 33.83749091767606 0.02339935302734375 3 0.9467901136400445 5.326248291403214 1379.0 7.285283018867924 0.0 - - - - - - - 162.92592592592592 2 27 RNF144A ring finger protein 144A 1403 179 C20140403_SF097_05 C20140403_SF097_05 TB148804.[MT7]-EGLETAISC[CAM]PDAAC[CAM]PK[MT7].3b5_1.heavy 669.664 / 674.348 2493.0 28.98925018310547 41 14 10 7 10 2.9553018645292615 33.83749091767606 0.02339935302734375 3 0.9467901136400445 5.326248291403214 2493.0 24.694811320754713 0.0 - - - - - - - 173.72222222222223 4 18 RNF144A ring finger protein 144A 1405 180 C20140403_SF097_05 C20140403_SF097_05 TB148806.[MT7]-ASSSLAGAAC[CAM]APLFALLSR.2y10_1.heavy 1004.04 / 1147.63 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 1407 180 C20140403_SF097_05 C20140403_SF097_05 TB148806.[MT7]-ASSSLAGAAC[CAM]APLFALLSR.2b7_1.heavy 1004.04 / 718.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 1409 180 C20140403_SF097_05 C20140403_SF097_05 TB148806.[MT7]-ASSSLAGAAC[CAM]APLFALLSR.2b5_1.heavy 1004.04 / 590.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 1411 180 C20140403_SF097_05 C20140403_SF097_05 TB148806.[MT7]-ASSSLAGAAC[CAM]APLFALLSR.2y11_1.heavy 1004.04 / 1218.67 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 1413 181 C20140403_SF097_05 C20140403_SF097_05 TB148805.[MT7]-ASSSLAGAAC[CAM]APLFALLSR.3y6_1.heavy 669.699 / 706.425 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 1415 181 C20140403_SF097_05 C20140403_SF097_05 TB148805.[MT7]-ASSSLAGAAC[CAM]APLFALLSR.3b5_1.heavy 669.699 / 590.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 1417 181 C20140403_SF097_05 C20140403_SF097_05 TB148805.[MT7]-ASSSLAGAAC[CAM]APLFALLSR.3y8_1.heavy 669.699 / 916.562 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 1419 181 C20140403_SF097_05 C20140403_SF097_05 TB148805.[MT7]-ASSSLAGAAC[CAM]APLFALLSR.3b7_1.heavy 669.699 / 718.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - HS6ST2 heparan sulfate 6-O-sulfotransferase 2 1421 182 C20140403_SF097_05 C20140403_SF097_05 TB148045.[MT7]-ISQLDTR.2y5_1.heavy 488.781 / 632.336 2680.0 23.245975017547607 38 12 10 6 10 1.4991017342691908 39.39155637032029 0.03709983825683594 3 0.8901202982458752 3.6884536414234486 2680.0 31.299270072992698 1.0 - - - - - - - 178.66666666666666 18 15 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1423 182 C20140403_SF097_05 C20140403_SF097_05 TB148045.[MT7]-ISQLDTR.2b4_1.heavy 488.781 / 586.368 6460.0 23.245975017547607 38 12 10 6 10 1.4991017342691908 39.39155637032029 0.03709983825683594 3 0.8901202982458752 3.6884536414234486 6460.0 22.333468667255076 0.0 - - - - - - - 270.2 12 15 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1425 182 C20140403_SF097_05 C20140403_SF097_05 TB148045.[MT7]-ISQLDTR.2y6_1.heavy 488.781 / 719.368 19587.0 23.245975017547607 38 12 10 6 10 1.4991017342691908 39.39155637032029 0.03709983825683594 3 0.8901202982458752 3.6884536414234486 19587.0 117.85471203162005 0.0 - - - - - - - 216.6153846153846 39 13 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1427 182 C20140403_SF097_05 C20140403_SF097_05 TB148045.[MT7]-ISQLDTR.2b5_1.heavy 488.781 / 701.395 52369.0 23.245975017547607 38 12 10 6 10 1.4991017342691908 39.39155637032029 0.03709983825683594 3 0.8901202982458752 3.6884536414234486 52369.0 162.91813025536663 0.0 - - - - - - - 284.0 104 15 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1429 183 C20140403_SF097_05 C20140403_SF097_05 TB148692.[MT7]-GRPLLRPDITGGGK[MT7].4y5_1.heavy 432.015 / 563.327 26442.0 24.365100860595703 50 20 10 10 10 6.884301906291715 14.525801070491664 0.0 3 0.9958408248862294 19.129698549240402 26442.0 113.10272727272726 0.0 - - - - - - - 679.0 52 8 USP2 ubiquitin specific peptidase 2 1431 183 C20140403_SF097_05 C20140403_SF097_05 TB148692.[MT7]-GRPLLRPDITGGGK[MT7].4y4_1.heavy 432.015 / 462.279 114843.0 24.365100860595703 50 20 10 10 10 6.884301906291715 14.525801070491664 0.0 3 0.9958408248862294 19.129698549240402 114843.0 432.50308867602985 0.0 - - - - - - - 240.1818181818182 229 11 USP2 ubiquitin specific peptidase 2 1433 183 C20140403_SF097_05 C20140403_SF097_05 TB148692.[MT7]-GRPLLRPDITGGGK[MT7].4b8_2.heavy 432.015 / 525.32 45737.0 24.365100860595703 50 20 10 10 10 6.884301906291715 14.525801070491664 0.0 3 0.9958408248862294 19.129698549240402 45737.0 89.68658608880831 0.0 - - - - - - - 280.3076923076923 91 13 USP2 ubiquitin specific peptidase 2 1435 183 C20140403_SF097_05 C20140403_SF097_05 TB148692.[MT7]-GRPLLRPDITGGGK[MT7].4y6_1.heavy 432.015 / 676.411 17938.0 24.365100860595703 50 20 10 10 10 6.884301906291715 14.525801070491664 0.0 3 0.9958408248862294 19.129698549240402 17938.0 81.41092307692308 0.0 - - - - - - - 214.21428571428572 35 14 USP2 ubiquitin specific peptidase 2 1437 184 C20140403_SF097_05 C20140403_SF097_05 TB148754.[MT7]-TLLHLAVSLGHLESAR.3y7_1.heavy 621.031 / 769.395 761.0 40.25877380371094 43 17 10 6 10 2.3855112974835833 28.394810265448324 0.0364990234375 3 0.9747427921188678 7.749101494982646 761.0 15.052432275822106 0.0 - - - - - - - 0.0 1 0 ANKRD13A ankyrin repeat domain 13A 1439 184 C20140403_SF097_05 C20140403_SF097_05 TB148754.[MT7]-TLLHLAVSLGHLESAR.3y11_1.heavy 621.031 / 1139.62 585.0 40.25877380371094 43 17 10 6 10 2.3855112974835833 28.394810265448324 0.0364990234375 3 0.9747427921188678 7.749101494982646 585.0 7.466101694915254 0.0 - - - - - - - 0.0 1 0 ANKRD13A ankyrin repeat domain 13A 1441 184 C20140403_SF097_05 C20140403_SF097_05 TB148754.[MT7]-TLLHLAVSLGHLESAR.3b4_1.heavy 621.031 / 609.384 819.0 40.25877380371094 43 17 10 6 10 2.3855112974835833 28.394810265448324 0.0364990234375 3 0.9747427921188678 7.749101494982646 819.0 17.67084745762712 0.0 - - - - - - - 0.0 1 0 ANKRD13A ankyrin repeat domain 13A 1443 184 C20140403_SF097_05 C20140403_SF097_05 TB148754.[MT7]-TLLHLAVSLGHLESAR.3y9_1.heavy 621.031 / 969.511 1170.0 40.25877380371094 43 17 10 6 10 2.3855112974835833 28.394810265448324 0.0364990234375 3 0.9747427921188678 7.749101494982646 1170.0 24.847457627118644 0.0 - - - - - - - 104.33333333333333 2 9 ANKRD13A ankyrin repeat domain 13A 1445 185 C20140403_SF097_05 C20140403_SF097_05 TB148753.[MT7]-TLLHLAVSLGHLESAR.4y7_1.heavy 466.025 / 769.395 12851.0 40.25573221842448 46 20 10 6 10 10.414007105095672 9.602451677901108 0.0364990234375 3 0.9976695353398145 25.559757587529056 12851.0 323.4963709106985 0.0 - - - - - - - 107.0 25 6 ANKRD13A ankyrin repeat domain 13A 1447 185 C20140403_SF097_05 C20140403_SF097_05 TB148753.[MT7]-TLLHLAVSLGHLESAR.4y9_1.heavy 466.025 / 969.511 N/A 40.25573221842448 46 20 10 6 10 10.414007105095672 9.602451677901108 0.0364990234375 3 0.9976695353398145 25.559757587529056 58.0 1.1982905982905983 3.0 - - - - - - - 0.0 0 0 ANKRD13A ankyrin repeat domain 13A 1449 185 C20140403_SF097_05 C20140403_SF097_05 TB148753.[MT7]-TLLHLAVSLGHLESAR.4b3_1.heavy 466.025 / 472.325 31777.0 40.25573221842448 46 20 10 6 10 10.414007105095672 9.602451677901108 0.0364990234375 3 0.9976695353398145 25.559757587529056 31777.0 292.4146253366116 0.0 - - - - - - - 171.5 63 16 ANKRD13A ankyrin repeat domain 13A 1451 185 C20140403_SF097_05 C20140403_SF097_05 TB148753.[MT7]-TLLHLAVSLGHLESAR.4b4_1.heavy 466.025 / 609.384 13026.0 40.25573221842448 46 20 10 6 10 10.414007105095672 9.602451677901108 0.0364990234375 3 0.9976695353398145 25.559757587529056 13026.0 254.4542528735632 0.0 - - - - - - - 153.8181818181818 26 11 ANKRD13A ankyrin repeat domain 13A 1453 186 C20140403_SF097_05 C20140403_SF097_05 TB147892.[MT7]-NVEAIR.2b3_1.heavy 423.252 / 487.263 27758.0 19.812000274658203 47 17 10 10 10 3.3441346747702854 29.903101915854865 0.0 3 0.9789279264564387 8.486783940636101 27758.0 76.5524347107438 0.0 - - - - - - - 729.6666666666666 55 12 TTC35 tetratricopeptide repeat domain 35 1455 186 C20140403_SF097_05 C20140403_SF097_05 TB147892.[MT7]-NVEAIR.2y5_1.heavy 423.252 / 587.351 47993.0 19.812000274658203 47 17 10 10 10 3.3441346747702854 29.903101915854865 0.0 3 0.9789279264564387 8.486783940636101 47993.0 390.94776315789466 0.0 - - - - - - - 236.21052631578948 95 19 TTC35 tetratricopeptide repeat domain 35 1457 186 C20140403_SF097_05 C20140403_SF097_05 TB147892.[MT7]-NVEAIR.2b4_1.heavy 423.252 / 558.3 53228.0 19.812000274658203 47 17 10 10 10 3.3441346747702854 29.903101915854865 0.0 3 0.9789279264564387 8.486783940636101 53228.0 124.27198347107438 0.0 - - - - - - - 766.3333333333334 106 12 TTC35 tetratricopeptide repeat domain 35 1459 186 C20140403_SF097_05 C20140403_SF097_05 TB147892.[MT7]-NVEAIR.2b5_1.heavy 423.252 / 671.385 7874.0 19.812000274658203 47 17 10 10 10 3.3441346747702854 29.903101915854865 0.0 3 0.9789279264564387 8.486783940636101 7874.0 21.387250554323728 1.0 - - - - - - - 700.0 15 11 TTC35 tetratricopeptide repeat domain 35 1461 187 C20140403_SF097_05 C20140403_SF097_05 TNAA_ECO24.GLTFTYEPK.2y7.peptide 528.27 / 885.44 55590.0 31.318500518798828 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 55590.0 640.7204225352112 0.0 - - - - - - - 116.18181818181819 111 11 1463 187 C20140403_SF097_05 C20140403_SF097_05 TNAA_ECO24.GLTFTYEPK.2y6.peptide 528.27 / 784.39 62059.0 31.318500518798828 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 62059.0 273.108744521749 0.0 - - - - - - - 234.5 124 10 1465 187 C20140403_SF097_05 C20140403_SF097_05 TNAA_ECO24.GLTFTYEPK.2y5.peptide 528.27 / 637.32 114450.0 31.318500518798828 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 114450.0 1693.8484564677062 0.0 - - - - - - - 284.25 228 4 1467 188 C20140403_SF097_05 C20140403_SF097_05 TB346283.[MT7]-QIAQFSQK[MT7].2b4_1.heavy 619.361 / 585.348 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1469 188 C20140403_SF097_05 C20140403_SF097_05 TB346283.[MT7]-QIAQFSQK[MT7].2y3_1.heavy 619.361 / 506.306 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1471 188 C20140403_SF097_05 C20140403_SF097_05 TB346283.[MT7]-QIAQFSQK[MT7].2y6_1.heavy 619.361 / 852.47 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1473 188 C20140403_SF097_05 C20140403_SF097_05 TB346283.[MT7]-QIAQFSQK[MT7].2y7_1.heavy 619.361 / 965.554 N/A N/A - - - - - - - - - 0.0 - - - - - - - PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1475 189 C20140403_SF097_05 C20140403_SF097_05 TB480557.[MT7]-MVLSNTSPQITFLK[MT7].3y3_1.heavy 623.025 / 551.367 681.0 39.6265983581543 50 20 10 10 10 7.2830432945443535 13.73052389718854 0.0 3 0.9950188776772269 17.479070280742686 681.0 9.885483870967741 2.0 - - - - - - - 0.0 1 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1477 189 C20140403_SF097_05 C20140403_SF097_05 TB480557.[MT7]-MVLSNTSPQITFLK[MT7].3y5_1.heavy 623.025 / 765.499 681.0 39.6265983581543 50 20 10 10 10 7.2830432945443535 13.73052389718854 0.0 3 0.9950188776772269 17.479070280742686 681.0 10.654354838709677 0.0 - - - - - - - 0.0 1 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1479 189 C20140403_SF097_05 C20140403_SF097_05 TB480557.[MT7]-MVLSNTSPQITFLK[MT7].3b5_1.heavy 623.025 / 689.377 557.0 39.6265983581543 50 20 10 10 10 7.2830432945443535 13.73052389718854 0.0 3 0.9950188776772269 17.479070280742686 557.0 6.797795698924732 0.0 - - - - - - - 0.0 1 0 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1481 189 C20140403_SF097_05 C20140403_SF097_05 TB480557.[MT7]-MVLSNTSPQITFLK[MT7].3y4_1.heavy 623.025 / 652.415 1176.0 39.6265983581543 50 20 10 10 10 7.2830432945443535 13.73052389718854 0.0 3 0.9950188776772269 17.479070280742686 1176.0 21.338709677419356 0.0 - - - - - - - 108.5 2 12 PYROXD2 pyridine nucleotide-disulphide oxidoreductase domain 2 1483 190 C20140403_SF097_05 C20140403_SF097_05 TB346339.[MT7]-LTTFVNFPLR.2y8_1.heavy 676.396 / 993.552 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 1485 190 C20140403_SF097_05 C20140403_SF097_05 TB346339.[MT7]-LTTFVNFPLR.2b4_1.heavy 676.396 / 607.357 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 1487 190 C20140403_SF097_05 C20140403_SF097_05 TB346339.[MT7]-LTTFVNFPLR.2y9_1.heavy 676.396 / 1094.6 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 1489 190 C20140403_SF097_05 C20140403_SF097_05 TB346339.[MT7]-LTTFVNFPLR.2y6_1.heavy 676.396 / 745.435 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP2 ubiquitin specific peptidase 2 1491 191 C20140403_SF097_05 C20140403_SF097_05 TB346581.[MT7]-RLGALVMFPLQMIYLVVK[MT7].4b8_1.heavy 595.612 / 1032.61 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 1493 191 C20140403_SF097_05 C20140403_SF097_05 TB346581.[MT7]-RLGALVMFPLQMIYLVVK[MT7].4b8_2.heavy 595.612 / 516.811 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 1495 191 C20140403_SF097_05 C20140403_SF097_05 TB346581.[MT7]-RLGALVMFPLQMIYLVVK[MT7].4b7_1.heavy 595.612 / 885.546 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3 1497 191 C20140403_SF097_05 C20140403_SF097_05 TB346581.[MT7]-RLGALVMFPLQMIYLVVK[MT7].4b6_1.heavy 595.612 / 754.506 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHRS3 dehydrogenase/reductase (SDR family) member 3